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ABSTRACT 
The metabolome is the end product of all biochemical reactions in the body and 
is sensitive to external perturbations, such as diet, genetics, sex, disease, and 
environment. Understanding the dynamic relationship between metabolites and external 
inputs is key to delineating the metabolic underpinnings of disease. Mass-spectrometry 
based metabolomics provides a means through which the metabolome can be 
systemically and systematically profiled to discern alterations across thousands of 
metabolites at a time. The research in this dissertation characterized the effects of diet, 
genetics, and sex on the tissue metabolome. Adipose, skeletal muscle, and liver tissue 
were chosen due to their role in energy metabolism. In the first study, we characterized 
the effects of five diets (Japanese, ketogenic, Mediterranean, American, and standard 
chow) on the tissue metabolome, across both sexes. This study described the metabolic 
response to diets that altered in macronutrient ratio and composition, independent of 
genetic differences. Our results revealed that liver tissue was most sensitive to 
metabolic changes but responded similarly for diet, sex, and sex-by-diet interaction 
while adipose and muscle remained largely stable. In the second study, we 
characterized the effects of four strains (A/J, C57BL/6J, FVB/NJ, and NOD/ShiLtJ) on 
the tissue metabolome, across both sexes. This study assessed the metabolic response 
to differing genetic backgrounds represented by various predispositions to metabolic 
disease, independent of diet. Our results showed that strain exerted the largest effect 
on metabolites across all three tissues. In contrast, sex and sex-by-strain interaction 
had little effect on adipose, muscle, and liver. The third study characterized the effects 
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of diet, genetics, and sex on the tissue metabolome. We assessed the metabolic 
response to diet, genetics, sex, and their interactions to determine which factor/s were 
potentially driving metabolic differences. Strain exerted the largest effect across all 
tissues. Liver was most sensitive to metabolite changes when all factors and 
interactions were collectively assessed. Overall, the results in this dissertation aid in the 
understanding of complex relationships between diet, genetics, and sex at the systems-
level. Furthermore, it was shown that tissues responded differentially to the same stimuli 
highlighting the need to consider sample type when performing metabolomics. 
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CHAPTER ONE  
GENERAL EXPERIMENTAL DESIGN 
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The goal of this dissertation was to identify “metabotypes”, phenotypes defined 
by distinct strain- and diet-dependent metabolite profiles, which could be linked to 
systems’ phenotypes relevant to metabolic disease.  
 Little is known about the metabolic response to whole diets at the tissue level 
and even less is known about how genetic background intersects with diet to alter these 
responses. Metabolomics is an analytical tool that allows us to obtain relative 
abundances of individual metabolites within whole tissue or cells. It allows us to identify 
how metabolism is affected on a systems level. 
 This project is part of a larger project designed to identify how gene by diet 
interactions affect colon tumor initiation.  The first phase of the project assessed how 
gene by diet interaction affected physiology in the absence of tumors. This study 
focused on the identification of metabolites during the first phase of the project. 
 Males and females across four strains of mice (A/J, C57Bl/6J, NOD, and FVB) 
were fed one of five diets (Japanese, Mediterranean, ketogenic, American, and 
standard chow) for 7 months. These mice were chosen due to their varying 
susceptibility to azoxymethane, a chemical carcinogen; however, these mice also have 
altering susceptibilities to metabolic disease. Mice were fed diets as libitum for 12 
weeks, to acclimate to the diets, prior to metabolic testing. During metabolic testing 
mice were placed in metabolic chambers to measure respiratory exchange rate, oxygen 
consumption, activity levels, and heat output. 
 The research in this dissertation measured thousands of metabolites within 
adipose, muscle, and liver tissue across multiple diets and genetic backgrounds for both 
sexes with the aim of understanding how all three factors intersect to modify the tissue 
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metabolome. The objectives of this study were: 1. Characterize the relative effects of 
genetics, sex, diet, and their interactions on tissue metabolomes, 2. Identify tissue-level 
metabolic effects of diets that are commonly recommended for health, and 3. Link tissue 
metabolite profiles to systems phenotypes relevant to metabolic syndrome. 
 Chapter 3 will provide the bioinformatics approach designed to deal with tissue 
metabolomics, including experimental procedure, sample preparation, and statistical 
procedures. Chapter 4 will characterize the effects of diet and sex on a single genetic 
background in adipose, skeletal muscle, and liver tissue. Chapter 5 will characterize the 
effect of strain and sex on the tissue metabolome when mice were fed a single diet. 
Chapter 6 will characterize the effects diet, genetics, and sex on the tissue metabolome. 
Chapter 7 will conclude the research presented in this dissertation and provide future 
directions.
  4 
CHAPTER TWO  
METABOLOMICS AND ITS ROLE IN DISSECTING SYSTEMS-LEVEL 
EFFECTS OF DIET, GENETICS, AND SEX 
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2.1 Energy Balance and Diet 
More than two-thirds of the United States (U.S.) population is classified as 
overweight or obese [1-3]. Obesity is associated with the comorbidities type 2 diabetes, 
hypertension, heart disease, and certain cancers [4]. In addition, obesity is the 5th 
leading cause of death worldwide [3]. Obesity and its comorbidities are an economic 
burden. As of 2008, the estimated annual cost of obesity in the U.S. was $147 billion [5].  
Obesity is traditionally accepted as the physiological response to excess caloric 
intake and low physical activity. Despite a large body of research investigating the 
relationship between obesity and diet and lifestyle interventions, no clear relationship 
has been elucidated. Current recommendations encourage individuals to increase their 
physical activity [6] and to consume a healthy eating pattern [7]. According to the 
Dietary Guidelines for Americans a healthy eating pattern consists of a variety of 
vegetables, fruits, grains, fat-free or low-fat dairy, a range of proteins consisting of lean 
meats, eggs, legumes, and seafood, and oils with limited consumption of saturated fats, 
sugar, and sodium [7]. Caloric intake is also considered important to maintaining a 
healthy lifestyle, in addition to the types of food consumed. Caloric intake for an 
individual is dependent on a number of factors; activity level, age, weight, sex, and 
height [8]. The aim of a healthy eating pattern and limiting caloric intake is to modulate 
energy metabolism. Energy metabolism at the cellular level is the production of ATP 
from nutrients. Nutrients from food come in the form of three macronutrients; protein, 
carbohydrates, and fat.  
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2.1.1 Protein 
Protein synthesis occurs through the transcription of DNA to RNA and the 
translation of RNA. This process is known as the central dogma in biology. Transcription 
of DNA generates messenger RNA (mRNA) and transfer RNA (tRNA), which are 
necessary to build proteins. The nucleotide sequences of mRNA are translated into 
amino acids, which bind together to create proteins. Proteins are generated from twenty 
amino acids. Nine of these amino acids are essential for humans and mice, which 
means they must be provided from dietary sources (Table 2.1). In addition to creating 
proteins from individual amino acids, individual amino acids can be incorporated into 
various metabolic reactions to produce glucose through gluconeogenesis and ATP 
through the TCA cycle. 
Although dietary intake of protein makes up approximately 1% of proteins stored 
in the body [9] various levels of protein in the diet have been investigated. Consumption 
of a high-protein diet can increase satiety; however, there is some concern that the 
liver’s capacity to convert nitrogen to urea may be exceeded inducing a disease state 
with long-term adherence [10]. Furthermore, a high-protein diet can prevent muscle 
catabolism during weight loss [11]. 
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Table 2.1: Twenty Amino Acids 
Non-essential Amino Acids Essential Amino Acids 
Alanine Histidine 
Arginine Isoleucine 
Asparagine Leucine 
Aspartate Lysine 
Cystine Methionine 
Glutamic acid Phenylalanine 
Glycine Threonine 
Ornithine Tryptophan 
Proline Valine 
Serine  
Tyrosine  
 
2.1.2 Carbohydrates 
 The simplest form of carbohydrates is monosaccharides. All monosaccharides 
are made up of carbons, hydrogens, and oxygens with the empirical formula Cm(H2O)n. 
Monosaccharides consist of a single glucose, fructose, galactose, or xylose. Other 
forms of carbohydrates can be built from monosaccharides. Disaccharides (sucrose, 
lactose, maltose, and trehalose) and polyols (sorbitol and mannitol) are made up of two 
monosaccharides. Oligosaccharides (raffinose, oligofructoses, and maltodextrins) are 
made up of three to nine monosaccharides. Polysaccharides are made up of more than 
nine monosaccharides. Polysaccharides consist of starches (amylose, amylopectin, and 
glycogen) and non-starches (cellulose and pectins). Carbohydrates are broken down 
into monosaccharides through digestive enzymes, such as α-amylase in order to utilize 
for energy metabolism. Monosaccharrides, disaccharides, and polyols are generally 
known as simple carbohydrates while oligosaccharides and polysaccharides are known 
as complex carbohydrates. 
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Fructose and galactose can be converted into glucose for energy metabolism. 
Adipose, muscle, and liver through glucose transporters take up glucose in an insulin-
dependent manner while excess glucose is stored as fat through de novo lipogenesis. 
Carbohydrates through dietary intake make up 50-100% of carbohydrate stores in the 
body, which is stored as glycogen [9].  
The relationship between carbohydrate intake and health remains controversial. 
Like protein, intake of carbohydrates has been shown to induce satiety for at least 90 
minutes postprandial [12]. Furthermore, current recommendations have suggested 
limiting fat intake to improve cardiovascular disease; however, a recent study has 
shown that high-carbohydrate diets have been associated with higher total mortality 
across the world [13, 14]. Conversely, high-carbohydrate diets have improved insulin 
sensitivity, lowered LDL cholesterol and reduced weight [15, 16]. 
2.1.3 Lipids 
Lipids can act as receptors, serve as the plasma membrane of a cell, or be 
broken down into non-esterified fatty acids for energy. Lipids consist of triacylglycerols, 
phospholipids, sphingolipids, as well as others. Triacylglycerols consist of three fatty 
acids attached to a glycerol backbone and serve as the primary component of adipose 
tissue. Triacylglycerols can be broken down via lipoprotein lipase into glycerol and non-
esterified fatty acids. In order for lipids to be accessible for metabolism breakdown of 
triacylglycerols is necessary. Non-esterified fatty acids, also known as free fatty acids, 
can then be shuttled to the mitochondria for ATP production. Free fatty acids are 
classified a short-chain, medium-chain, and long-chain fatty acids. Short-chain fatty 
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acids have six or fewer carbons, medium-chain fatty acids contain between eight and 
fourteen carbons, and long-chain fatty acids contain more than fourteen carbons. All 
fatty acids, regardless of length, consist of a carbon backbone and a carboxylic acid. 
Furthermore, fatty acids can be classified as either saturated of unsaturated. Saturated 
fatty acids contain hydrogens at all carbon atoms while unsaturated fatty acids contain 
at least one double bond.  
Two fatty acids, linoleic acid and α -linoleic acid, are essential for humans and 
mice and can only be provided by diet. These fatty acids are necessary to build omega-
3 and omega-6 fatty acids. Omega-3 and 6 fatty acids are named omega-3 and 6 
because their first double bond is at the third and sixth carbon from the methyl end. 
Omega-3 fatty acids convert to eicosapentanoic acid (EPA) and docosahexaenoic acid 
(DHA) while omega-6 fatty acids convert to arachadonic acid (AA). DHA and EPA are 
considered anti-inflammatory and AA is considered pro-inflammatory [17]. High omega-
6 to omega-3 ratios have been linked to obesity and diabetes and create a pro-
inflammatory response [17]. 
Fat intake makes up less than 1% of fat stores in the body [9]. While 
consumption of a high protein diet induces satiety, high intakes of fat have not resulted 
in the same levels of satiety for any length of time [12], which may lead to 
overconsumption of food. For this reason high-fat diets and fats, in general, have been 
touted as the primary contributor to obesity; however, the ketogenic diet, which is 
primarily made up of fat has not induced an obesogenic state in individuals suggesting 
another mechanism [18, 19]. 
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2.2 Health and Diet 
Diet modification has treated a host of diseases including type 2 diabetes, 
epilepsy, Celiac’s disease, irritable bowel disease (IBS), and cardiovascular disease 
[20-26]. Diet, however, can be used for more than disease reversal. Individuals may use 
diet to maintain a healthy weight or improve athletic performance [27-29]. The following 
four diets were chosen for this dissertation due to their known affects on human health. 
These diets were formulated to mimic the macronutrient and dietary composition of a 
human diet.  
2.2.1 American (Western) Diet 
 With the industrial revolution refined grains, oils, sugars, and high fructose corn 
syrup were developed. These foods became the staples of a western diet, particularly 
after WWII. The diet that stemmed from the industrial revolution and the term western 
became synonymous due to the association of industrialization with western countries, 
such as the U.S. and England.  From 2007-2008 the average caloric intake was 2,504 
and 1,771 for men and women, respectively [30, 31]. When calories were broken down 
by macronutrient approximately 50% were attributable to carbohydrates, nearly 16% to 
protein, and roughly 33% to fat with 11% of fat being saturated fat [30-32]. The Dietary 
Guidelines for Americans were developed in 1980 and have been updated and revised 
every five years to promote a healthy diet based on published research. In addition to 
dietary recommendations the guidelines assess the current state of nutrition in the 
United States. According to the 2015-2020 Dietary Guidelines the average U.S. adult 
under-consumed vegetables (<1-2 cups per day) but exceeded the dietary 
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recommendations for total grains, protein, sugars, saturated fats, and sodium [7]. 
Current dietary guidelines recommend 2.5 or more cups of vegetables, three cups or 
less of dairy, 7 ounces of protein, and less than 10% of calories from sugar or saturated 
fats. Despite these recommendations current research has shown an inverse 
relationship between vegetable consumption and weight gain, heart disease, and 
diabetes [33, 34]. This suggests that more than 2.5 cups of vegetables should be 
consumed to receive maximal health benefits. In agreement with the recommendations 
over-consumption of sugar showed an increased risk of cardiovascular disease and 
metabolic syndrome, according to the NHANES [35, 36]. As individuals pursue food that 
is pre-made, quick, and hyper palatable, diseases such as obesity, type 2 diabetes, 
certain cancers, and cardiovascular disease have also increased [37, 38]. Furthermore, 
as countries become westernized and consume more foods from an American diet the 
aforementioned diseases follow [39]. Since the wide adoption of the American diet both 
locally and globally, deaths due to preventable diseases, mentioned above, have 
become some of the top causes of death [40]. 
2.2.2 Japanese Diet 
 The Japanese diet is low in fat and high in carbohydrate [41]. Rice, soybeans, 
fish, some meats, oils, fermented foods, and vegetables typically make up the Japanese 
diet [42]. After WWII the Japanese population began eating what is now considered a 
traditional Japanese diet, mentioned above. Preceding WWII the Japanese population 
was impoverished and primarily ate a diet of rice. The association between the 
Japanese diet and longevity developed as a result of this alteration in dietary pattern. 
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Prior to WWII the average life expectancy of Japanese men and women was 42.8 and 
51.1 years, respectively [43]. From 1946 to 1951 life expectancy rose by 18 years for 
men and 13.7 years for women. The life expectancy of the Japanese population 
continued to increase until Japan had the highest life expectancy in the world in 1979 
[43]. As of today the average Japanese individual lives to 85, which is ranked third 
worldwide [44]. The high life expectancy of the Japanese population drew considerable 
attention to their eating habits. Okinawa, Japan, in particular, is known for having a 
large number of centenarians [45]. Okinawans tend to be resistant to acculturation and 
therefore maintain a traditional diet [45]. In 2002, the same scientists that research the 
Okinawan centenarian population published The Okinawa program [46]. This book 
provided dietary guidelines based on the Japanese diet in Okinawa popularizing the 
Japanese diet in the United States.  
Rates of coronary heart disease (CHD) and cancer, in Japan, are some of the 
lowest in the world [47-49]. Investigating CHD in Japanese-Americans revealed the 
same rates of CHD when consuming a traditional Japanese diet; however, when 
Japanese-Americans consumed a western diet they had a 3-5-fold increase in CHD 
prevalence [47]. Furthermore, Japanese individuals that moved to the U.S. and adopted 
a western diet had increased rates of certain cancers [48]. Individual markers of health 
are improved through the consumption of a Japanese diet. In the Japanese population, 
consumption of fish and soy were associated with higher HDL cholesterol and folate 
levels [50]. 
Studies investigating the Japanese diet in mice also show significant health 
improvements. Mice fed a Japanese diet had lower liver weights, adiposity levels, 
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serum glucose, insulin levels, and triglyceride levels compared to their counterparts fed 
a Mediterranean diet [51]. Furthermore, modification of the Japanese diet to contain 
more fish, soy, seaweed, vegetables, fruit, and dashi, a fermented seasoning reduced 
serum LDL cholesterol, liver total cholesterol, and IL-6 levels compared to mice fed a 
traditional Japanese diet [41]. Individual components of a Japanese diet were also 
shown to have protective effects. Consuming green tea in conjunction with a high-fat 
diet diminished the negative effects of the high-fat diet in mice [52]. 
2.2.3 Mediterranean Diet 
 The Mediterranean diet consists of a moderate level of carbohydrates and fats. 
Individuals eating a Mediterranean diet consume a low intake of saturated fats, meats, 
and dairy; high intake of vegetables, cereals, nuts, fruits, and legumes; and a moderate 
intake of fish and wine [53-55]. Ancel Keys was the first to promote a Mediterranean diet 
in the U.S.. Investigating the diets of 12,000 men across seven countries in a study, 
known as The Seven Countries study, he revealed that the Mediterranean diet had 
protective effects of CHD [56, 57]. The Mediterranean diet, however, didn’t become 
popular in the U.S. until the 1990’s. Despite the promotion of the Mediterranean diet by 
Ancel Keys decades earlier, Walter Willet is often accredited with creation of the 
Mediterranean diet in the U.S. [58, 59].  
In addition to the Japanese diet, consumption of a Mediterranean diet contributes 
to some of the longest life expectancies in the world [51]. Besides long life 
expectancies, the Mediterranean diet can improve specific markers of health. When 
assessing the health of an individual triglyceride levels, HDL, LDL, and blood glucose 
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levels are measured. These markers have been linked to CVD, NAFLD, and type 2 
diabetes [26, 60-62]. A healthy individual will have triglyceride levels that are less than 
150 mg/dL, HDL levels that are greater than 60mg/dL, LDL levels that are less than 
100mg/dL, and fasting glucose levels that are less than 100mg/dL [63, 64]. 
Furthermore, menopausal women are assessed for osteoporosis. The Mediterranean 
diet has been shown to increase bone mineral density and reduce triglyceride levels 
[55, 65]. The Mediterranean diet has also been shown to improve energy metabolism in 
obese individuals. Sirt 4 is a mitochondrial ADP-ribosyltransferase that aids in the 
downregulation of insulin secretion via inhibition of glutamate dehydrogenase 1 [66]. 
Obese individuals adhering to a Mediterranean diet showed improved sirt 4 levels [54]. 
Additionally, adherence to a Mediterranean diet lowered their body mass index, fasting 
blood glucose, LDL, and increased HDL levels [54].  
2.2.4 Ketogenic Diet 
 The ketogenic diet was formally developed in the 1920’s to treat epilepsy [20, 21, 
67]. Prior to the ketogenic diet starvation was the primary method to treat epilepsy [67]. 
The term “ketogenic” was coined due to the production of ketone bodies as a result of 
the diet [67]. The Ketogenic diet is predominantly comprised of fat. The original diet was 
developed by M.G. Peterman and consisted of 1g of protein per kilogram of body weight 
in children, 10-15g of carbohydrates per day, and the rest of the calories in fat [67, 68]. 
Ketosis is the basis of a ketogenic diet and occurs when fatty acid oxidation becomes 
the primary source of energy for the body in response to glucose depletion. As a result 
three ketone bodies—β-hydroxybutyrate, acetoacetate, and acetone are produced. 
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 The ketogenic diet has also been used to treat symptoms of autism [69] and as 
an adjuvant treatment for cancer [70, 71]. In addition to the therapeutic effects of the 
diet, interest in the ketogenic diet has continued to gain popularity despite few studies 
showing the efficacy of the ketogenic diet as a weight loss tool [18, 72, 73].  Moreover, 
endurance athletes use a ketogenic to increase their endurance by reducing the need 
for glucose supplementation during an event and improving their maximum volume of 
oxygen (VO2 max). Off-road cyclists fed a ketogenic diet utilized significantly more free 
fatty acids during exercise than cyclists on a mixed diet [29]. VO2 max was also 
significantly higher and RER was significantly lower in cyclists fed a ketogenic diet [29]. 
The ketogenic diet can also improve these markers for weeks after cessation of the diet. 
Individuals fed a ketogenic diet showed a reduced RER after 20 days and remained low 
at 40 days even after cessation of the ketogenic diet [72]. 
 
2.3 The Role of Genetics in Diet and Disease 
Diets are used to lose weight, improve health, or treat disease; however the 
efficacy of a diet can be influenced by genetic background. Studying dietary responses 
in humans can be challenging for many reasons, including but not limited to the inability 
for biological replicates, compliance, high-heterozygosity, and issues with self-reporting 
methods. Regardless, several human studies have been able to determine the genetic 
effects on diet and disease [45, 74, 75]. Postprandial plasma triglyceride levels are a 
risk factor for cardiovascular disease. Individuals fed a high-fat diet were assessed for 
genetic variants associated with plasma triglyceride levels. Two SNPs were associated 
with triglyceride response revealing genetic variants that may increase plasma 
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triglyceride levels [76].  
Mice are a good model to represent humans due to their genetic similarity, the 
ability for biological replications, and their inherent compliance. Inbred strains of mice 
are developed through the breeding between siblings or parent and progeny. In order 
for a mouse line to become homozygous must be bred for at least 20 sequential 
generations (F20). After 20 generations mice become 98.7% homozygous at all loci 
[77], which allows for biological replication. In addition to biological replication inbred 
mice make it possible to compare multiple scientific studies potentially produced at 
different times and in different locations. This allows researchers to comprehensively 
study the biology of a particular mouse strain. Due to the inbred nature of a mouse 
strain, however, it can be difficult to extrapolate results beyond the genetic breed. For 
this reason, multiple strains can be utilized to represent genetic diversity and allow us to 
better understand how individual variation can influence physiological responses to 
dietary inputs. For example, diet induced obesity has been shown to be induced in 
C57BL/6J mice, while A/J and NOD/ShiLtJ mice are obesity resistant [78-81]. 
Furthermore, genetic background has been shown to influence the severity of disease. 
Ob/ob mice on a FVB/NJ background developed severe diabetes while ob/ob mice on a 
C57BL/6J mice developed hyperglycemia [82]. Treatment of disease through diet has 
also been shown to have differing levels of success due to genetic background. 
Seizures have been successfully controlled through a ketogenic diet; however, between 
10-40% of patients do not experience a reduction in seizures, which is thought to be 
due to inherent genetic differences [83]. Investigating the effects of genetic background 
on mice consuming a ketogenic diet revealed that C57BL/6J and DBA/2J mice 
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remained seizure-free while FVB/NJ and A/J mice both continued to experience 
seizures [83]. In order to assess the role of genetics in our study four strains (A/J, 
NOD/ShiLtJ, FVB/NJ, and C57BL/6J) were chosen in this dissertation for their altering 
susceptibilities to common metabolic diseases.  
2.3.1 A/J 
A/J mice were developed by LC Strong in 1921 [84]. They are a cross between a 
Bagg albino and a Cold Spring Harbor albino. A/J mice are high susceptible to cancer 
and are used as a carcinogen induced cancer model [85, 86]. Conversely A/J mice are 
resistant to diabetes, obesity, atherosclerosis, insulin resistance, and glucose 
intolerance [78, 84, 87]. In addition to metabolic markers A/J mice were shown to have 
low levels of activity [88]. 
2.3.2 C57BL/6J 
The C57BL/6J mouse was developed using mice provided by Abbie Lanthrop, a 
high school teacher [77].  Clarence Little, along with Leonell Strong, and E.C. 
MacDowell created the C57BL/6J line around 1918 [77]. In contrast to A/J mice, 
C57BL/6J mice are susceptible to diet-induced obesity, type 2 diabetes, and 
atherosclerosis [78, 82, 89-91]. C57BL/6J also show high levels of activity [88] 
2.3.3 FVB/NJ 
FVB/NJ mice were developed in 1966. Outbred Swiss mice were bred for a 
resistance or sensitivity to histamine challenge after receiving a pertussis vaccination 
[92]. It was discovered that the sensitive line was also sensitive to the Friend leukemia 
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virus B strain (FVB) so this generation was then inbred specifically to develop the 
FVB/NJ strain [92]. FVB/NJ mice are susceptible to certain cancers, have higher basal 
body temperature, activity, and anxiety levels [93, 94]. Additionally, FVB/NJ mice are 
homozygous for the Pde6brd1 allele resulting in retinal degeneration [92].  
2.3.4 NOD/ShiLtJ 
NOD/ShiLtJ mice developed from the inbreeding of the Cataract Shionogi strain 
[95]. NOD/Shi mice developed at the F6 generation, marked by elevated fasting blood 
glucose. The F6 generation was then inbred and at the F20 generation, female mice 
spontaneously developed insulin-dependent diabetes [95]. These mice were then inbred 
in 1974 to develop the NOD/ShiLtJ strain. NOD/ShiLtJ mice are a model for type 1 
diabetes [96]. They are characterized by the leukocyte infiltration of pancreatic islets. In 
addition NOD/ShiLtJ females are the first to show decreased in pancreatic insulin, 
typically around 12 weeks, while males express this phenotype weeks later [81].  
 
2.4 The Role of Sex in Diet and Disease 
 Research investigating diet and disease over the last century has predominantly 
used males as their subjects; however, it has been shown that females differentially 
respond to diet and disease in some cases. The largest difference between males and 
females relates to their sex hormones. Females primarily produce estrogen and 
progesterone while males produce testosterone.  Physiologically females tend to have a 
higher proportion of body fat relative to men, regardless of ethnic group [97].  There are 
also sex differences when it comes to utilization of fats and carbohydrate at rest and 
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during exercise. Women store more fatty acids as triglycerides while men oxidize free 
fatty acids at the resting state [98], which may be due to estrogen levels in women [99]. 
Conversely, during exercise, women preferentially use fatty acids over carbohydrates 
while men preferentially use carbohydrates [98]. Free fatty acids have also been shown 
to have differential effects on insulin sensitivity. Free fatty acids in men played a role 
inhibiting tissue insulin sensitivity but had no effect on insulin sensitivity in women [100]. 
Furthermore, post-menopausal women or ovariectomized mice had increased insulin 
resistance [101]. 
Disease prevalence can also be due to sex dimorphisms. Seventy-eight percent 
of autoimmune disease diagnoses are women [102]. In contrast, men are more likely to 
develop type 1 diabetes [103]. Additionally, both men and women are nearly equally at 
risk for CVD; however, women have a higher rate of death [104].  
 
2.5 Metabolomics 
Chromatographs are used to separate analytes (i.e. compounds in a sample). 
The first chromatograph was developed by Mikhail Semenovich Tsvett in the early 
1900’s. This chromatograph was able to separate plant pigment. Paper chromatography 
was developed several decades later in 1941 by Richard Synge and Archer Martin. This 
allowed for the separation of colorless compounds as the solvent spread across the 
paper. Compounds would spread across the paper based on their solvency in the 
chosen solution. Paper chromatography was the primary method used until NMR was 
developed in the early 1950’s. NMR spectroscopy determines the physical and chemical 
  20 
properties using the magnetic properties of the atomic nuclei [105]. The intramolecular 
magnetic field that surrounds an atom in a whole molecule alters the resonance 
frequency, which provides structural information. A major advantage to NMR is sample 
recovery, but the inability to resolve compounds due to low sensitivity must be 
considered. Less than a decade after the development of NMR, in 1959, the first gas 
chromatographer was coupled to a mass spectrometer occurred [106]. Analytes 
measured using gas chromatography-mass spectrometry (GC-MS) must be volatile 
limiting the types of analytes that can be analyzed, however, the resolving power—the 
ability to provide a specific mass resolution (chapter 3.6.2)—is higher than NMR due to 
higher sensitivity. The first paper published using metabolomics as it is currently thought 
of analyzed urine and breath using GC to discern nutritional differences in 1971. 
Robinson and Pauling measured approximately 250 metabolites in breath and 280 
metabolites in urine.  
Electrospray ionization (ESI) coupled with liquid chromatography and mass 
spectrometry was developed in 1989 [107] (see section 3.6.1 for details). The addition 
of ESI was an important technological advancement in metabolomics because it 
allowed for the ionization and measurement of larger molecules, such as metabolites, 
with very little fragmentation. This paved the way to be able to measure metabolites, 
such as peptides, nucleic acids, and other polar hydrophilic compounds.  
The term metabolomics was not coined until 1998 by S.G. Oliver, et. al. [108]. 
Metabolomics is the quantification and identification of metabolites that are left by 
biochemical reactions that occur throughout the body. These measurements are usually 
taken at a single point in time. Metabolomics is usually thought of as the phenotypic 
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response to the completion of the central dogma (Fig. 2.2). Metabolites in the body are 
influenced by diet, disease, environment, genetics, and many other factors. To 
understand the number and types of metabolites that could be identified the human 
metabolome project was formed. The first draft of the human metabolome was 
completed in January 23, 2007. This metabolome consisted of approximately 2,500 
metabolites, 1,200 drugs, and 3,500 food components.  
There are two major types of metabolomics: untargeted and targeted. Untargeted 
metabolomics can detect thousands of metabolites while targeted metabolomics 
measures a set of pre-defined metabolites or pathways. Untargeted metabolomics can 
investigate metabolic disruptions due to an external perturbation without prior biological 
information. This allows for the potential to identify novel metabolites, which may be a 
biomarker of disease. The sensitivity of the measurements, however, can be lower 
compared to targeted metabolomics due to the large range of metabolites being 
measured and the inability to perform absolute quantification [109]. In contrast, targeted 
metabolomics can allow for absolute quantification of metabolites of interest by 
comparing metabolites of interest to known quantities of their respective 13C-labeled 
standard. Targeted metabolomics, however, does not measure unknown metabolites. 
Conversely, an untargeted approach allows for the identification of unknown metabolites 
(metabolites that are not defined by a retention time and mass-to-charge ratio). 
Although these metabolites cannot be identified they can potentially be linked to 
diseases as the field of metabolomics progresses. 
With the potential to identify thousands of metabolites in a single sample 
bioinformatics tools have been employed to hand the complex data. Furthermore, due 
  22 
to the potential limitations in detection, data must be handled carefully to deal with 
missing values, background noise, and alterations in retention time due to column drift 
(see chapter 3). 
Most metabolomics studies use non-invasive samples (i.e. serum, urine, etc.) to 
identify metabolites rather than tissue. This provides a global metabolite profile but does 
not provide any tissue specific information; however, understanding how tissue 
metabolites are influenced has become of interest recently. Using untargeted 
metabolomics, adipose, muscle, and liver tissue were assessed to identify alterations in 
the metabolome due to diet, genetic, and/or sex effects. 
2.5.1 The Role of Metabolomics in Understanding Diet 
Diet and disease are inextricably linked. Understanding how diet alters 
underlying metabolic pathways can provide insight into how whole diets and/or 
supplements influence health and ultimately disease. Many studies use low-fat and 
high-fat diets to assess diet differences. Metabolomics studies have investigated the 
differences between high- and low-fat diets in serum, liver, feces, and urine. Metabolites 
involved in energy metabolism and amino acid metabolism were all increased with the 
consumption of a high-fat diet [110, 111]. Furthermore, individuals consuming a Nordic 
diet, which consists of whole-grains, berries, root vegetables, and fatty fish showed 
altered amino acid metabolism and fatty acid profiles [112]. 
23 
 
Figure 2.1: Depiction of the Central Dogma through –omics studies.  
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Individual dietary components can also influence the metabolome. Consumption 
of meat provides an exogenous influx of amino acids into the body. Investigating 
humans consuming a vegan diet, which consists of zero animal products, had lower 
amino acid levels compared to omnivores [113]. Additionally, specific metabolites can 
be associated with dietary components. Vegetable intake was positively correlated with 
phenylacetylglutamine while red-meat intake was associated with o-acetylcarnitine, 
which aids in the transport of acetyl-CoA to the mitochondria during fatty acid oxidation 
[114]. Moreover, increased pipecolic acid and s-methylcysteine levels in serum for both 
humans and mice are associated with consumption of dry beans [115].  
It has been shown that individual dietary components can be attributable to 
changes in the metabolome; however, dietary components can interact to modulate the 
effects of one another with the potential to cancel out deleterious effects. Metabolites 
influenced by a high-fat diet in mice were mediated by consumption of green tea [52]. In 
addition to diet-driven alterations in the metabolome, caloric differences can also affect 
the metabolite levels. Metabolites in the TCA cycle and glycolysis were altered by 
energy-restriction [116].  
2.5.2 The Role of Metabolomics in Understanding Disease 
 Metabolomics can be used to identify biomarkers that can predict a disease state 
or as a means to identify potential treatment targets. Leucine, isoleucine, and valine are 
branched-chain amino acids (BCAA), which are necessary for protein synthesis and 
metabolism of glucose. Levels of BCAA were increased in obese individuals, type 2 
diabetics, and individuals displaying insulin resistance [117-119]. Furthermore, 
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increases in body mass index—a tool used to determine overweight and obesity—in 
addition to obesity were associated with increased levels of amino acids [117, 119]. 
Moreover, alterations in amino acid metabolism and tryptophan metabolism were also 
altered in obese individuals resulting in increased levels of kynurenine, kynurenic acid, 
and quinolinate [119, 120].  
The ability to predict the development of disease is important for prevention. As 
of 2015, it is estimated that approximately 30 million individuals have diabetes in the 
U.S. [121]. The Framingham Heart Study profiled 2,383 individuals to identify 
relationships between body mass index and cardiometabolic traits. Plasma metabolites 
from the Framingham Heart study identified 2-aminoadipic acid as a predictor of 
developing diabetes. This longitudinal study showed that increased levels of 2-
aminoadipic acid were associated with a >4-fold risk of developing diabetes up to 12 
years prior to developing type 2 diabetes [122]. 
Non-alcoholic fatty liver disease (NAFLD) is marked by inflammation and excess 
storage of fat in the liver. Chronic NAFLD can lead to cirrhosis. Dysregulation of amino 
acids has been linked to NAFLD [123]. Additionally, obesity-associated NAFLD in 
humans revealed increased BCAA in serum in individuals with steatosis [124].  
Although metabolic diseases alter amino acid metabolism, obesity treatments 
can reverse these alterations. Both dietary intervention and gastric by-pass surgery 
decreased branched chain amino acids and other amino acids [125]. In addition to 
alterations in metabolites, glucose homeostasis was improved, which may be due to 
lowering BCAA levels [125].  
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The development or treatment of metabolic diseases has been shown to alter the 
metabolome; however, bodily injury can also alter the metabolome. Injury to the anterior 
cruciate ligament (ACL) resulted in changes in the following pathways in synovial fluid: 
glycine, serine, and threonine; arginine and proline; alanine, aspartate, and glutamate 
[126]. Additionally, joint injury resulted in changes in several amino acids, including 
hydroxyproline and proline [126]. Amino acids have been shown to play a role in joint 
health [127]. Furthermore, hydroxyproline and proline are critical for collagen formation 
[128]. 
2.5.3 The Role of Metabolomics in Understanding Genetics 
Genetics may influence an individual’s response to diet or disease. Metabolomics 
can assess how different genetic backgrounds influence the underlying metabolome. 
Leptin is important in the regulation of energy balance and reduces appetite. 
Dysregulation of hunger signals can occur if an individual becomes leptin resistant. 
Furthermore, absence of leptin or the leptin receptor can also alter hunger signals. Two 
genetically obese mouse models, db/db (leptin receptor deficient) and ob/ob (leptin 
deficient), showed an increase in BCAA and a decrease in other amino acids [129]. 
Db/db mice, however, are also a model for type 2 diabetes. Glycoxylate, a biomarker for 
diabetes [130] was elevated in db/db mice while lysine and arginine were decreased 
[129]. 
Type 1 diabetes (T1D) is a polygenic autoimmune disorder that results in the 
destruction of pancreatic β -cells. NOD/ShiLtJ, a T1D mouse model, were compared to 
C57BL/6J mice to assess metabolic alterations due to type 1 diabetes. Metabolites in 
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the TCA cycle were higher in C57BL/6J mice with the exception of glutamic acid, 
succinate, and asparate [96]. Glutamic acid is converted to gamma-aminobutyric acid 
(GABA) via glutamic acid decarboxylase (GAD). NOD/ShiLtJ mice express anti-GAD 
enzymes, which prevent the conversion of glutamic acid to GABA. 
Humans are inherently genetically diverse making it difficult to separate genetic 
influences from environmental influences; however, differences in metabolites can still 
be assessed as potential biomarkers of disease. Genome wide associations studies can 
be combined with metabolomics to identify genetic alterations linked to metabolic 
differences. Genetic variants that correspond to metabolic phenotypes have been 
matched to metabolic pathways. For example, FADS1 is an enzyme that aids in the 
metabolism of omega-3 and omega-6 fatty acids. SNPs containing the FADS1 gene 
have been shown to explain up to 10% of the variance in glycerophospholipd 
concentrations [131]. 
 
2.6 Summary 
 Metabolic diseases in the U.S. and worldwide continue to rise despite current 
treatments. Metabolomics studies have revealed a complex relationship between 
metabolic diseases, diet, and genetics. Branched chain amino acids as well as other 
amino acids were often altered in response to diet or disease, although it is not clear 
why. Some metabolic differences are also due to sex. The complex relationships 
between diet, genetics, and the potential role of sex have yet to be studied in a 
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comprehensive way. Understanding the influence of each and their interactions may 
provide insight into how the metabolome is altered to affect physiology. 
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CHAPTER THREE  
EXPERIMENTAL AND COMPUTATIONAL METHODS TO PERFORM 
NUTRITIONAL METABOLOMICS 
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3.1 General Workflow to Perform Tissue Level Metabolomics 
Untargeted metabolomics was performed for all experiments discussed using 
liquid chromatography coupled with electrospray ionization quadropole mass 
spectrometry (Fig. 3.1).  To understand and characterize how diet, genetics, and sex 
interact to influence the metabolome adipose, skeletal muscle, and liver tissue were 
flash frozen from four strains of mice after being fed five diets for 6-7 months. Extracting 
metabolites from tissue was not inconsequential due to potential metabolic shifts if the 
tissue samples degrade. As a result, tissue samples are kept frozen throughout the 
extraction process as well as all equipment and solutions. High-performance liquid 
chromatography separated metabolites based on size and polarity. Metabolites are then 
ionized through electrospray ionization and transferred to the mass analyzer and 
detector. This is where mass-to-charge (m/z) and relative abundance are measured in a 
full mass spectrum (MS1). This dataset is then compared against known retention times 
and m/z to identify metabolites. Using retention time and m/z to identify metabolites is 
moderately specific; however, some metabolites such glucose-1-phosphate and 
glucose-6-phosphate cannot be discerned with using tandem mass spectrometry (MS2). 
The steps mentioned above allow us to identify and quantify thousands of metabolites in  
complex tissue samples across multiple interactions. Each step is discussed in detail 
below. 
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Figure 3.1: Schematic of Q-Exactive Plus Hybrid Quadropole-Orbitrap Mass Spectrometer (Image 
source: Thermo Scientific Q Exactive Plus Orbitrap LC-MS/MS System product specification 
sheet: https://assets.thermofisher.com/TFS-Assets/CMD/Specification-Sheets/PS-63912-LC-MS-Q-
Exactive-Plus-Orbitrap-PS63912-EN.pdf) 
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3.2 Sample Preparation 
Metabolite measurements typically come from cells, due to their ability to easily 
perform flux analysis and quantitative labeling. Metabolite measurements, however, 
from tissue can provide insight into systemic changes despite the additional challenges; 
tissue cannot be easily labeled, quantifying turnover rates is difficult at best, and 
preventing degradation of the sample during the extraction process requires special 
care. Measurements from a single time point can provide a lot of information regarding 
long-term changes and which metabolites are sensitive to perturbations and which are 
not. Tissue metabolites also provide a much more comprehensive picture since tissues 
interact within the body. 
Adipose, skeletal muscle, and liver tissue was collected from male and female 
mice from A/J, NOD/ShiLtJ, C57BL/6J, and FVB/NJ strains. Mice were fed one of five 
diets (Japanese, ketogenic, Mediterranean, Western, and standard chow) for a total of 
6-7 months. Dissections were performed by Dr. David Threadgill’s laboratory and 
samples were sent on dry ice to the University of Tennessee-Knoxville. Mice were 
staggered throughout the experiment due to volume. Although I was largely uninvolved 
with mouse work, I did participate in dissections and assisted with some laboratory work 
while visiting Dr. Threadgill’s laboratory for a total of two weeks. Samples were stored at 
-80°C and remained frozen until methanol extraction.  
3.3 Metabolite Extraction 
 Different methods can be utilized to extract metabolites from biological samples 
to analyze hydrophilic (e.g. methanol, freeze thaw methanol) or hydrophobic 
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metabolites (e.g. Hydrochloric acid, chloroform, and methanol:chloroform) . Currently, 
there are no methods that extract all of the metabolites present in a sample; therefore, 
the extraction method is crucial to identifying metabolites of interest. Two solvents; 
methanol and methanol:water were chosen for metabolite extraction in the following 
studies. One hundred percent methanol and 80:20 methanol:water were chosen for 
their low decomposition rates of high energy molecules [132].  
 
3.4 Internal Standard 
 Internal standards in mass spectrometry are used to quantify metabolite 
abundances or to control for run-to-run variation when running a high volume of 
samples that exceed the capacity of the mass spectrometer. To quantify metabolites a 
purified version of the metabolite of interest is used. Quantification requires that the 
metabolite of interest is labeled with 13C. A known quantity is injected into the mass 
spectrometer and is subsequently compared across all samples of interest to quantify 
the abundance of the metabolite in each sample. A single purified metabolite with 
known m/z and retention time can also be used to measure run-to-run variation 
ensuring that metabolites are being properly identified.  
 Another method that is less common is to uniformly label bacteria, such as 
Escherichia coli (E.Coli) and spike samples of interest. This allows for multiple 
metabolites to be assessed at the same time. To uniformly label bacteria, bacteria are 
grown on 13C-glucose agar plates and then transferred to 13C-glucose liquid cultures. 
The bacteria are then tested for uniform labeling on the mass spectrometer before being 
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used as an internal sample for any experiment. 13C-labeled E. Coli NCM3722 were 
spiked into all samples for each experiment discussed. 
 
3.5 Liquid Chromatography 
 Extraction of metabolites from tissue results in a complex mixture of compounds. 
A reverse phase liquid chromatography column was used for experiments discussed. 
Liquid chromatography is used to separate mixtures of compounds in a high throughput 
manner. There are two separation methods that can be performed to accomplish this; 
normal phase liquid chromatography (NPLC) and reverse phase liquid chromatography 
(RPLC). Normal phase liquid chromatography refers to a situation when the stationary 
phase is more polar than the mobile phase, while reverse phase liquid chromatography 
refers to a situation where the stationary phase is less polar than the mobile phase. 
RPLC retains hydrophobic compounds on the column while allowing hydrophilic 
compounds to be released quickly. NPLC results in the opposite response. Choice of 
column is important depending on the type of molecules of interest.  
 
3.6 Mass Spectrometry Instrumentation 
All mass spectrometers consist of an ionization source, a mass analyzer, and a 
detector. The compounds of interest are first ionized with a negative or positive charge 
and converted into a gaseous substance. These gaseous ions then pass on to the mass 
analyzer where they are resolved according to their mass-to-charge ratio. Finally, the 
ions that emerge from the analyzer are detected and their relative abundance is 
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measured. The relative abundance value is then converted into an intensity signal, 
which is then graphed with the m/z ratio as the independent variable and the relative 
abundance as the dependent variable.  
3.6.1 Electrospray Ionization 
 Electrospray Ionization (ESI) is a soft ionization method that is used to ionize 
compounds with very little fragmentation. This allows biologists to identify and analyze 
large, nonvolatile molecules that were previously difficult to capture [107]. ESI is 
performed by applying a voltage to a capillary tube that transfers the eluent to the mass 
spectrometer. The following experiments were performed using a spray voltage of 3kV.  
The eluent that moves through the capillary tube becomes a protonated eluent and 
develops a Taylor cone at the tip of the capillary tube [133]. When the voltage is 
applied, a fine spray of liquid is ejected from the Taylor cone. This liquid breaks into tiny 
like-charged droplets. As these like-charged droplets move towards the mass 
spectrometer their solvent evaporates due to the heated capillary. As the droplet size 
shrinks their surface charge density increases until they hit the “Rayleigh stability limit” 
[134]. This is when their surface tension can longer be sustained and they undergo 
“Coloumb fission” [135]. Smaller droplets are continuously formed until positively 
charged ions in the gas-phase are formed. These will then pass through the heated 
capillary and into the mass analyzer (Fig. 3.2). The nitrogen sheath gas was set to a 
flow rate of 10psi and the capillary temperature for the following experiments was set at 
320°C. 
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3.6.2 Mass analyzer and Detector 
The mass analyzer is where ions are separated by their m/z ratio. There are 
many different types of mass analyzers. Each one is specific to a subset of molecule 
types. When considering which analyzer to use figures of merit must be considered. 
Figures of merit consist of five items: mass resolution, mass resolving power, mass 
accuracy, mass precision, and dynamic range. Mass resolution is the observed mass-
to-charge divided by the smallest distance that two m/z can be separated, while mass 
resolving power is the ability of the mass spectrometer to provide a specified value of 
mass resolution [136]. Mass resolution is also defined at 50% of the maximum peak 
height for an Orbitrap mass spectrometer. Mass accuracy is defined as the difference 
between the measurement result and the exact mass of a measured value. Mass 
precision (or sensitivity) is the difference between independent mass measurements 
[137].  Dynamic range is the range between the smallest m/z and the largest m/z that 
the analyzer can detect. 
The Orbitrap is used in the following experiments (Fig. 3.1). It has a mass range 
of 50-6,000 m/z, a dynamic range of >5,000:1, a mass accuracy of <1PPM RMS 
internally and <3PPM RMA externally, and a sensitivity of 500fg buspirone on column 
S/N 100:1 [138]. Samples in the following experiments were analyzed with a resolution 
of 140,000. A scan window of 85 to 800 m/z was used from 0 to 9 minutes, and a 
window of 110 to 1000 m/z from 9 to 25 minutes in the following studies. 
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Figure 3.2: Schematic Depicting Formation of Charged Analyte from Electrospray Ionization 
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Before ions are analyzed they must go through the RF-lens, quadropole, and C-
trap. The RF-lens and quadropole store and isolate ions, which are scanned by m/z 
before being transported into the C-trap to measure their mass. 
 
3.7 Analysis of Metabolomics Data 
 Full MS1 allows for thousands of molecules with different m/z to be scanned and 
measured. To properly analyze any biological data as many sources of variation must 
be removed as possible. High-throughput data, such as metabolomics, creates a unique 
set of issues that must be addressed due to computational and instrumentation limits. 
To limit external variation the experimental design must be considered. Samples should 
be randomized according to the experimental design to reduce run-to-run variation on 
the mass spectrometry. If samples cannot be computationally processed together then 
they should be randomized again before picking peaks, otherwise systematic variation 
may be introduced. 
Metabolites measured from the mass spectrometer are defined by their retention 
time on the column and their m/z ratio. The first step in defining a metabolite involves 
correcting for column drift. As the column in the mass spectrometer is used the 
metabolites tend to remain attached to column longer. To obtain the correct retention 
time an algorithm to correct for column drift must be used. Many programs automatically 
correct for column drift, including MAVEN, the program used to identify metabolites for 
the following studies. 
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3.7.1 MAVEN 
 Raw files are created by Xcalibur, which is the software associated with a 
Thermofisher Scientific mass spectrometer. These files must be converted to an mzML 
file, which can be read by MAVEN. Conversion can occur via msconvert [139]. MAVEN 
is an open source data analyzer for metabolomics data [140, 141]. When samples are 
loaded into MAVEN total ion chromatograms are corrected based on retention time 
automatically, for each sample (Fig. 3.3). A list of known metabolites; metabolites that 
have a retention time and m/z, can be uploaded to identify metabolites. Metabolites can 
then be manually chosen or automatically chosen. All of the following experiments used 
both manual and automatic peak picking techniques. Identified metabolites were 
manually chosen and peak abundance was integrated by mass (±5 ppm) and retention 
time. Unidentified metabolites were chosen using an algorithm with the following 
settings: minimum peak width, 5; minimum signal/blank ratio, 3 or greater; minimum 
peak intensity, 10,000; and minimum peak/baseline, 3.  Unidentified peaks were filtered 
manually to remove those that did not meet the above criteria. 
 
3.8 Normalization of Data 
3.8.1 Imputation 
Often there are missing values in metabolomics data, which are generally 
thought to be below the sensitivity of the mass spectrometer. As a result, researchers 
replace the missing values with one of several techniques. Our study used k-Nearest 
Numbers (kNN) imputation to replace missing values. kNN imputation averages k- 
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Figure 3.3: Example of Peak Analysis in MAVEN software (Image source: http://genomics-
pubs.princeton.edu/mzroll/index.php?show=screenshots) 
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neighbors to determine a value for the missing number. Using a small k allows for noise 
to be more influential while a large k will reduce the local effects of the data allowing the 
data to become more generalizable. To find the k-nearest neighbors a Euclidean metric 
is used (eq. 3.1) [142]. 
 
Equation 3.1 
dist(A,B) =
xi − yi( )i=1
m∑
2
m
 
 
where m is the dimensionality of the data matrix and A and B are data vectors. 
Replacing missing values in metabolomics is important to the matrix structure for 
downstream analysis. Missing values are not well tolerated in certain multivariate 
analysis techniques, such as partial least squares discriminant analysis (PLS-DA) or 
principal component analysis (PCA). Metabolites that were missing 70% or more 
sample measurements were removed from analysis prior to kNN imputation.  
3.8.2 Covariates 
 Metabolomics data may have confounding factors so covariates are sometimes 
needed. Metabolite abundance is sensitive to the quantity of sample measured, usually 
in a linear fashion. For this reason it is important to adjust metabolite abundance for 
sample weight to correct the metabolite abundance. Another important covariate to 
consider including is an internal standard. Run-to-run variation may occur on a mass 
spectrometer. One way to correct for this is to run a single internal standard of known 
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mass and retention time. Another method is to spike samples with a 13C-labeled 
bacterial species, such as E. Coli, to standardize metabolite measurements across 
runs. This allows for direct comparisons between individual metabolites within a known 
sample and individual metabolites within a 13C-labeled sample of known quantity. An 
internal standard should correct for any sample variation from run-to-run given that the 
internal standard is homogenous across all samples. 
Metabolites measured from the 13C E. Coli internal standard were matched with 
their corresponding metabolite; otherwise metabolites measured were matched with a 
13C metabolite of the same class according to their chemical taxonomy. Classes were 
identified using the Human Metabolome Database [143-145]. Tissue weight and internal 
standard were treated as covariates for the statistical models in this dissertation to 
control for biological and technical variation.  
 
3.8.3 Scaling and Transformations 
Due to variation across mice, even within the same strain, it is important to 
consider scaling methods. Additionally, scaling across metabolites may be necessary to 
interpret high and low signals. Scaling can occur across samples, metabolites, or both, 
which allows for variation reduction. Pareto scaling mean centers the data and then 
divides by the square root of the standard deviation. This shrinks high signal data 
without losing low signal data. Pareto scaling was performed on each metabolite, across 
samples, in this dissertation. Mice were then median normalized, across metabolites, 
and cube-root transformed to create a normal distribution. 
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3.9 Statistical Techniques Used to Analyze Metabolomics Data 
3.9.1 Benjamini-Hochberg to Control for Type 1 error 
 The Benjamini-Hochberg procedure controls the expected proportion of 
significant effects that are in fact type 1 errors (or false positives). This is called the 
False Discovery Rate (FDR). In this dissertation, we will set an upper bound for FDR of 
q = 5%. Let p(1)≤ p(2)...≤p(k) be the ordered p-values for m independent tests. For our 
given upper bound q = 0.05, determine k to be the maximum i for which  
 
Equation 3.2 
 
p(i) ≤
i
m
⎛
⎝⎜
⎞
⎠⎟
q . 
Then the k smallest p-values all correspond to significant effects, controlling for FDR ≤ 
q. 
 Another method to correct for type 1 error is the Bonferroni correction, which is a 
way to control the family wise error rate. The family wise error rate is the probability of 
having one or more false discoveries when performing multiple hypothesis tests. To 
perform the Bonferroni correction the significant p-value is multiplied by the total number 
of tests. The Benjamini-Hochberg procedure is more appropriate for metabolomics data 
because it is less conservative than the Bonferroni correction. Since the Bonferroni 
correction is a family wise error rate it reduces the number of type 1 errors at the cost of 
increasing the number of type 2 errors (or false negatives). In metabolomics data this 
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can result in a large reduction in the number of significant metabolites due to the volume 
of metabolites being measured. The Benjamini-Hochberg procedure, however, controls 
the expected proportion of false discoveries allowing for a less stringent cutoff. As a 
trade-off this procedure allows for a percentage of type 1 errors to remain in the 
analysis in order to gain power while the Bonferroni correction attempts to remove all 
type 1 errors at the cost of power. All of the following experiments used the Benjamini-
Hochberg procedure to adjust for multiple comparisons. 
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CHAPTER FOUR  
TISSUE LEVEL DIET AND SEX-BY-DIET INTERACTIONS REVEAL 
UNIQUE METABOLITE AND CLUSTERING PROFILES USING 
UNTARGETED LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY 
ON ADIPOSE, SKELETAL MUSCLE, AND LIVER TISSUE IN C57BL6/J 
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4.1 Abstract 
Diet is a common tool used for weight loss or to improve health. Obesity, 
however, contributes to the intersection between diet and disease due its effect on risk 
of developing type 2 diabetes, hypertension, cardiovascular disease, stroke, 
osteoarthritis, and certain cancers. Various dietary profiles are associated with effects 
on health, yet little is known about the effects of diet at the tissue level. Using 
untargeted metabolomics, this study aimed to identify changes in water-soluble 
metabolites in C57BL/6J males and females, fed one of five diets (Japanese, ketogenic, 
Mediterranean, American, and standard mouse chow) for seven months. Metabolite 
abundance was examined in liver, skeletal muscle, and adipose tissue for sex, diet, and 
sex-by-diet interaction. Analysis of variance (ANOVA) suggests that liver tissue is most 
metabolically active under dietary changes compared to adipose and skeletal muscle. 
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The ketogenic diet was distinguishable from other diets for both males and females, 
according to partial least squares discriminant analysis. Pathway analysis revealed that 
the majority of pathways affected play an important role in amino acid metabolism in 
liver tissue. Not surprisingly, amino acid profiles were affected by dietary patterns in 
skeletal muscle. Few metabolites were significantly altered for adipose tissue relative to 
skeletal muscle and liver tissue indicating it was largely stable, regardless of diet 
alterations. The results of this study revealed that the ketogenic diet had the largest 
affect on physiology, particularly for females. Furthermore, metabolomics revealed that 
diet affects metabolites in a tissue-specific manner; however, liver was most sensitive to 
dietary changes. 
 
4.2 Introduction 
Diet is arguably the most commonly used tool for weight loss or to improve 
health.  The physiological consequences of diet manifest in its close association with 
disease. Four (diabetes, cardiovascular disease (CVD), cancer, and stroke) of the top 
10 causes of death in the United States are associated with diet[146]. Obesity is a major 
contributor to the intersection between diet and disease due its effect on risk of 
developing type 2 diabetes, hypertension, cardiovascular disease, stroke, osteoarthritis, 
and certain cancers[2, 147, 148]. In the United States (U.S.) more than two-thirds of the 
population is classified as overweight or obese. Globally, overweight and obesity are 
now related to more deaths than underweight, except in parts of Asia and sub-Saharan 
Africa [2]. Accordingly, a recent meta-analysis indicated that approximately 40% of the 
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U.S. general population is attempting to lose weight at any given time, and primarily 
through changes in diet [149].  
Various dietary profiles around the globe are associated with effects on health. 
For example, American diet is used to describe the high fat and sucrose intake that are 
characteristic of the United States and, increasingly, of other developed countries. 
Consumption of an American diet is associated with increased risk of obesity and its co-
morbid disorders in both humans and experimental models [37, 38]. Conversely, dietary 
patterns that are enriched in fiber, certain unsaturated fats, and plant-derived bioactive 
compounds are associated with beneficial effects on body weight and on risks of diet-
related syndromes such as cardiovascular disease and diabetes. Diets characteristic of 
Japan and the Mediterranean region both contain relatively high intake of 
polyunsaturated fatty acids and fiber- and flavonoid-rich fruits and vegetables, with 
modest consumption of the sugar and saturated fat that are hallmarks of the American 
diet. Accordingly, both the Japanese and Mediterranean eating patterns are associated 
with reduced risk of obesity and metabolic syndrome. Rates of coronary heart disease 
(CHD), hypertension, and cancer in individuals following a Japanese diet have 
remained low compared to individuals following an American diet [47-49, 150, 151]. 
Likewise, consumption of a Mediterranean diet is associated with reduced risk of 
cardiovascular disease, type 2 diabetes and obesity compared to Western-style eating 
patterns [26, 152, 153]. In stark contrast to complex carbohydrate-rich diets, like 
Japanese and Mediterranean diet profiles, ketogenic or Atkins-type regimens, which 
consist primarily of fat and protein, are also widely popular for weight loss. An inherent 
assumption of diet regimens is that they alter cellular metabolism, particularly in 
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important metabolic tissues such as adipose and liver.  However, despite the widely 
accepted relationship between diet and health, and the prevalent use of diets for weight 
loss, relatively little is known about the fundamental impact of diet on metabolism at the 
tissue level.  
Mass spectrometry-based metabolomic platforms now enable global, discovery-
based profiling of tissue and circulating metabolomes. Accordingly, metabolomics has 
emerged as a tool with which to understand the impact of diet on metabolism and to 
identify metabolites and pathways that are associated with disease [90, 110, 154]. 
Metabolomics studies on the effects of diets in humans and mice frequently use 
samples that can be obtained noninvasively (e.g., plasma, erythrocytes or urine). Less 
is known, however, about the impact of diet at the tissue level, and the extent to which 
tissues may respond to diet in a similar manner. The objective of this study was to use 
metabolomics to determine the effects of diet on metabolomes at the tissue level and to 
associate tissue metabolites with systems level phenotypes of energy utilization and 
body composition in mice. Four common dietary profiles (American, Japanese, 
Mediterranean and ketogenic) were chosen because of their relationships to various 
aspects of metabolic health in humans, and because they vary widely in composition. 
Mouse diets were formulated to represent both the macronutrient profiles and sources 
that are characteristic of each of these four eating patterns, while maintaining similar 
caloric values and sufficient amounts of micronutrients. The C57BL/6J strain was used 
because it has been extensively characterized as a model of diet-induced obesity. Both 
males and females were used to evaluate the relative effects of diet, sex, and sex-by-
diet interaction on tissue metabolism. Untargeted metabolomics was used to 
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comprehensively profile the metabolomes of liver, skeletal muscle, and adipose tissue 
because of their roles in energy balance [155, 156].  
 
4.3 Materials and Methods 
4.3.1 Animals and Diets 
All husbandry and experimental procedures were approved by the Institutional 
Animal Care and Use Committee of the University of North Carolina. Four-week old 
C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice 
were allowed to acclimate for 14 days and consumed a standard mouse chow (PicoLab 
Mouse Diet 20, LabDiet, St. Louis, MO) during this period. At 42 days of age, five male 
and five female mice were assigned to each of five diets: American, Mediterranean, 
Japanese, ketogenic, or chow. Diets were designed in collaboration with Research 
Diets, Inc. (New Brunswick, NJ) to contain calories, macronutrient ratios, sources of 
ingredients, fiber content, and lipid profiles that are reflective of each diet pattern. (Table 
4.1, macronutrient ratios, Appendix I and J, detailed formulations). Mice were 
maintained on a 12-hour light/dark cycle throughout the study. At age 18 weeks, after 
12 weeks on the diets, mice were housed in Phenomaster metabolic chambers (TSE 
Systems, Inc.) for 48 hours for measurement of metabolic rate and activity. The 
chambers measured respiratory exchange rate (RER), volume of oxygen (VO2), and 
heat output via heat dissipation, and activity level by laser detection. Activity levels 
measured voluntary movement of the mouse in the x and y plane. Mice were 
euthanized at seven months of age by CO2 asphyxiation.  Perigonadal adipose tissue 
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was dissected and weighed as a measure of adiposity. Samples of adipose tissue, the 
left lobe of the liver and the vastus medialis, vastus lateralis, and rectus femoris muscle 
were snap-frozen in liquid N2 and stored at -80oC for metabolomics analysis. 
 
Table 4.1: Dietary Composition 
 Ketogenic 
D12052706 
American 
D12052705 
Mediterranean 
D12052702 
Japanese 
D12052703 
chow 
D12052701 
Fat 84% 
Butter, Lard 
35% 
Corn oil, butter, 
Olive oil 
42.6% 
Olive oil 
11% 
Soybean oil, 
Olive oil 
18% 
Soybean oil 
Carbohydrate None 50% 
Corn starch, 
Wheat starch, 
Sucrose, potato 
starch 
44.69% 
Wheat starch, 
Sucrose, Fructose 
76% 
Rice starch, 
Sucrose 
63% 
Corn starch 
Protein 16% 
Casein 
15% 
Soy, Beef, Egg 
white 
12.71% 
Soy, Fish, Beef 
13% 
Soy, Fish 
19% 
Casein 
 
4.3.2 Metabolite Extraction and Liquid Chromatography Mass Spectrometry 
Frozen tissue samples were pulverized under liquid N. Approximately 25 mg of 
pulverized tissue were weighed and extracted sequentially in methanol and then in 
methanol:water (4:1), as previously described [157]. Supernatants were dried under 
nitrogen and reconstituted in 160 μL of sterile MilliQ water. Internal standard (60 μL of a 
13C-labeled E.Coli metabolite pool) was added to each sample. 
4.3.3 Preparation of 13C-labelled E. Coli metabolite pool 
Cultures of Escherichia coli NCM3722 were grown on minimal media 13C-glucose 
agar plates and passed five times. Single colonies were then transferred to minimal 
media 13C-glucose liquid cultures (0.4% w/v made from 99% U-13C-glucose, Cambridge 
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Isotope Laboratories). Liquid cultures were set back five times before samples were 
extracted and run on mass spectrometer to ensure complete 13C-labeling of all 
metabolites. 
E. Coli cells were extracted by vacuum filtering three 10 mL aliquots, per culture, 
for three different cultures (grown to ~0.4 OD600) through Magna nylon membrane filters 
(0.45 micron, 47 mm filter, Maine Manufacturing, Sanford, ME). The filters were 
transferred face down into petri dishes containing 1.3 mL of extraction solvent (40:40:20 
HPLC grade methanol, acetonitrile, water with 0.1M formic acid) chilled to -20 ˚C. The 
extraction was allowed to proceed for 15 min at -20 ˚C. The following extraction was 
carried out in a room maintained at 4 ˚C unless otherwise specified. The filters were 
rotated so that the cell side was on top and rinsed by pipetting the extraction solvent 
over the face of the filters. The extraction fluid was then transferred to 1.5 mL centrifuge 
tubes and an additional 300 µL of new extraction fluid was used to wash the filters 
again. The remaining extraction solvent was also transferred to the 1.5 mL centrifuge 
tube and centrifuged for 5 minutes (16.1 rcf). The resulting supernatant was transferred 
to new vials and the pelleted cell was resuspended in 50 µL of extraction solvent. The 
extraction was allowed to proceed for 15 min at -20 ˚C at which time the samples were 
centrifuged for 5 min (16.1 rcf). The supernatant was transferred to the vials and 
another 50 µL of extraction solvent was added to the pelleted cell repeating the previous 
extraction once more. Vials containing all of the collected supernatant were dried under 
a stream of N2 until all the extraction solvent had been evaporated. Following the 
resuspension of extracted E. coli residue in 300 µL of sterile water, samples were 
physically averaged and 10 mL were directly spiked into unlabeled samples.  
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4.3.4 Metabolomics Data Processing 
Raw files generated by Xcalibur were converted to mzML, an open-source 
format, using msconvert [139]. An open source data analyzer for metabolomics, 
MAVEN [140, 141] (Princeton University) was used to correct total ion chromatograms 
based on retention time automatically, for each sample. Known metabolites were 
manually chosen and peak abundance was integrated by mass (±5 ppm) and retention 
time. Unknown metabolites were chosen using an algorithm with the following settings: 
minimum peak width, 5; minimum signal/blank ratio, 3 or greater; minimum peak 
intensity, 10,000; and minimum peak/baseline, 3.  Unknown peaks were filtered 
manually to remove those that did not meet the above criteria. 
4.3.5 Statistical Analysis 
All statistical analyses were performed in the language R (3.1.0 and 3.2.2) [158]. 
An ANOVA model was used to identify significant effects of diet, sex, and sex-by-diet 
interaction on physiological traits and metabolites. Tukey’s Honest Significant Difference 
(HSD) was used for post-hoc testing. Significance for physiological traits was based on 
raw p-values (p < 0.05). 
Metabolite peak area data files were read into R using the package XLConnect [159]. 
Metabolites that were missing 70% or more sample measurements were removed from 
analysis. Missing values in the remaining metabolites were imputed using k-nearest 
numbers from the function impute [160] (Additional File 1 and 2). Metabolites were 
matched to their corresponding 13C-labeled internal standard, or to a 13C-labeled 
standard of the same compound class. Class types were identified using the Human 
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Metabolome Database [143-145]. Prior to statistical analyses, a linear model was 
created for each metabolite using the terms sex, diet, sex*diet, tissue weight and 
internal standard (eq. 4.1): 
 
Equation 4.1 
Metabolite = sex + diet + sex*diet + tissue weight + internal s tandard ?
 
Coefficients for the terms for tissue weight and internal standard were used to 
adjust metabolite abundance for technical variation using eq. 4.2: 
 
Equation 4.2 
Adjusted metabolite =metabolite+ tissue weight coefficient(mean tissue weight −
tissue weight)+ internal s tandard coefficient(mean internal s tandard −
internal s tandard)
 
 
Adjusted metabolites were Pareto scaled across all mice for each metabolite 
using the package MetabolAnalyze [161], normalized to the median across all 
metabolites for each mouse, and cube root transformed to create a normal distribution. 
Normalized metabolite values were analyzed for effects of sex, diet and sex*diet. Data 
were assessed for normality using Q-Q plots, residuals, and the Shapiro-Wilks test. 
False discovery rate for ANOVA and correlation analyses was set to 5% using the 
method of Benjamin-Hochberg [162]. Venn diagrams were created using the package 
VennDiagram [163].  
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4.3.6 Correlation Analysis 
Associations between physiological measurements and metabolite 
measurements across tissues were assessed using Pearson correlation from the 
package Hmisc [164] and the package R.Utils [165]. Correlation p-values were FDR-
adjusted using the Benjamini-Hochberg procedure. Correlations were visualized using 
the Cytoscape app Metscape [166].   
4.3.7 Functional Pathway Analysis 
Overrepresentation pathway analysis was performed using Metaboanalyst [167]. 
KEGG IDs were input and compared against the mouse KEGG reference metabolome. 
Statistical significance of pathway overrepresentation was evaluated using Fisher’s 
exact test. Pathway topology was performed using relative-between centrality. 
 
4.4 Results 
4.4.1 Physiological Measurements Reveal Differences Among Diet and Sex-by-
diet 
Body composition and indirect calorimetry were used to define system-level 
effects of diet and sex on metabolism. Body weight, adiposity, oxygen consumption 
(VO2), respiratory exchange ratio (RER), and heat output were all significantly 
influenced by diet but in a sex-dependent manner (psex X diet < 0.05; Table 4.2).  In 
contrast, activity level was significantly affected by sex (p = 0.036) but not by diet or 
sex-by-diet interaction. Females consuming the Mediterranean diet were significantly 
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heavier than those fed the ketogenic or standard chow diets and numerically heavier 
than all four diet groups (Fig. 4.1A). Ketogenic females also weighed significantly less 
than those consuming the American diet (Fig. 4.1A).  The heaviest males were those 
eating the American diet, which weighed significantly more than males fed the standard 
or Japanese diets (Fig. 4.1A). Evidence of interaction between sex and diet were clearly 
visible in adipose tissue, particularly with regard to the ketogenic diet.  This diet 
produced the leanest females but the fattest males, based on relative weight of the 
abdominal fat pad (Fig. 4.1B). Ketogenic diet females were significantly leaner than 
Mediterranean females. The Japanese diet yielded the leanest males (2.1 ± 0.71%), 
which had significantly less adipose tissue than those fed the Mediterranean (4.96 ± 
0.24%, p=0.015), ketogenic (6.25 ± 1.15%, p=0.006), and American (4.29 ± 0.94%, 
p=0.002) diets. Oxygen consumption in both sexes was lowest in mice consuming the 
Japanese diet, which is consistent with its lower fat content compared to other diets 
(Fig. 4.1C). Differences in fat and carbohydrate content of the diets were reflected in 
RER values, which were comparable between males and females. Mice of both sexes 
consuming the ketogenic diet had the lowest RER values (0.73), and differed 
significantly from all other diets (Fig. 4.1D). In males, the high carbohydrate content of 
the Japanese diet was reflected in a significantly higher RER value than in all other 
diets. Heat output (an indicator of energy expenditure), was higher in females than 
males across diets. In both sexes, heat output was lowest in mice fed the Japanese diet 
and highest in those on the ketogenic diet (Fig. 4.1E). Activity levels varied but were not 
significantly affected by diet or sex-by-diet (Fig. 4.1F).    
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Table 4.2: P-values for Effects of Sex, Diet, and Sex-by-diet Interaction on Weight and Metabolism. 
 Sex Diet Sex-by-diet 
Weight <0.001 <0.001 0.013 
Adiposity 0.004 0.005 0.001 
VO2 0.002 <0.001 0.302 
RER 0.222 <0.001 0.004 
Heat Output <0.001 <0.001 0.011 
Activity 0.036 0.367 0.856 
p<0.05 is considered significant 
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Figure 4.1: Effects of sex and diet on weight and metabolic phenotypes; N=5/ sex and diet group, 
avg. ± std. dev. Dots represent individual mice within sex-by-diet combination. Horizontal bars 
represent pairwise comparisons performed using Tukey’s HSD post-hoc analysis; * p<0.05, ** 
p<0.01, and *** p<0.001 Body weight (A) and adiposity (B) were measured at 28 weeks of age, after 
16 weeks on the experimental diets. Adiposity is expressed as the relative weight of the 
perigonadal adipose fat pads. Oxygen consumption (C), RER (D), heat output (E), and activity (F) 
were measured during a 48 hr. period when mice were housed in Phenomaster metabolic cages.   
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4.4.2 Significant Effects of Sex, Diet, and Sex-by-diet Interaction on Tissue 
Metabolomes 
Liver, skeletal muscle, and adipose tissue are fundamental to systemic energy 
balance and play central roles in the body’s response to diet. Global metabolomic 
profiling of these tissues was used to characterize the effects of sex and diet on tissue 
metabolism. A total of 184 known compounds, those for which m/z and retention time 
have been mapped to specific metabolites on our platform, were detected in one or 
more tissues. In addition, several thousand features corresponding to unknown 
metabolites (6,245, 4,909, and 4, 477) were detected in liver, skeletal muscle, and 
adipose tissue, respectively.   
An ANOVA model was used to identify metabolites that were robustly affected by 
sex, diet, and sex-by-diet interaction (Appendix A, Additional File 3, Fig. 4.2). A total of 
85 metabolites (46% of all known metabolites detected) were significantly affected (FDR 
< 0.05) by diet, sex, or diet interacting with sex in one or more tissues (Fig. 4.2A). 
Approximately one-third (28 of 85) of these metabolites were influenced by diet in a sex-
dependent manner in at least one tissue.  Some metabolites differed only by sex (23), 
with no influence of diet in any tissue. Likewise, 18 metabolites differed only between 
diets, with no impact of sex in any tissue. Of the 41 known metabolites that were 
significantly affected in one or more tissues by diet or sex-by-diet interaction, only two 
(proline and hydroxyproline) were altered in all three tissues (Appendix A). 
The impact of both sex and diet on tissue metabolomes was most apparent in 
liver. Twenty-six metabolites responded to the variation in diets but in a manner that 
differed between males and females (Fig. 4.2B). An additional 30 metabolites were 
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affected by diet similarly in both sexes. Likewise, 31 metabolites differed between males 
and females independently of diet effects. Nineteen metabolites were only affected by 
sex and showed no response to diet, while 18 differed between diets but not between 
males and females. In contrast to liver, the majority of metabolites in muscle and 
adipose tissue did not show sex-dependent responses to diet (Figs. 4.2C, D).  Only 
three metabolites were significant for sex-by-diet interaction in adipose tissue (Fig. 
4.2C), and none in muscle (Fig. 4.2D). Within adipose tissue the relative effect of sex 
was greater than that of diet, with eight metabolites differing significantly between males 
and females (Fig. 4.2C). Only three metabolites were affected by diet alone.  Fourteen 
metabolites showed effects of sex in muscle, and 11 of diet, with four influenced by both 
factors independently (Fig. 4.2D). Unsupervised hierarchical clustering was performed 
to visualize the relatedness of each of the 10-sex/diet groups, based on similarities 
between hepatic metabolomes (Fig. 4.3).  Males and females clustered separately, 
indicating that the effect of diet did not override intrinsic metabolic differences between 
males and females. 
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Figure 4.2: Shared and unique effects of sex, diet, and sex-by-diet interactions on tissue 
metabolomes. The sets of metabolites that differed significantly, based on ANOVA (FDR < 0.05) 
by sex, diet, or sex-by-diet interaction across tissues, (A), and in liver (B), adipose (C), and 
muscle (D) were visualized for shared and factor-specific effects using Venn diagrams. Only sex 
and diet are shown for muscle (D) because there were no metabolites significantly affected by the 
interaction term in the ANOVA model. Metabolites significantly affected by the interaction term 
were excluded from those significant for main effects of sex or diet.   
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Figure 4.3: Hierarchical clustering of sex/diet groups based on metabolite abundance in liver. 
Heatmaps were generated in Metaboanalyst (v3.0) using group averages of the 50 metabolites 
that varied the most across sex and diet combinations.  Samples were normalized to median 
values and values were scaled using Pareto scaling.  Z-score was used to determine scale. 
Abbreviations: Deoxyribose-P: Deoxyribose-phosphate, 6-P-Gluconate: 6-phosphogluconate, 
G1/6P: Glucose-1/6-phosphate, Sedoheptulose-BP: Sedoheptulose-bisphosphate, G3P: Glycerol-
3-phosphate 
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4.4.3 Functional Annotation of Diet and Sex Effects 
The sets of metabolites affected by the interaction between diet and sex, and by 
sex and diet independently, were functionally annotated using KEGG pathways (Table 
4.3, Fig. 4.4). Sex and diet interacted to significantly affect purine metabolism in liver (p 
< 0.001), with nine metabolites mapping onto this pathway (referred to as hits). 
Interactions between sex and diet also influenced amino acid metabolism. Six 
metabolites are included in the KEGG pathway aminoacyl-tRNA biosynthesis (p = 
0.001), which represents incorporation of amino acids into protein. Additional pathways 
(pantothenate and CoA biosynthesis, arginine and proline metabolism, and valine, 
leucine, and isoleucine biosynthesis) contain metabolites that were affected by sex-by-
diet interaction but were not significantly overrepresented after adjusting for FDR ( > 
0.05). Metabolites affected by diet, independently of sex, also represented components 
of amino acid metabolism, including an additional four metabolites in the aminoacyl-
tRNA biosynthesis pathway. Other aspects of amino acid metabolism (e.g., arginine and 
proline metabolism) were represented by at least two metabolites. Only two metabolites 
affected by diet are components of the TCA cycle. Sex affected aspects of pyrimidine 
(hits=3), riboflavin (hits=2), and beta-alanine (hits=2) metabolism, as well as 
pantothenate and CoA biosynthesis (hits=2) but no pathways were significantly 
overrepresented (FDR > 0.05).  
Diet significantly affected amino acid metabolism (aminoacyl-tRNA biosynthesis, 
p = 0.002) in muscle, but metabolites affected by sex did not map onto specific KEGG 
pathways (i.e., < 2 metabolites/pathway). In adipose tissue, the eight metabolites that 
differed between males and females included components of purine metabolism (hits=3)  
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Table 4.3: KEGG Pathway Enrichment of Metabolites Affected by Diet, Sex and Sex-by-diet 
Interaction. 
Tissue Factor Pathway Hits P-value (k/m)q 
All Tissues Sex-by-diet Purine metabolism 10 <0.001 0.002 
  Aminoacyl-tRNA biosynthesis 7 <0.001 0.002 
      
 Diet Arginine and proline metabolism 5 <0.001 0.004 
      
 Sex Purine metabolism 6 0.002 0.002 
      
Liver Diet Arginine and proline metabolism 4 0.001 0.003 
      
 Sex-by-diet Purine metabolism 9 <0.001 0.005 
  Aminoacyl-tRNA biosynthesis 6 0.001 0.005 
      
Muscle Diet Aminoacyl-tRNA biosynthesis 3 0.002 0.02 
      
Adipose Sex Purine metabolism 3 0.003 0.013 
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Figure 4.4: Sex-by-diet influenced purine metabolism. Purine metabolites affected by sex-by-diet 
were plotted. Horizontal bars represent significant pairwise comparisons performed using 
Tukey’s HSD post-hoc analysis; * p<0.05, ** p<0.01, *** p<0.001. 
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and arginine and proline metabolism (hits=2). The small numbers of metabolites 
affected by sex-by-diet interaction (hits=3) or diet alone (hits=2) in adipose tissue were 
not matched to pathways. 
4.4.4 Relationships Between Known Metabolites and Phenotypes 
The relationships between metabolite profiles in each tissue and systems level 
energy balance traits were identified using a correlation-based approach.  Energy 
expenditure and adiposity were significantly correlated with 27 and 20 metabolites, 
respectively, across the three tissues, with the majority of associations due to hepatic 
(17 heat, 12 adiposity) and adipose (5 heat, 8 adiposity) metabolomes (Fig. 4.5). Partial 
correlation was used to adjust for spurious correlations to body weight, after which 15 (4 
in adipose and 11 in liver) metabolites remained significantly correlated with adiposity 
and 19 (5 in adipose and 16 in liver) with heat output. In muscle, four metabolites 
(pantothenate, N-acetyl-glutamate, orotate, and kynurenine) were correlated with heat 
output and none with adiposity.  
The relationships between tissue metabolites and systems level energy balance 
traits were assessed by constructing a correlation-based network. The network consists 
of metabolites (39, 8 and 5 from liver, adipose and muscle, respectively) that were 
significantly correlated with at least one energy balance trait and with one or more 
metabolites in any of the three tissues (Fig. 4.6, Appendix B). The majority of the 
metabolites that were correlated within and across all tissues were purine metabolites, 
amino acids, and energy molecules. Pantothenate, vitamin B5, is a metabolite that is 
necessary for coenzyme A synthesis. Pantothenate in skeletal muscle was positively 
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correlated with pantothenate (r=0.68) in adipose tissue. Pantothenate in both tissues 
was positively correlated with aminoadipic acid (adipose, r=0.59; muscle, r=0.46), 
allantoate (r=0.58, 0.69), and butyryl-CoA (r=0.51, 0.47) and negatively correlated with 
n-acetyl-glutamine (r=-0.66, -0.73), n-acetyl-L-alanine (r=-0.57, -0.49), in liver. 
Pantothenate in both tissues was also positively correlated with s-adenosyl-L-
homoCysteine (r=0.66, 0.51) in adipose tissue. Another B vitamin, riboflavin, in liver, 
was positively correlated with adiposity (r=0.50); however, it was not correlated with any 
metabolites in adipose or skeletal muscle. Methionine, in liver, was negatively correlated 
with arginine (r=-0.47), erythrose-4-phosphate (r=-0.48), and lysine (r=-0.48), in skeletal 
muscle.  Riboflavin is necessary for the formation of FAD and FMN. 
 
4.5 Discussion 
Diet is a primary determinant of health, but the fundamental relationship between 
dietary intake and metabolism at the tissue level is poorly understood. We used an 
untargeted metabolomics approach to investigate the effects of diet and sex on tissue 
metabolomes, and to relate metabolites to body composition and energy expenditure.  
Experimental diets were designed to model eating patterns (American, Japanese, 
Mediterranean, and ketogenic) that are known to affect various aspects of metabolic 
health in humans. Diet composition varied widely in terms of the sources of ingredients, 
relative contribution of animal- and plant-based ingredients, and macronutrient and 
micronutrient composition.  In combination with sex, these diets imposed a strong and 
diverse stimulus on tissue metabolism. This allowed us to query the extent to which 
tissue metabolomes were influenced by diet, sex, and their interactions, and to  
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Figure 4.5: Correlations between metabolites and system phenotypes.  Pearson correlation was 
used to associate metabolites in adipose (A), muscle (B), and liver (C) with weight, adiposity, and 
metabolic phenotypes. Significant correlations (FDR < 0.05) are represented by an asterisk (*). For 
metabolites that were significantly correlated for adiposity and/or heat output, partial correlation 
was used to determine if the relationship between metabolite and trait was due to spurious 
correlation with body weight. Correlations that remained significant are indicated by a bold 
asterisk (*). 
70 
 
Figure 4.6: Cross-tissue metabolite and phenotype network.  Pearson correlation was used to 
associate metabolites within and across each tissue with weight, adiposity, and metabolic 
phenotypes. Only significant correlations (FDR < 0.05) are shown. To assess relationships within 
and across tissues and phenotypes, metabolites are clustered by their respective tissue or 
phenotype. The size of each node represents the number of edges connected to the node. A red 
line represents positively correlated metabolites, while a blue line represents negatively 
correlated metabolites.  
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characterize their relative impact on liver, adipose tissue, and skeletal muscle.  Our 
model, which included 10 unique combinations of diet and sex, also enabled us to use 
correlation to relate metabolites to body composition and energy expenditure.  
Because of the sex-dependent effects of diet on weight and energy expenditure 
phenotypes, we expected that a considerable proportion of metabolites would be 
influenced by diet in a sex-dependent manner. This was true in liver, in which the 
number of metabolites affected by the interaction (n=26) was comparable to those 
responding to diet (n=30) and sex (n=31) independently. In contrast, the metabolomes 
of adipose tissue and muscle showed little evidence of sex-specific response to diet, 
which may be due to the fact that liver is one of the first tissue to receive and digest 
nutrients from the diet. Only three metabolites responded to diet in a sex-dependent 
way in adipose tissue, and none in muscle. Approximately one-third (9 of 27) of 
metabolites in liver that were influenced by sex-by-diet interactions are involved in 
purine metabolism. Purine metabolism includes the synthesis and breakdown of purine 
nucleotides, which are building blocks of nucleic acids and cofactors that are required 
for energy metabolism.  While these functions are fundamentally important for all cells, 
recent metabolomic studies associate this pathway with adaptation to energetic 
challenges and to metabolic syndrome. Progressive exposure to cold rapidly increased 
purine metabolites in brown adipose tissue, in parallel with mitochondrial thermogenesis 
[168].   No effects of cold exposure were observed in white adipose from the same 
animals, suggesting a relationship to mitochondrial uncoupling and fatty acid oxidation.  
Metformin is a widely used anti-diabetic drug that improves glycemia and lipidemia 
through the energy-sensing kinase AMPK and other targets in liver. Metformin 
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administration to diet-induced obese increased purine metabolites in serum [169]. 
Circulating levels of purine metabolites have also been shown to discriminate between 
obese patients with and without metabolic syndrome [170]. How flux through the purine 
metabolism pathway may regulate cellular utilization is not yet clear. One potential 
mechanism is through effects on 5-Aminoimidazole-4-carboxamide ribonucleotide 
(AICAR), an intermediate in the de novo purine synthesis pathway  [171]. AICAR 
interacts with the gamma subunit of AMPK, inducing a conformational change that 
enhances its phosphorylation and activation [172]. This AMP-mimicking action of AICAR 
has resulted in its widespread use as an AMP analog in experimental studies, although 
the physiological effects of endogenous AICAR in mammals are unknown [173]. We 
recently proposed that endogenous AICAR mediates anti-obesity actions of the 
polyherbal supplement Zyflamend, which both alters tissue purine metabolism and 
activates AMPK [174]. Whether AICAR levels were altered in the current study has not 
been determined because we do not consistently detect it with sufficient sensitivity for 
quantitation in tissues. Additional, more focused studies are necessary to determine the 
consequences of variation in purine metabolism and how this pathway might influence 
the response to diet. 
Various aspects of amino acid metabolism were influenced by sex-by-diet 
interactions in liver, as well as by diet alone in muscle.  Twelve of the 20 amino acids 
differed between diets in at least one tissue, along with numerous amino acid 
metabolites. The percentage of protein in each diet was sufficient for mice but varied 
across diets (from ~ 13 – 19%). In addition, different types of protein were used, from 
both plant and animal sources.  Some of the effects of diet may therefore be attributed 
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to variation in amino acid composition of the diets.  Other changes in amino acids and 
their metabolites likely resulted from metabolic adaptations to varying levels of 
carbohydrates and fat. Metabolomic studies have been valuable in identifying 
relationships between amino acid metabolism and various aspects of metabolic health 
that had previously gone undetected [175-177]. In particular, several analyses of the 
serum metabolome in humans have revealed a link between branched chain amino acid 
metabolism and cardiometabolic health [117, 178]. A recent, large scale study of 
individuals in the Framingham Offspring cohort determined that a broad collection of 
serum amino acids, and not just branched chain species, are associated with abdominal 
obesity, BMI, insulin resistance, lipidemia and other metabolic traits [119]. Our study 
design was not of sufficient scope to link specific tissue amino acid levels to the 
metabolic traits that we measured. We also did not profile the serum metabolome and 
thus cannot determine how tissue amino acid changes are reflected in those in 
circulation.  Nonetheless, assuming that these tissues contribute to serum amino acid 
profiles, our results suggest that diet may influence the risk of metabolic disease 
through effects on tissue amino acid metabolism.  
The Framingham Offspring cohort study described above also identified 
aminoadipic acid, which we found to be significantly influenced by diet in liver and 
muscle, as a novel metabolite that predicts future development of type 2 diabetes in 
normoglycemic individuals [119].  Other metabolomic studies have also associated this 
metabolite, which is a poorly understood intermediate in lysine catabolism, with 
metabolic health in humans [170] and in Zucker rats. Levels of aminoadipic acid in 
serum are elevated years prior to the development of insulin resistance in humans 
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[122].  Experimental studies show that it augments the hypoglycemic actions of insulin, 
suggesting an adaptive role in maintaining glucose homeostasis. Despite its emerging 
role in metabolic disease, little is known about dietary regulation of aminoadipic acid. 
Consumption of beef was shown to acutely increase plasma levels of aminoadipic acid, 
compared to a meal containing fish [179]. However in our study, tissue levels were 
lowest in the Japanese and Mediterranean diets, one of which (Japanese) is devoid of 
bovine protein while the other (Mediterranean) derived almost 70% of its protein from 
bovine sources (beef and casein).  Therefore although we cannot identify a specific 
dietary component that regulates aminoadipic acid levels, the significant impact of diet 
in both muscle and liver in our results warrant future investigation into this relationship.  
Given that the experimental diets used in this study are associated with pro- or 
anti-obesogenic effects, the relatively modest impact of diet on the adipose metabolome 
is somewhat surprising. Only five metabolites were significantly affected by diet, either 
alone (n=3) or through interaction with sex (n=2). One of these metabolites, 3-
methylphenylacetic acid, is a metabolite of common herbicides [143-145]. Interestingly, 
this metabolite was significantly more abundant in adipose tissue from mice fed the 
Japanese diet, which contains the highest proportion of plant-derived ingredients (e.g., 
rice starch, soy protein).  Many organic pollutants have been shown to accumulate in 
the lipid-rich matrix of adipose tissue and to increase risk of obesity and metabolic 
disease.  Although we are not aware of such associations for 3-methylphenylacete, its 
significant enrichment emphasizes the potential for unintended consequences of 
experimental diets on tissue metabolomes.  
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Sex influenced the adipose metabolome more so than diet, based on both the 
ANOVA results and unsupervised clustering. Notably, pantothenate levels differed 
significantly by sex, with increased levels in adipose tissue from females.  Comparable 
differences were seen in skeletal muscle, and levels in both tissues correlated 
significantly with energy expenditure. Pantothenate plays a pivotal role in energy 
metabolism because it is the substrate from which Coenzyme A (CoA) is synthesized. 
This essential nutrient is provided in the diet and actively transported into tissues. 
Pantothenate kinase is the rate-limiting enzyme for synthesis of CoA from pantothenate, 
and is under nutritional, hormonal, and allosteric control [180-182].  Differences in tissue 
pantothenate content between males and females may therefore be due to sex effects 
on pantothenate uptake or on regulation of its conversion to CoA.  Either way, the 
relationship between energy expenditure and pantothenate in both adipose tissue and 
muscle suggests that CoA levels contribute to metabolic differences between males and 
females. Although pantothenate levels were not affected by diets included in this study, 
according to the network analysis they were correlated with seven metabolites across 
tissues, including aminoadipic acid suggesting a potential relationship between 
pantothenate and potential predictors of disease.  Collectively, these relationships 
suggest that pantothenate availability or uptake may be an important variable in 
metabolic disease. Interestingly, pantothenate supplementation was recently shown to 
attenuate the consequences of a high sucrose diet on lipid metabolism in Drosophila 
[183].  
While our focus was on tissue metabolomes, effects of the ketogenic diet on 
adiposity were notable. Ketogenic diets are popular for weight loss, although clinical 
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studies do not consistently support their efficacy. Studies in rodents have shown that a 
ketogenic diet paradoxically increases the percentage of body fat, often at the expense 
of lean mass and despite increased energy expenditure [184, 185]. Our data from males 
are consistent with these studies, all of which also used only male mice. In contrast, 
ketogenic diet females in our study had the lowest adiposity of all diets, although some 
pairwise comparisons to other diets were not significantly different. Both males and 
females had the lowest RER values, suggesting that fat utilization was comparably 
affected in both sexes. To our knowledge, ours is the first study to demonstrate sex-
specific effects of a ketogenic diet on body composition.  
Several limitations of our study should be emphasized.  In particular, the diets 
were designed to reflect common patterns of global consumption in humans. 
Accordingly, we cannot the range of variation in diet composition prevents us from 
associating specific dietary factors with metabolite patterns. We have also measured 
metabolites at a single time point. Effects of diet or sex on metabolite turnover therefore 
go undetected in our study. Furthermore, the extraction method we used targets polar 
metabolites at the expense of lipids, which are also likely subject to extensive sex and 
diet regulation. Finally, due to the specificity of the extraction method and the limited 
number of metabolites that can be identified using our in-house database, it is difficult to 
ascertain whether pathways significantly altered are affected by sex, diet or sex-by-diet 
interaction or because a metabolite is more easily identified to due inherent biases in 
the experimental procedure. 
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4.6 Conclusion 
We profiled three tissues (adipose, muscle, and liver), which play a major role in 
energy metabolism to determine the effects of diet and sex on the tissue metabolome. 
The stratified results showed tissue-specific effects of sex and diet on tissue 
metabolites. This study, however, was performed in the context of a single genetic 
background. Including other genetic backgrounds may reveal a more complex 
relationship between the tissue metabolome and diet. Nonetheless, this study has 
shown several metabolites that could be investigated to determine their role in 
metabolism and disease. 
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CHAPTER FIVE  
TISSUE LEVEL STRAIN AND SEX-BY-STRAIN INTERACTIONS 
REVEAL UNIQUE METABOLITE AND CLUSTERING PROFILES USING 
UNTARGETED LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY 
ON ADIPOSE, SKELETAL MUSCLE, AND LIVER TISSUE IN MICE FED 
A STANDARD CHOW DIET 
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5.1 Abstract 
Genetics have been shown to play an important role in the development of 
metabolic diseases. Despite the known role of genetics in metabolic diseases it is 
unknown how genetic background alters metabolism at the tissue level, particularly 
when fed the same diet. Using untargeted metabolomics, this study aimed to identify 
changes in water-soluble metabolites in A/J, C57BL/6J, FVB/NJ, and NOD/ShiLtJ males 
and females, fed a standard mouse chow diet for seven months. Metabolite abundance 
was examined in liver, skeletal muscle, and adipose tissue for sex, strain, and sex-by-
strain interaction. Females were lighter than males, independent of strain. A/J females 
had more adiposity than all other sex-by-strain combinations. ANOVA suggests that 
liver is most metabolically active across different genetic backgrounds, although 
adipose and muscle tissue were sensitive to genetic differences as well. Purine 
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metabolism and pathways that played a role in amino acid metabolism were significantly 
altered (FDR < 0.05) by strain in adipose and liver. All three tissues were largely 
unaffected by sex or sex-by-strain interaction relative to strain, suggesting that the 
tissue metabolome remains largely stable across genders consuming the same diet. 
This study revealed that no one strain had the predominant affect on physiology. 
Metabolomics revealed that strain affected the metabolome in a tissue-specific manner; 
however, liver was most sensitive to genetic differences. 
 
5.2 Introduction 
 Genetics have been shown to play an important role in the development of 
metabolic diseases, such as type 2 diabetes [186, 187], cardiovascular disease [188-
190], and obesity [191, 192]. Furthermore, markers for fasting glucose and insulin, body 
mass index, and triglycerides have been linked to genetic loci, independent of the 
disease state [191, 193, 194]. Despite the known role of genetics in metabolic diseases 
it is unknown how genetic background alters metabolism at the tissue level, particularly 
when fed the same diet.  
Due to the inherent genetic differences in humans it can be difficult to ascertain 
the role of genes associated with metabolic states. Moreover, investigating the role of 
metabolism at the tissue level is difficult at best in humans. Mice are an ideal alternative 
due their genetic similarity, inherent compliance, and replicative ability. Accordingly, the 
severity of disease due to genetic background has been shown through phenotypic 
markers in mice [82, 91]. Four strains of mice (A/J, C57BL/6J, FVB/NJ, and 
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NOD/ShiLtJ) were chosen to represent different metabolic states, both diseased and 
non-diseased. A/J mice are susceptible to cancer; however, they are resistant to 
diabetes, obesity, atherosclerosis, insulin resistance, and glucose intolerance [78, 84, 
87]. In contrast, C57BL/6J mice are susceptible to diet-induced obesity, type 2 diabetes, 
and atherosclerosis [78, 82, 89-91]. FVB/NJ mice are susceptible to certain cancers, 
have higher basal body temperature, activity, and anxiety levels [93, 94]. NOD/ShiLtJ 
mice are a model for type 1 diabetes [96]. In addition NOD/ShiLtJ females are the first 
to show decreased in pancreatic insulin, while males express this phenotype weeks 
later [81].  
Mass spectrometry-based metabolomic platforms now enable global, discovery-
based profiling of tissue and circulating metabolomes. Metabolomics has emerged as a 
tool to understand the impact of genetics on metabolism and identify metabolites and 
pathways that are associated with disease [96, 195]. Furthermore, metabolomics 
studies are typically limited to samples that can be obtained noninvasively (e.g., plasma, 
erythrocytes or urine). Less is known, however, about the impact of genetics at the 
tissue level, and the extent to which tissues respond to genetics in a similar manner 
when fed the same diet. The objective of this study was to use metabolomics to address 
the fundamental question of how genetics, which can vary widely, affect tissue 
metabolomes and to associate tissue metabolites with systems level phenotypes of 
energy utilization and body composition in mice. This was accomplished by comparing 
the effects of genetic differences, using A/J, C57BL/6J, FVB/NJ, and NOD/ShiLtJ males 
and females fed a standard chow diet, on metabolism in liver, skeletal muscle, and 
adipose tissues, in the context of a single diet. Males and females were used to 
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evaluate the relative effects of strain, sex, and sex-by-strain interaction on tissue 
metabolism. Untargeted metabolomics was used to comprehensively profile the 
metabolomes of liver, skeletal muscle, and adipose tissue because of their roles in 
energy balance [155, 156].  
 
5.3 Materials and Methods 
5.3.1 Animals and Diets 
All husbandry and experimental procedures were approved by the Institutional 
Animal Care and Use Committee of the University of North Carolina. Four-week old A/J, 
C57BL/6J, FVB/NJ, and NOD/ShiLtJ mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME). Mice were allowed to acclimate for 14 days and 
consumed a standard mouse chow (PicoLab Mouse Diet 20, LabDiet, St. Louis, MO) 
with 23.2% of calories provided by protein. At 42 days of age, five male and five female 
mice were switched to a marginally lower protein standard chow diet (19% protein). 
Mice were maintained on a 12-hour light/dark cycle throughout the study. At age 18 
weeks, after 12 weeks on the diets, mice were housed in Phenomaster metabolic 
chambers (TSE Systems, Inc.) for 48 hours for measurement of metabolic rate and 
activity. The chambers measured respiratory exchange rate (RER), volume of oxygen 
(VO2), and heat output via heat dissipation, and activity level by laser detection. Activity 
levels measured voluntary movement of the mouse in the x and y plane. Mice were 
euthanized at seven months of age by CO2 asphyxiation.  Perigonadal adipose tissue 
was dissected and weighed as a measure of adiposity. Samples of adipose tissue, the 
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left lobe of the liver and the vastus medialis, vastus lateralis, and rectus femoris muscle 
were snap-frozen in liquid N and stored at -80oC for metabolomics analysis. 
5.3.2 Metabolite Extraction and Liquid Chromatography Mass Spectrometry 
Frozen tissue samples were pulverized under liquid N. Approximately 25 mg of 
pulverized tissue was extracted sequentially in methanol and then in methanol:water 
(4:1), as previously described [157]. Supernatants were dried under nitrogen and 
reconstituted in 160 μl of sterile MilliQ water. Internal standard (60 μL of a 13C-labeled 
E.Coli metabolite pool) was added to each sample. 
5.3.3 Preparation of 13C-labelled E. Coli metabolite pool 
Cultures of Escherichia coli NCM3722 were grown on minimal media 13C-glucose 
agar plates and passed 5 times. Single colonies were then transferred to minimal media 
13C-glucose liquid cultures (0.4% w/v made from 99% U-13C-glucose, Cambridge 
Isotope Laboratories). Liquid cultures were set back 5 times before samples were 
extracted and run on mass spectrometer to ensure complete 13C-labeling of all 
metabolites. 
E. coli cells were extracted by vacuum filtering three 10 mL aliquots, per culture, 
for three different cultures (grown to ~0.4 OD600) through Magna nylon membrane filters 
(0.45 micron, 47 mm filter, Maine Manufacturing, Sanford, ME). The filters were 
transferred face down into petri dishes containing 1.3 mL of extraction solvent (40:40:20 
HPLC grade methanol, acetonitrile, water with 0.1M formic acid) chilled to -20 ˚C. The 
extraction was allowed to proceed for 15 min at -20 ˚C. The following extraction was 
carried out in a room maintained at 4 ˚C unless otherwise specified. The filters were 
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rotated so that the cell side was on top and rinsed by pipetting the extraction solvent 
over the face of the filters. The extraction fluid was then transferred to 1.5 mL centrifuge 
tubes and an additional 300 µL of new extraction fluid was used to wash the filters 
again. The remaining extraction solvent was also transferred to the 1.5 mL centrifuge 
tube and centrifuged for 5 minutes (16.1 rcf). The resulting supernatant was transferred 
to new vials and the pelleted cell was resuspended in 50 µL of extraction solvent. The 
extraction was allowed to proceed for 15 min at -20 ˚C at which time the samples were 
centrifuged for 5 min (16.1 rcf). The supernatant was transferred to the vials and 
another 50 µL of extraction solvent was added to the pelleted cell repeating the previous 
extraction once more. Vials containing all of the collected supernatant were dried under 
a stream of N2 until all the extraction solvent had been evaporated. Following the 
resuspension of extracted E. coli residue in 300 µL of sterile water, samples were 
physically averaged and 10 mL were directly spiked into unlabeled samples.  
5.3.4 Metabolomics data Processing 
Raw files generated by Xcalibur were converted to mzML, an open-source 
format, using msconvert[139]. An open source data analyzer for metabolomics, MAVEN 
[140, 141] (Princeton University) was used to correct total ion chromatograms based on 
retention time automatically, for each sample. Known metabolites were manually 
chosen and peak abundance was integrated by mass (±5 ppm) and retention time. 
Unknown metabolites were chosen using an algorithm with the following settings: 
minimum peak width, 5; minimum signal/blank ratio, 3 or greater; minimum peak 
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intensity, 10,000; and minimum peak/baseline, 3.  Unknown peaks were filtered 
manually to remove those that did not meet the above criteria. 
5.3.5 Statistical Analysis 
All statistical analyses were performed in the language R (3.1.0 and 3.2.2) [158]. 
An ANOVA model was used to identify significant effects of sex, strain, and sex-by-
strain interaction on physiological traits and metabolites. Tukey’s Honest Significant 
Difference (HSD) was used for post-hoc testing. Significance for physiological traits was 
based on raw p-values (p < 0.05). 
Metabolite peak area data files were read into R using the package XLConnect 
[159]. Metabolites that were missing 70% or more sample measurements were removed 
from analysis. Missing values in the remaining metabolites were imputed using k-
nearest numbers from the function impute [160] (Additional File 1 and 2). Metabolites 
were matched to their corresponding 13C-labeled internal standard, or to a 13C-labeled 
standard of the same compound class. Class types were identified using the Human 
Metabolome Database [143-145]. The actual weight of tissue that was extracted and the 
peak intensity of the corresponding internal standard were used as covariates in 
statistical analyses.  
Prior to statistical analyses, a linear model was created for each metabolite using the 
terms sex, strain, sex* strain, tissue weight and internal standard (eq. 5.1): 
 
Equation 5.1  
Metabolite = sex + strain+ sex* strain+ tissue weight + internal s tandard ?
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Coefficients for the terms for tissue weight and internal standard were used to 
adjust metabolite abundance for technical variation using eq. 5.2: 
 
Equation 5.2 
Adjusted metabolite =metabolite+ tissue weight coefficient(mean tissue weight −
tissue weight)+ internal s tandard coefficient(mean internal s tandard −
internal s tandard)
?
  
 
Adjusted metabolites were Pareto scaled across all mice for each metabolite 
using the package MetabolAnalyze [161], normalized to the median across all 
metabolites for each mouse, and cube root transformed to create a normal distribution. 
Normalized metabolite values were analyzed for effects of sex, diet and sex*diet. Data 
were assessed for normality using Q-Q plots, residuals, and the Shapiro-Wilks test. 
False discovery rate for ANOVA and correlation analyses was set to 5% using the 
method of Benjamin-Hochberg [162]. Venn diagrams were created using the package 
VennDiagram [163].  
5.3.6 Correlation Analysis 
Associations between physiological measurements and metabolite 
measurements across tissues were assessed using Pearson correlation from the 
package Hmisc [164] and the package R.Utils [165]. Correlation p-values were FDR-
adjusted using the Benjamini-Hochberg procedure. Correlations were visualized using 
the Cytoscape app Metscape [166].   
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5.3.7 Functional Pathway Analysis 
 Overrepresentation pathway analysis was performed using Metaboanalyst [167]. 
KEGG IDs were input and compared against the mouse KEGG reference metabolome. 
Overrepresentation was performed using the algorithm Fisher’s exact test. Pathway 
topology was performed using relative-between centrality. 
 
5.4 Results 
5.4.1 Physiological Measurements Reveal Differences Among Strain and Sex-by-
strain 
Body composition and indirect calorimetry were used to define system-level 
effects of strain and sex on metabolism. Adiposity, oxygen consumption (VO2), and heat 
output were all significantly influenced by strain, but in a sex-dependent manner 
(psexXstrain<0.05; Table 5.1). In contrast, body weight was significantly affected by sex 
(p<0.001) but not by strain or sex-by-strain interaction. Activity levels were significantly 
affected by sex (p=0.009) and strain (p=0.020) but not sex-by-strain interaction. Tukey’s 
post-hoc comparisons were assessed to determine significant pairwise comparisons. 
Evidence of sex-by-strain interaction were clearly visible in adipose tissue. Adiposity 
levels in A/J females (4.01±0.3%) were significantly higher than female FVB/NJ 
(1.14±0.21%, p<0.001) and NOD/ShiLtJ mice (1.71±0.26%, p=0.004) and numerically 
higher than all other female mice regardless of strain (Fig. 5.1B). Conversely, adiposity 
levels in C57BL/6J males (3.8±0.69%) were significantly higher compared to male 
FVB/NJ mice (1.64±0.7%, p=0.01) and numerically higher than the other three mice 
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strains. Despite differences in adiposity across sex and strain, weight was only 
significant for sex. Males were heaviest compared to females, regardless of strain (Fig. 
5.1A). Oxygen consumption, an indirect measurement of energy expenditure, in both 
sexes was lowest in A/J mice (Fig. 5.1C). Male FVB/NJ mice had the highest VO2 levels 
compared to the other three strains, however; only A/J (p=0.003) and C57BL/6J 
(p=0.020) male mice were significantly different. Female A/J mice had significantly lower 
VO2 levels than C57BL/6J (p=0.020) and NOD/ShiLtJ (p=0.026) females. Female 
C57BL/6J mice produced significantly more heat than A/J (p=0.002) and NOD/ShiLtJ 
(p=0.010) females (Fig. 5.1E). FVB/NJ males produced significantly more heat than 
C57BL/6J (p=0.033) and NOD/ShiLtJ (p=0.037) males. Activity levels varied between 
sexes and strains but in an independent manner. Females had significantly higher 
levels of activity while C57BL/6J mice had the highest levels of activity relative to all 
other strains. RER had no significant difference for sex, strain, or sex-by-strain, which 
was expected due to all strains being fed a single diet (Fig. 5.1D).  
 
Table 5.1: P-values for Effects of Sex, Strain, and Sex-by-strain Interaction on Weight and 
Metabolism.  
Sex Strain Sex-by-Strain 
Weight <0.001 0.284 0.052 
Adiposity 0.338 <0.001 0.015 
VO2 0.001 <0.001 0.023 
RER 0.148 0.594 0.100 
Heat Output <0.001 0.001 <0.001 
Activity 0.009 0.020 0.124 
P<0.05 is considered significant. 
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5.4.2 Significant Effects of Strain, Sex and their Interactions on Tissue 
Metabolomes 
 Liver, skeletal muscle, and adipose tissue are fundamental to systemic energy 
balance and play central roles in the body’s response to diet, but it is unclear how 
genetics influences these tissues. Global metabolomic profiling of these tissues was 
used to characterize the effects of sex and strain on tissue metabolism. A total of 191 
known compounds, those for which m/z and retention time have been mapped to 
specific metabolites on our platform, were detected in one or more tissues. In addition, 
several thousand features corresponding to unidentified metabolites (6,292, 4,877, and 
4,864) were detected in liver, skeletal muscle, and adipose, respectively. 
 
 An ANOVA model was used to identify metabolites that were affected by sex, 
strain, and sex-by-strain interaction (Appendix C, Additional File 4, Fig. 5.2). A total of 
146 metabolites (76% of all known metabolites) were significantly affected by sex, 
strain, or sex-by-strain interaction, in one or more tissues. Approximately ninety percent 
(130 of 146) of these metabolites were influenced by strain in at least one tissue. To 
determine which tissue was most affected by strain we compared all significant 
metabolites across all tissues (Fig. 5.2A). Strain affected 105 metabolites in liver with 
seventy-two metabolites specific to liver. Adipose and skeletal muscle were less 
sensitive to strain with 38 and 30 metabolites. Thirteen and eight of the total metabolites 
were specific to adipose and skeletal muscle. Only six metabolites were significant for 
strain in all three tissues. 
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Figure 5.1: Effects of sex and strain on weight and metabolic phenotypes; N=5/ sex and strain 
group, avg. ± std. dev. Dots represent individual mice within sex-by-strain combination. 
Horizontal bars represent pairwise comparisons performed using Tukey’s HSD post-hoc analysis; 
* p<0.05, ** p<0.01, and *** p<0.001. Body weight (A) and adiposity (B) were measured at 28 weeks 
of age, after 16 weeks on the experimental diets. Adiposity is expressed as the relative weight of 
the perigonadal adipose fat pads. Oxygen consumption (C), RER (D), heat output (E), and activity 
(F) were measured during a 48 hr. period when mice were housed in Phenomaster metabolic 
cages.   
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 We then assessed the effects of sex, strain, and sex-by-strain in each tissue. 
Strain had the largest affect on the liver metabolome. Ninety-two metabolites responded 
to strain variation, independent of sex (Fig. 5.2B). Seventeen metabolites responded to 
strain in a sex dependent manner but only one metabolite (citrulline) was specific for 
sex-by-strain interaction only. Another 26 metabolites were significant for sex, 
independent of strain. Three of these metabolites (acetyllysine, glutamine, and 3-
methylphenylacetic acid) were specific to sex. Strain also affected adipose and skeletal 
muscle (Fig. 5.2C, D). Thirty-eight metabolites were altered in adipose tissue and 29 
metabolites were altered in skeletal muscle by strain, independent of sex. Only three 
metabolites (pantothenate, s-adenosyl-l-homocysteine, and threonine) were altered by 
sex, independent of strain, in adipose tissue. In contrast, no metabolites were altered by 
sex-by-strain interaction in adipose. Five metabolites were altered by sex, independent 
of strain, in skeletal muscle. Only four metabolites (shikimate, ornithine, 
hydroxyphenylacetic acid, and 2-isopropylmalic acid) were altered by sex-by-strain, in 
muscle. Assessing metabolites significant for strain using Tukey’s HSD post-hoc 
analysis revealed no one dominant pairwise comparison for any tissue (Fig. 5.2E, F, 
and G). Unsupervised hierarchical clustering was performed to visualize the relatedness 
of each of the 8-sex/strain groups, based on similarities between hepatic metabolomes. 
A/J and FVB/NJ mice clustered by strain and then sex, however, C57BL/6J and 
NOD/ShiLtJ mice clustered by sex (Fig. 5.3). This indicates that genetic background 
and sex have varying levels of influence on the metabolome. 
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5.4.3 Functional Annotation of Strain Effects 
 The sets of metabolites affected by sex, strain, or sex-by-strain interaction were 
functionally annotated using KEGG pathways (Table 5.2). Strain had the largest effect 
on pathways in adipose and liver tissue. Purine metabolism was significantly altered for 
strain with eight and sixteen metabolites (referred to as hits) mapping onto the KEGG 
pathway for adipose (p < 0.001) and liver tissue (p < 0.001) (Fig. 5.4). In addition, 13 
metabolites mapped onto pyrimidine metabolism (p < 0.001), in liver, for strain. Amino 
acid metabolism (alanine, aspartate, and glutamate metabolism (adipose, p < 0.001, 
hits=5) and aminoacyl-tRNA biosynthesis (adipose, p = 0.001, hits=7; muscle, p = 
0.002, hits=6)) was also significantly altered by strain for both tissues (FDR < 0.05). 
Metabolites affected by strain, independent of sex, also mapped onto pathways that 
represent amino acid metabolism (aminoacyl-tRNA and lysine biosynthesis), in muscle, 
but were not significantly overrepresented after controlling for FDR (> 0.05). Sex, 
independent of strain, also significantly affected purine metabolism (p < 0.001) with 
eight metabolites mapping on to the pathway in liver tissue. Sex, in muscle, also 
significantly altered by sex (lysine biosynthesis, p = 0.001, hits=2 and aminoacyl-tRNA 
biosynthesis, p = 0.001, hits=5). Sex-by-strain interaction did not affect any pathways 
for any tissue. 
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Figure 5.2: Shared and unique effects of strain on tissue metabolomes. The sets of metabolites 
that differed significantly, based on ANOVA (FDR < 0.05) by strain across tissues, (A), and by sex, 
strain, and sex-by-strain interaction in liver (B), adipose (C), and muscle (D) were visualized for 
shared and factor-specific effects using Venn diagrams. Metabolites that differed significantly for 
strain in adipose (E), muscle (F), and liver (G) were assessed for pairwise comparisons using 
Tukey’s HSD and visualized for shared and specific effects using Venn diagrams.  
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Figure 5.3: Hierarchical clustering of sex/strain groups based on metabolite abundance in liver. 
Heatmaps were generated in Metaboanalyst (v3.0) using group averages of the 50 metabolites 
that varied the most across sex and strain combinations.  Samples were normalized to median 
values and values were scaled using Pareto scaling.  Z-score was used to determine scale. 
  95 
5.4.4 Relationship Between Known Metabolites and Phenotypes 
The relationships between metabolite profiles in each tissue and systems level 
energy balance traits were identified using a correlation-based approach (Fig. 5.5). 
Energy expenditure and adiposity were significantly correlated with 18 and 25 
metabolites, respectively, across all three tissues. The majority of the associations with 
adiposity are due to hepatic (15) and adipose (10) metabolomes while liver (9) and 
muscle (5) are responsible for most of the associations with heat. Partial correlation was 
used to adjust for misleading correlations to body weight, after which all of the 
metabolites remained significantly correlated with adiposity and heat output. 
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Figure 5.4: Purine metabolism in adipose and liver tissue. Metabolites significant for strain were 
plotted for adipose and liver tissue. Dashed lines represent missing metabolites in the pathway. 
Horizontal bars represent pairwise comparisons performed using Tukey’s HSD post-hoc analysis; 
* p<0.05, ** p<0.01, and *** p<0.001. 
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Table 5.2: KEGG Pathway Enrichment of Metabolites Affected by Sex, Strain, and Sex-By-Strain 
Tissue Factor Pathway Hits P-value (k/m)q 
All Tissues Sex Purine metabolism 9 <0.001 0.005 
  Aminoacyl-tRNA biosynthesis 7 0.002 0.005 
  Riboflavin metabolism 3 0.002 0.005 
  Lysine biosynthesis 2 0.004 0.005 
      
 Strain Purine metabolism 22 <0.001 0.007 
  Pyrimidine metabolism 15 <0.001 0.007 
  Alanine, aspartate and glutamate metabolism 9 <0.001 0.007 
  Citrate cycle (TCA cycle) 7 0.001 0.007 
  Pantothenate and CoA biosynthesis 6 0.001 0.007 
  Glyoxylate and dicarboxylate metabolism 6 0.002 0.007 
  Ascorbate and aldarate metabolism 4 0.004 0.007 
      
Adipose Sex Cysteine and methionine metabolism 2 0.002 0.025 
  Aminoacyl-tRNA biosynthesis 2 0.013 0.025 
      
 Strain Purine metabolism 8 <0.001 0.007 
  Alanine, aspartate and glutamate metabolism 5 <0.001 0.007 
  Aminoacyl-tRNA biosynthesis 7 0.001 0.007 
  Pyrimidine metabolism 5 0.003 0.007 
      
Muscle Sex Lysine biosynthesis 2 0.001 0.004 
  Aminoacyl-tRNA biosynthesis 5 0.001 0.004 
      
 Strain Aminoacyl-tRNA biosynthesis 6 0.002 0.003 
  Lysine biosynthesis 2 0.002 0.003 
      
Liver Sex Purine metabolism 9 <0.001 0.003 
  Riboflavin metabolism 3 0.001 0.003 
      
 Strain Purine metabolism 16 <0.001 0.004 
  Pyrimidine metabolism 13 <0.001 0.004 
  Glyoxylate and dicarboxylate metabolism 6 <0.001 0.004 
  Citrate cycle (TCA cycle) 5 0.002 0.004 
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The relationships between metabolite profiles and systems level energy balance 
traits across all three tissues were assessed. Metabolites that were associated with one 
or more traits were included. Eight, 15, and 24 metabolites were associated with one or 
more traits and one or more metabolites within or across tissues in adipose, muscle, 
and liver tissue (Fig. 5.6, Appendix D). Methionine in adipose tissue was negatively 
correlated with the bile salt taurodeoxycholic acid (r=-0.66, p<0.001) in muscle but was 
not associated with taurodeoxycholic acid (r=0.12) in liver tissue. Metabolites that were 
significant in more than one tissue showed tissue-specific responses. Pantothenate, in 
skeletal muscle, was negatively correlated with glycerol-3-phosphate (r=-0.54, p=0.001) 
in liver while glycerol-3-phosphate in muscle was positively correlated with pantothenate 
(r=0.23, p=0.18) in liver tissue. Furthermore, glycerol-3-phosphate in muscle was 
correlated with several energy molecules in skeletal muscle and liver tissue, however, 
glycerol-3-phosphate, in liver tissue, was only correlated with pantothenate in muscle 
(Fig. 5.6). Pantothenate is critical for the biosynthesis of coenzyme A while glycerol-3-
phosphate is the first step in de novo lipogenesis, as well as a glycolysis intermediate. 
Additionally, when mapping metabolites from all three tissues onto KEGG pathways 
pantothenate and CoA biosynthesis was significantly altered by strain (Table 5.2). 
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Figure 5.5: Correlations between metabolites and system phenotypes.  Pearson correlation was 
used to associate metabolites in adipose (A), muscle (B), and liver (C) with weight, adiposity, and 
metabolic phenotypes. Significant correlations (FDR < 0.05) are represented by an asterisk (*). For 
metabolites that were significantly correlated for adiposity and/or heat output, partial correlation 
was used to determine if the relationship between metabolite and trait was due to spurious 
correlation with body weight. Correlations that remained significant are indicated by a bold 
asterisk (*). 
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Figure 5.6:  Cross-tissue metabolite and phenotype network.  Pearson correlation was used to 
associate metabolites within and across each tissue with weight, adiposity, and metabolic 
phenotypes. Only significant correlations (FDR < 0.05) are shown. To assess relationships within 
and across tissues and phenotypes, metabolites are clustered by their respective tissue or 
phenotype. The size of each node represents the number of edges connected to the node. A red 
line represents positively correlated metabolites, while a blue line represents negatively 
correlated metabolites.  
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5.5 Discussion 
Genetics has long been associated with health outcomes in an individual, but the 
relationship between genetics and metabolism at the tissue level are poorly understood. 
We used untargeted metabolomics to investigate the effects of strain and sex on tissue 
metabolomes, and to relate metabolites to body composition and energy expenditure. 
Mouse strains varied with regards to their genetic backgrounds. This gave us insight 
into how diverse genetic backgrounds alter the tissue metabolome when fed the same 
diet. Strain, in combination with sex allowed us to query the extent to which tissue 
metabolomes were influenced by sex, strain, and their interaction, and to characterize 
their relative impact on liver, adipose, and skeletal muscle. Our model, which included 
eight unique combinations of sex and strain, also enabled us to use correlation to relate 
metabolites to body composition and energy expenditure. 
Since body weight was not affected by sex-by-strain interaction while adiposity, 
VO2, and heat output were we expected that a modest number of metabolites would be 
influenced by strain in a sex-dependent manner. Few metabolites, however, were 
influenced by sex-by-diet for any tissue; liver (n=17), adipose (n=0), and muscle (n=6). 
Conversely, strain exerted substantial effects on the metabolome across all tissues; 
liver (n=92), adipose (n=38), and muscle (n=29) relative to sex and sex-by-strain 
interaction. Approximately one-third (26 of 92) of metabolites in liver that were 
influenced by strain are involved in purine and pyrimidine metabolism. Purine and 
pyrimidine metabolism consist of the breakdown and synthesis of purine and pyrimidine 
nucleotides, which are building blocks of nucleic acids and cofactors that are required 
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for energy metabolism. Although purine and pyrimidine metabolism are fundamentally 
important for all cells, recent metabolomics studies have shown alterations in these 
pathways due to differences in genetic background. C57BL/6J females had higher 
levels of hypoxanthine in plasma at 3 weeks compared to NOD/ShiLtJ mice while 
NOD/ShiLtJ mice showed higher levels of inosine over 15 weeks [96]. In contrast, our 
study showed no differences between NOD/ShiLtJ and C57BL/6J mice for hypoxanthine 
although the duration of our study was 7 months and included males. Our study also 
revealed significantly higher levels of inosine in C57BL/6J mice compared to 
NOD/ShiLtJ mice contradicting the aforementioned study. Our conflicting results could 
be due to the fact that our measurements were performed in liver tissue versus plasma, 
which represents the systemic pool of metabolites rather than tissue specific metabolite 
pools. 
 Alanine, aspartate, and glutamate metabolism was influenced by strain in liver, 
as well as adipose tissue with six and five metabolites significantly altered between 
strains. NOD/ShiLtJ mice had the lowest levels of alanine and highest levels of 
aspartate while glutamate levels were highest in A/J mice. Glutamine converts to 
glutamate via increased glutaminase activity in uncontrolled diabetes [196]. NOD/ShiLtJ 
mice, which develop type-1-diabetes, showed increased levels of glutamate relative to 
glutamine. Moreover, C57BL/6J mice can develop type 2 diabetes while ob/ob mice on 
a FVB/NJ background developed severe diabetes indicating that FVB/NJ can develop a 
diabetic phenotype [82]. C57BL/6J and FVB/NJ mice showed similar 
glutamate:glutamine levels to NOD/ShiLtJ mice. Although glutaminase was not 
measured in our study, querying single nucleotide polymorphisms (SNP) using the 
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mouse phenome database showed three SNPs across all four strains for glutaminase 
with two SNPs belonging to NOD/ShiLtJ and one belonging to FVB/NJ. In contrast, A/J 
mice, which are resistant to developing diabetes, only showed a slight increase in 
glutamate relative to glutamine despite having the highest levels of glutamate. In 
addition to glutamate, alanine and aspartate levels may be increased due to higher 
levels of alanine (ALT) and aspartate aminotransferase (AST). Both of these enzymes 
have been shown to be increased in individuals at risk for type 2 diabetes [197]. ALT, in 
particular, has been used as a marker of liver damage. Querying SNPs for ALT using 
the mouse phenome database showed eight SNPs across all four strains with all eight 
SNPs belonging to NOD/ShiLtJ and one belonging to C57BL/6J mice. ALT levels, 
measured in the liver in our study, were highest in A/J mice (data not shown), which 
also had the highest alanine levels in liver, despite their resistance to type 2 diabetes. 
ALT levels in the liver are also a marker of non-alcoholic fatty liver disease [60], 
although A/J mice have also been shown to be resistant to developing NAFLD [198]. 
Our study was not designed to link specific metabolites with specific genetic markers. 
Despite this investigating the potential association between ALT levels, alanine and the 
effects of A/J mice on this relationship requires further investigation. 
 In addition to pathways that were significantly affected in this study recent 
metabolomics studies have shown different metabolic signatures in plasma between 
C57BL/6J and NOD/ShiLtJ female mice. C57BL/6J mice had significantly increased 
levels of TCA cycle intermediaries (citrate, α-ketoglutarate, fumarate, malate, β-alanine, 
and glutamine) compared to NOD/ShiLtJ mice [96]. Although the TCA cycle pathway, in 
liver, was not significantly altered there were significant differences across metabolites 
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present in the TCA cycle. In contrast to the findings in plasma, our study revealed that 
NOD/ShiLtJ mice had significantly higher levels of citrate/isocitrate and fumarate 
compared to C57BL/6J mice; however, these results were specific to liver. When 
assessing differences within the TCA cycle across all strains, in liver, A/J mice had 
significantly higher levels of acetyl-CoA, citrate/isocitrate, coenzyme A, fumarate, 
malate, and succinate compared to C57BL/6J. A previous study revealed higher levels 
of metabolites in the TCA cycle for adipose compared to muscle and liver, in males, of 
two obesity mouse models, ob/ob and C57BL/6J fed a high-fat diet [199]. Our study 
included males and females, which may account for the differences found across the 
literature. Additionally, our measurements are relative. In the context of different strains 
metabolites abundances from C57BL/6J mice may appear to contradict previous 
studies. Regardless, these results emphasize that metabolite pools can change 
significantly based on location in the body. 
 Phenotypes were associated with metabolites in all three tissues. Cofactors are 
important for biochemical reactions to occur. NAD+ was positively correlated with 
activity levels in adipose and liver tissue. Previous studies have shown an increase in 
NAD+ during exercise [200]. Furthermore, ADP and ATP also showed a positive 
relationship with activity levels in liver while AMP had an inverse relationship with 
adiposity. AMP is necessary for the activation of AMPK, which plays an important role in 
energy metabolism. In the liver, activation of AMPK inhibits fatty acid synthesis through 
the phosphorylation of acetyl-CoA carboxylase 1 and 2 (ACC 1 and 2) [201].  Without 
AMP to activate AMPK fatty acid synthesis is not controlled potentially leading to 
NAFLD. Recent advancements have shown therapeutic potential in treating NAFLD 
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through modulation of AMPK levels [202]. Furthermore, metformin and salicylate have 
been shown to increase AMPK levels in liver tissue improving insulin sensitivity and 
inhibiting lipogenesis [201]. The negative association between AMP and adiposity in our 
study may provide an explanation for lowered AMPK levels during increased weight 
gain; however, we did not measure AMPK or ACC1 and 2 levels in our mice. Further 
studies investigating the relationship between adiposity, AMP, and AMPK levels are 
warranted. 
 Several limitations should be noted. First, our study measured metabolites in a 
steady state, at a single time point. Thus we are unable to assess potential turnover due 
to genetic differences. Second, our extraction method targets polar metabolites at the 
expense of lipid metabolites, so we are unable to assess the effects of genetics on the 
lipid metabolome, which are likely to be affected by sex and genetic differences. 
Furthermore, due to the specificity of the extraction method and the limited number of 
metabolites that can be identified using our in-house database, it is difficult to ascertain 
whether pathways significantly altered are affected by sex, strain or sex-by-strain 
interaction or because a metabolite is more easily identified to due inherent biases in 
the experimental procedure. Finally, although we know the strains of mice chosen have 
been genetically profiled we did not genetically assess the mice in this study. 
 
5.6 Conclusion 
 We profiled three tissues (adipose, muscle, and liver), which play a major role in 
energy metabolism to determine the effects of strain and sex on the tissue metabolome. 
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The stratified results showed tissue-specific effects of strain and sex on tissue 
metabolites. This study, however, was performed in the context of a single diet. 
Including other diets may reveal a more complex relationship between the tissue 
metabolome and genetics. Nonetheless, this study has shown several metabolites that 
could be investigated to determine their role in metabolism and disease. 
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6.1 Abstract 
The physiological consequences of diet can vary widely due to differences in 
genetic background and gender yet diet remains one of the most commonly used tools 
for weight loss or to improve health. Although the relationship between diet and health is 
widely accepted, and countless individuals use various diets for weight loss, relatively 
little is known about the fundamental impact of diet on metabolism at the tissue level. 
Using untargeted metabolomics, this study aimed to identify changes in water-soluble 
metabolites in A/J, C57BL/6J, FVB/NJ, and NOD/ShiLtJ males and females, fed one of 
five diets (Japanese, ketogenic, Mediterranean, American, and standard mouse chow) 
for seven months. Metabolite abundance was examined in liver, skeletal muscle, and 
adipose tissue for sex, strain, diet, sex-by-strain, sex-by-diet, strain-by-diet, and sex-by-
strain-by-diet interaction. ANOVA suggests that liver is the most metabolically active 
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when assessing all factors; however, muscle was most sensitive to strain effects. 
Unsupervised clustering revealed that mice clustered by strain then sex when 
comparing known metabolites. Pathway analysis showed that the majority of pathways 
affected played a role in amino acids metabolism across all three tissues. Purine 
metabolism, in liver tissue, however, was the only pathway altered by sex-by-strain-by-
diet. The results of this study revealed that amino acid metabolism is sensitive to diet, 
genetic, and strain effects but not necessarily their interactions. Furthermore, 
metabolites were affected in a tissue specific manner. 
 
6.2 Introduction 
The physiological consequences of diet can vary widely due to differences in 
genetic background and gender yet diet remains one of the most commonly used tools 
for weight loss or to improve health. Obesity is a major contributor to the intersection 
between diet and disease due its effect on risk of developing type 2 diabetes, 
hypertension, cardiovascular disease, stroke, osteoarthritis, and certain cancers [2, 147, 
148]. Obesity rates, however, stratify based on gender and race [203]. Accordingly, the 
prevalence of metabolic diseases such as type 2 diabetes have also shown disparities 
between races. Native Americans (33%) had the highest rates of type 2 diabetes while 
Alaskan natives (5.5%) had the lowest [204].  
Previous studies investigating the efficacy of diet on health have shown marked 
differences in the response to certain aspects of diet. Intake of fruits and vegetables 
showed higher circulating levels of beta-cryptoxanthin and lutein in women compared to 
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men [205]. Significant effects genetic risk scores and dietary intake were identified in 
relation to markers of adiposity [206]. Individuals with the A allele of melanocortin-4 
receptor had a positive association between total fat intake and consumption of an 
American diet and abdominal obesity [207]. Additionally, individuals with the TCF7L2-
rs7903146 polymorphism have an increased incidence of type 2 diabetes, CVD, and 
stroke. Adherence to a Mediterranean diet improved fasting glucose and reduced their 
risk of CVD and stroke [208]. Despite the growing body of knowledge dissecting the 
effects of sex and diet and genetics and diet, a more comprehensive understanding of 
the intersection between all three is necessary.  
Investigation of diet and health in humans has provided insight into the potential 
relationships between diet and sex, and diet and genome, however, humans are often 
non-compliant and under report dietary intake on food frequency questionnaires [209]. 
Mice are an ideal alternative due their genetic similarity, inherent compliance, and 
replicative ability. Accordingly, the severity of disease due to genetic background has 
been shown through phenotypic markers in mice [82, 91]. Although the relationship 
between diet and health is widely accepted, and countless individuals use various diets 
for weight loss, relatively little is known about the fundamental impact of diet on 
metabolism, especially in the context of different genetic backgrounds, at the tissue 
level.  
Mass spectrometry-based metabolomic platforms now enable global, discovery-
based profiling of tissue and circulating metabolomes. Accordingly, metabolomics has 
emerged as a tool with which to understand the impact of diet, genetics, and sex on 
metabolism and to identify metabolites and pathways that are associated with disease 
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[90, 110, 154]. Metabolomics studies on the effects of diet, genetics, or sex in humans 
and mice frequently use samples that can be obtained noninvasively (e.g., plasma, 
erythrocytes or urine). Less is known, however, about the impact of diet, genetics, or 
sex at the tissue level, and the extent to which tissues may respond to diet, genetics, or 
sex in a similar manner. The objective of this study was to use metabolomics to 
determine the effects of diet, genetics, and sex on metabolomes at the tissue level and 
to associate tissue metabolites with systems level phenotypes of energy utilization and 
body composition in mice. Four common dietary profiles (American, Japanese, 
Mediterranean and ketogenic) were chosen because of their relationships to various 
aspects of metabolic health in humans, and because they vary widely in composition. 
Mouse diets were formulated to represent both the macronutrient profiles and sources 
that are characteristic of each of these four eating patterns, while maintaining the same 
caloric value and sufficient amounts of micronutrients. Four strains of mice (A/J, 
C57BL/6J, FVB/NJ, and NOD/ShiLtJ) were chosen for their genetic diversity. Both 
males and females were used to evaluate the relative effects of diet, strain, sex, sex-by-
strain, sex-by-diet, strain-by-diet, and sex-by-strain-diet interaction on tissue 
metabolism. Untargeted metabolomics was used to comprehensively profile the 
metabolomes of liver, skeletal muscle, and adipose tissue because of their roles in 
energy balance [155, 156].  
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6.3 Materials and Methods 
6.3.1 Animals and Diets 
All husbandry and experimental procedures were approved by the Institutional 
Animal Care and Use Committee of the University of North Carolina. Four-week old A/J, 
C57BL/6J, FVB/NJ, and NOD/ShiLtJ mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME). Mice were allowed to acclimate for 14 days and 
consumed a standard mouse chow (PicoLab Mouse Diet 20, LabDiet, St. Louis, MO) 
during this period. At 42 days of age, five male and five female mice from each strain 
were assigned to each of five diets: American, Mediterranean, Japanese, ketogenic, or 
chow. Diets were designed in collaboration with Research Diets, Inc. (New Brunswick, 
NJ) to contain calories, macronutrient ratios, sources of ingredients, fiber content, and 
lipid profiles that are reflective of each diet pattern. (Table 6.1, macronutrient ratios, 
Appendix I and J, detailed formulations). Mice were maintained on a 12-hour light/dark 
cycle throughout the study. At age 18 weeks, after 12 weeks on the diets, mice were 
housed in Phenomaster metabolic chambers (TSE Systems, Inc.) for 48 hours for 
measurement of metabolic rate and activity. The chambers measured respiratory 
exchange rate (RER), volume of oxygen (VO2), and heat output via heat dissipation, 
and activity level by laser detection. Activity levels measured voluntary movement of the 
mouse in the x and y plane. Mice were euthanized at seven months of age by CO2 
asphyxiation.  Perigonadal adipose tissue was dissected and weighed as a measure of 
adiposity. Samples of adipose tissue, the left lobe of the liver and the vastus medialis, 
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vastus lateralis, and rectus femoris muscle were snap-frozen in liquid N2 and stored at -
80°C for metabolomics analysis. 
 
Table 6.1: Dietary Composition 
 Ketogenic 
D12052706 
American 
D12052705 
Mediterranean 
D12052702 
Japanese 
D12052703 
chow 
D12052701 
Fat 84% 
Butter, Lard 
35% 
Corn oil, butter, 
Olive oil 
42.6% 
Olive oil 
11% 
Soybean oil, 
Olive oil 
18% 
Soybean oil 
Carbohydrate None 50% 
Corn starch, 
Wheat starch, 
Sucrose, potato 
starch 
44.69% 
Wheat starch, 
Sucrose, Fructose 
76% 
Rice starch, 
Sucrose 
63% 
Corn starch 
Protein 16% 
Casein 
15% 
Soy, Beef, Egg 
white 
12.71% 
Soy, Fish, Beef 
13% 
Soy, Fish 
19% 
Casein 
 
6.3.2 Metabolite Extraction and Liquid Chromatography Mass Spectrometry 
Frozen tissue samples were pulverized under liquid N2. Approximately 25 mg of 
pulverized tissue were weighed and extracted sequentially in methanol and then in 
methanol:water (4:1), as previously described [157]. Supernatants were dried under 
nitrogen and reconstituted in 160 μL of sterile MilliQ water. Internal standard (60 μL of a 
13C-labeled E.Coli metabolite pool) was added to each sample. 
6.3.3 Preparation of 13C-labelled E. Coli metabolite pool 
Cultures of Escherichia coli NCM3722 were grown on minimal media 13C-glucose 
agar plates and passed five times. Single colonies were then transferred to minimal 
media 13C-glucose liquid cultures (0.4% w/v made from 99% U-13C-glucose, Cambridge 
Isotope Laboratories). Liquid cultures were set back five times before samples were 
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extracted and run on mass spectrometer to ensure complete 13C-labeling of all 
metabolites. 
E. Coli cells were extracted by vacuum filtering three 10 mL aliquots, per culture, 
for three different cultures (grown to ~0.4 OD600) through Magna nylon membrane 
filters (0.45 micron, 47 mm filter, Maine Manufacturing, Sanford, ME). The filters were 
transferred face down into petri dishes containing 1.3 mL of extraction solvent (40:40:20 
HPLC grade methanol, acetonitrile, water with 0.1M formic acid) chilled to -20 ˚C. The 
extraction was allowed to proceed for 15 min at -20˚C. The following extraction was 
carried out in a room maintained at 4˚C unless otherwise specified. The filters were 
rotated so that the cell side was on top and rinsed by pipetting the extraction solvent 
over the face of the filters. The extraction fluid was then transferred to 1.5 mL centrifuge 
tubes and an additional 300 µL of new extraction fluid was used to wash the filters 
again. The remaining extraction solvent was also transferred to the 1.5 mL centrifuge 
tube and centrifuged for 5 minutes (16.1 rcf). The resulting supernatant was transferred 
to new vials and the pelleted cell was resuspended in 50 µL of extraction solvent. The 
extraction was allowed to proceed for 15 min at -20˚C at which time the samples were 
centrifuged for 5 min (16.1 rcf). The supernatant was transferred to the vials and 
another 50 µL of extraction solvent was added to the pelleted cell repeating the previous 
extraction once more. Vials containing all of the collected supernatant were dried under 
a stream of N2 until all the extraction solvent had been evaporated. Following the 
resuspension of extracted E. coli residue in 300 µL of sterile water, samples were 
physically averaged and 10 mL were directly spiked into unlabeled samples.  
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6.3.4 Metabolomics Data Processing 
Raw files generated by Xcalibur were converted to mzML, an open-source 
format, using msconvert [139]. An open source data analyzer for metabolomics, 
MAVEN [140, 141] (Princeton University) was used to correct total ion chromatograms 
based on retention time automatically, for each sample. Known metabolites were 
manually chosen and peak abundance was integrated by mass (±5 ppm) and retention 
time. Unknown metabolites were chosen using an algorithm with the following settings: 
minimum peak width, 5; minimum signal/blank ratio, 3 or greater; minimum peak 
intensity, 10,000; and minimum peak/baseline, 3.  Unknown peaks were filtered 
manually to remove those that did not meet the above criteria. 
6.3.5 Statistical Analysis 
All statistical analyses were performed in the language R (3.1.0 and 3.2.2) [158]. 
An ANOVA model was used to identify significant effects of sex, strain, diet, sex-by-diet, 
sex-by-strain, strain-by-diet, and sex-by-diet interaction on physiological traits and 
metabolites. Tukey’s Honest Significant Difference (HSD) was used for post-hoc testing. 
Significance for physiological traits was based on raw p-values (p < 0.05). 
Metabolite peak area data files were read into R using the package XLConnect 
[159]. Metabolites that were missing 70% or more sample measurements were removed 
from analysis. Missing values in the remaining metabolites were imputed using k-
nearest numbers from the function impute [160] (Additional File 1 and 2). Metabolites 
were matched to their corresponding 13C-labeled internal standard, or to a 13C-labeled 
standard of the same compound class. Class types were identified using the Human 
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Metabolome Database [143-145]. Prior to statistical analyses, a linear model was 
created for each metabolite using the terms sex, strain, diet, sex*diet, sex*strain, 
strain*diet, sex*strain*diet tissue weight and internal standard (eq. 6.1): 
Equation 6.1 
Metabolite = sex + strain+ diet + sex*diet + sex* strain
+strain*diet + sex* strain*diet + tissue weight + internal s tandard
?
 
Coefficients for the terms for tissue weight and internal standard were used to adjust 
metabolite abundance for technical variation using eq. 6.2: 
Equation 6.2 
Adjusted metabolite =metabolite+ tissue weight coefficient(mean tissue weight −
tissue weight)+ internal s tandard coefficient(mean internal s tandard −
internal s tandard)
?
 
Adjusted metabolites were Pareto scaled across all mice for each metabolite 
using the package MetabolAnalyze [161], normalized to the median across all 
metabolites for each mouse, and cube root transformed to create a normal distribution. 
Normalized metabolite values were analyzed for effects of sex, strain, diet, sex*diet, 
sex*strain, strain*diet, and sex*strain*diet. Data were assessed for normality using Q-Q 
plots, residuals, and the Shapiro-Wilks test. False discovery rate for ANOVA and 
correlation analyses was set to 5% using the method of Benjamin-Hochberg [162]. Venn 
diagrams were created using the package VennDiagram [163].  
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6.3.6 Correlation Analysis 
Associations between physiological measurements and metabolite 
measurements across tissues were assessed using Pearson correlation from the 
package Hmisc [164] and the package R.Utils [165]. Correlation p-values were FDR-
adjusted using the Benjamini-Hochberg procedure. Correlations were visualized using 
the Cytoscape app Metscape [166].   
6.3.7 Functional Pathway Analysis 
Overrepresentation pathway analysis was performed using Metaboanalyst [167]. 
KEGG IDs were input and compared against the mouse KEGG reference metabolome. 
Statistical significance of pathway overrepresentation was evaluated using Fisher’s 
exact test. Pathway topology was performed using relative-between centrality. 
 
6.4 Results 
6.4.1 Physiological Measurements Reveal Difference Among Sex-by-strain-by-diet 
 Body composition and indirect calorimetry were used to define system-level 
effects of sex, strain, and diet on metabolism. Body weight, adiposity, VO2, RER, and 
heat output were significant for sex-by-strain-by-diet (Table 6.2). In contrast, activity was 
significant for sex-by-strain, independent of diet. Tukey’s post-hoc comparisons were 
assessed to determine significant pairwise comparisons. Male and female C57BL/6J 
mice had the highest body weights relative to the other strains (Fig. 6.1A). Female A/J 
mice fed a ketogenic diet had the lowest bodyweight compared to all other mice. 
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Female FVB/NJ mice fed a Japanese diet were significantly different from all other diets 
fed to female FVB/NJ mice (Fig. 6.1A). Male C57BL/6J mice fed a Japanese diet were 
the lightest compared to all other Male C57BL/6J mice. Female C57BL/6J mice fed a 
ketogenic diet were lightest compared to all other female C57BL/6J mice. Although 
adiposity is significantly different for sex-by-strain-by-diet interaction there were very few 
significant pairwise comparisons (Fig. 6.1B). Female A/J mice fed a Mediterranean diet 
(4.91±0.76%, p<0.001) had significantly more adiposity then female A/J mice fed a 
ketogenic diet (1.38±0.13%). Likewise, Female C57BL/6J mice fed a Mediterranean diet 
(5.19±0.77%) had significantly more adiposity then female C57BL/6J mice fed a 
ketogenic (1.85±0.53%, p<0.001) or chow diet (2.4±0.35%, p=0.15). Female FVB/NJ 
mice were lightest relative to all other mice; however, they were not significantly 
different. VO2 levels were used to measure energy expenditure. Female A/J mice fed a 
ketogenic diet had the highest VO2 levels relative to all other female A/J mice (Fig. 
6.1C). RER responded in a similar manner for each strain and sex across diets. The 
Japanese diet, which is high in carbohydrates was represented by a high RER value 
(~0.9) while the ketogenic diet, which is high in fat was represented by a low RER value 
(~0.73) (Fig. 6.1D). Heat output was highest in male and female A/J mice relative to all 
other diets (Fig. 6.1E). Furthermore, female FVB/NJ mice had the highest heat output 
compared to female FVB/NJ fed a Japanese diet or chow diet. Activity levels were not 
affected by diet but rather by sex-by-strain interaction (Fig.6.1F). Female A/J mice 
(1855 beam breaks) had significantly lower activity levels compared to female FVB/NJ 
(3620, p<0.001), NOD/ShiLtJ (7135, p<0.001), and C57BL/6J mice (3638, p<0.001). 
Conversely, male A/J mice showed no difference in activity levels. Male FVB/NJ mice 
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(1520) had significantly lower activity levels compared to male C57BL/6J mice (2782, 
p=0.040). 
 
Table 6.2: P-values of Effects of Sex, Strain, Diet, and Sex-by-Strain, Sex-by-Diet, Strain-by-Diet, 
and Sex-by-Strain-by-Diet Interaction on Weight and Metabolism. 
 Sex Strain Diet Sex by Strain Sex by Diet Strain by Diet Sex by Strain by Diet 
Weight <0.001 <0.001 <0.001 <0.001 0.005 <0.001 0.022 
Adiposity <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.003 
RER 0.539 <0.001 <0.001 0.003 0.417 0.533 0.008 
VO2 <0.001 <0.001 <0.001 0.001 0.080 <0.001 0.009 
Heat Output <0.001 <0.001 <0.001 <0.001 0.003 <0.001 0.001 
Activity <0.001 <0.001 0.137 0.004 0.857 0.978 0.750 
 
6.4.2 Significant Effects of Sex, Diet, Strain, and Their Interactions on Tissue 
Metabolomes 
 An ANOVA model was used to identify metabolites that were robustly affect by 
sex, strain, diet, and their interactions. A total of 178 metabolites (98% of all known 
metabolites detected) were significantly affected by sex, strain, diet, or their interactions 
in one or more tissues (Appendix E, Additional File 5, Fig. 6.2). One hundred and fifty-
four metabolites (84% of total effected metabolites) were influenced by strain in at least 
one tissue. Twenty of these metabolites were significant for strain independent of all 
other factors. Only one metabolite was significant for each factor; sex (thymine), diet 
(dAMP), strain-by-diet (citrate/isocitrate), and sex-by-strain-by-diet (nicotinamide 
ribotide), independent of all other factors.  
  
  121 
Figure 6.1: Effects of sex, strain, and diet on weight and metabolic phenotypes; N=5/ sex, strain, 
and diet group, avg. ± std. dev. Dots represent individual mice within sex-by-strain-by-diet 
combination. Horizontal bars represent pairwise comparisons performed using Tukey’s HSD 
post-hoc analysis; * p<0.05, ** p<0.01, and *** p<0.001 Body weight (A) and adiposity (B) were 
measured at 28 weeks of age, after 16 weeks on the experimental diets. Adiposity is expressed as 
the relative weight of the perigonadal adipose fat pads. Oxygen consumption (C), RER (D), heat 
output (E), and activity (F) were measured during a 48 hr. period when mice were housed in 
Phenomaster metabolic cages.   
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Strain, independent of all other factors, affected the largest number of metabolites in 
muscle (n=40); however, adipose (n=34) and liver (n=19) were also affected. In 
contrast, adipose tissue was most sensitive to sex (n=12), independent of other factors, 
relative to liver (n=0) and skeletal muscle (n=3). Only liver tissue was affected by diet 
(n=3), independent of all other factors. 
 Unsupervised hierarchical clustering was performed to visualize the relatedness 
of each of the 40-sex/strain/diet combinations, based on similarities between 
metabolomes (Fig. 6.3). In liver, A/J and C57BL/6J mice clustered separately, while 
NOD/ShiLtJ and FVB/NJ mice were predominantly independently clustered with one 
NOD/ShiLtJ mouse clustered with FVB/NJ  
mice. Additionally, mice predominantly clustered by sex secondarily to genetic 
background. Skeletal muscle primarily followed the same pattern, however, A/J and 
C57BL/6J mice did not cluster together perfectly as in liver. Conversely, adipose tissue 
did not show a specific clustering pattern for any factor. 
 
6.4.3 Functional Annotation of Sex, Strain, and Diet Effects 
 The sets of metabolites affected by each factor and their interactions were 
functionally annotated using KEGG pathways (Table 6.3). Strain, sex, and diet 
interacted to significantly affect purine metabolism in liver (FDR, p<0.001), with seven 
metabolites (referred to as hits) mapping onto this pathway. Purine metabolism was 
also significantly affected by diet (hits=12), strain (hits=18), and sex-by-strain (hits=12) 
interaction in liver. Strain affected pathways involved in energy metabolism 
(pantothenate and CoA biosynthesis and TCA cycle). Additionally, diet affected amino 
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Figure 6.2: Shared and unique effects of sex, strain, diet, sex-by-diet, sex-by-strain, strain-by-diet, 
and sex-by-strain-by-diet interactions on tissue metabolomes. The sets of metabolites that 
differed significantly, based on ANOVA (FDR < 0.05) by sex, diet, strain, sex-by-diet, strain-by-
diet, or sex-by-strain-by-diet interaction across tissues, (A), and in adipose (B), muscle (C), and 
liver (D) were visualized for shared and factor-specific effects using Venn diagrams. 
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Figure 6.3: Hierarchical clustering of sex/diet groups based on metabolite abundance in liver. Heatmaps were generated in 
Metaboanalyst (v3.0) using group averages of the 50 metabolites that varied the most across diet/genetic/sex combinations.  Samples 
were normalized to median values and values were scaled using Pareto scaling. Z-score was used to determine scale. Abbreviations: 
F-1/6-BP: Fructose-1,6-bisphosphate, Sedoheptulose-BP: Sedoheptulose-bisphosphate
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acid metabolism (aminoacyl-tRNA biosynthesis and arginine and proline metabolism). In 
muscle, sex, strain, and diet all affected amino acid metabolism (aminoacyl-tRNA 
biosynthesis, lysine biosynthesis, arginine and proline biosynthesis, and glutamate and 
glutamine metabolism, and alanine, aspartate, and glutamate metabolism) (Fig. 6.4). 
Additionally, strain affected the TCA cycle (hits=6). Likewise, sex and strain affected 
amino acid metabolism (aminoacyl-tRNA biosynthesis, arginine and proline metabolism, 
and alanine, aspartate, and glutamate metabolism) in adipose tissue. 
 
6.4.4 Relationship Between Known Metabolites and Phenotypes 
 The relationships between metabolite profiles in each tissue and systems level 
energy balance traits were identified using a correlation-based approach (Fig. 6.5).  
Energy expenditure and adiposity were significantly correlated with 58 and 84 
metabolites, respectively, across the three tissues. Hepatic (26 heat, 33 adiposity), 
adipose (16 heat, 33 adiposity), and skeletal muscle (16 heat, 18 adiposity) 
metabolomes contributed the associations in a similar manner. Partial correlation was 
used to adjust for spurious correlations to body weight, after which 75 (33 in adipose, 33 
in liver, and 9 in muscle) metabolites remained significantly correlated with adiposity 
and 54 (16 in adipose, 26 in liver, and 12 in muscle) with heat output.  
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Figure 6.4: Metabolites mapped onto pathways in a cell. Metabolites identified in adipose, muscle, 
and liver were mapped onto pathways in a cell. Amino acids are highlighted in red. 
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Table 6.3:KEGG Pathway Enrichment of Metabolites Affected by Sex, Strain, Diet, Sex-by-diet, 
Sex-by-strain, Strain-by-diet, and Sex-strain-by-diet Interaction. 
Tissue Effect Pathway Hits P-value (k/m)q 
All Tissues Sex Pyrimidine metabolism 11 <0.001 0.004 
  Purine metabolism 14 <0.001 0.004 
  Arginine and proline metabolism 9 <0.001 0.004 
  Aminoacyl-tRNA biosynthesis 11 0.001 0.004 
      
 Strain Pyrimidine metabolism 18 <0.001 0.011 
  Purine metabolism 20 <0.001 0.011 
  Alanine, aspartate and glutamate metabolism 9 <0.001 0.011 
  Glycine, serine and threonine metabolism 10 <0.001 0.011 
  Arginine and proline metabolism 12 <0.001 0.011 
  Ascorbate and aldarate metabolism 5 0.001 0.011 
  Aminoacyl-tRNA biosynthesis 15 0.001 0.011 
  Citrate cycle (TCA cycle) 7 0.001 0.011 
  Pantothenate and CoA biosynthesis 6 0.001 0.011 
  Phenylalanine, tyrosine and tryptophan biosynthesis 3 0.003 0.011 
  D-Glutamine and D-glutamate metabolism 3 0.007 0.011 
  Glutathione metabolism 7 0.007 0.011 
      
 Diet Aminoacyl-tRNA biosynthesis 13 <0.001 0.005 
  Arginine and proline metabolism 10 <0.001 0.005 
  Purine metabolism 12 <0.001 0.005 
  Pyrimidine metabolism 9 <0.001 0.005 
  Ascorbate and aldarate metabolism 4 0.001 0.005 
      
 Sex-by-strain Purine metabolism 14 <0.001 0.002 
  Pyrimidine metabolism 9 <0.001 0.002 
      
 Sex-by-diet Glycine, serine and threonine metabolism 4 <0.001 0.003 
      
 Sex-by-strain-by-diet Purine metabolism 8 <0.001 0.002 
      
Adipose Sex Aminoacyl-tRNA biosynthesis 11 <0.001 0.007 
  Arginine and proline metabolism 8 <0.001 0.007 
  Alanine, aspartate and glutamate metabolism 4 0.003 0.007 
  Lysine biosynthesis 2 0.004 0.007 
  Pantothenate and CoA biosynthesis 3 0.006 0.007 
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Table 6.3 continued 
Tissue Effect Pathway Hits P-value (i/m)q 
      
 Strain Arginine and proline metabolism 10 <0.001 0.011 
  Aminoacyl-tRNA biosynthesis 12 <0.001 0.011 
  Pyrimidine metabolism 7 0.002 0.011 
  Glycine, serine and threonine metabolism 6 0.002 0.011 
  Alanine, aspartate and glutamate metabolism 5 0.003 0.011 
  Ascorbate and aldarate metabolism 3 0.006 0.011 
  Purine metabolism 8 0.008 0.011 
  Citrate cycle (TCA cycle) 4 0.01 0.011 
      
 Sex-by-Strain Purine metabolism 8 <0.001 0.005 
  Pyrimidine metabolism 3 0.002 0.005 
  Pantothenate and CoA biosynthesis 2 0.004 0.005 
      
Muscle Sex Pyrimidine metabolism 6 <0.001 0.008 
  Arginine and proline metabolism 5 0.002 0.008 
  Aminoacyl-tRNA biosynthesis 6 0.002 0.008 
  Lysine biosynthesis 2 0.002 0.008 
      
 Strain Pyrimidine metabolism 11 <0.001 0.011 
  Purine metabolism 13 <0.001 0.011 
  Aminoacyl-tRNA biosynthesis 13 <0.001 0.011 
  Arginine and proline metabolism 10 <0.001 0.011 
  Citrate cycle (TCA cycle) 6 0.001 0.011 
  Ascorbate and aldarate metabolism 4 0.001 0.011 
  D-Glutamine and D-glutamate metabolism 3 0.002 0.011 
  Alanine, aspartate and glutamate metabolism 6 0.002 0.011 
  Glycine, serine and threonine metabolism 6 0.009 0.011 
  Pantothenate and CoA biosynthesis 4 0.01 0.011 
      
 Diet Aminoacyl-tRNA biosynthesis 10 <0.001 0.005 
  Lysine biosynthesis 2 0.001 0.005 
      
Liver Strain Pyrimidine metabolism 16 <0.001 0.007 
  Purine metabolism 18 <0.001 0.007 
  Alanine, aspartate and glutamate metabolism 9 <0.001 0.007 
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Table 6.3 continued 
Tissue Effect Pathway Hits P-value (i/m)q 
  Phenylalanine, tyrosine and tryptophan biosynthesis 3 0.002 0.007 
  Citrate cycle (TCA cycle) 6 0.003 0.007 
  Ascorbate and aldarate metabolism 4 0.003 0.007 
  Pantothenate and CoA biosynthesis 5 0.004 0.007 
      
 Diet Purine metabolism 12 <0.001 0.005 
  Aminoacyl-tRNA biosynthesis 12 <0.001 0.005 
  Pyrimidine metabolism 9 <0.001 0.005 
  Arginine and proline metabolism 9 <0.001 0.005 
  Ascorbate and aldarate metabolism 4 <0.001 0.005 
      
 Sex-by-Strain Purine metabolism 12 <0.001 0.002 
  Pyrimidine metabolism 7 0.001 0.002 
      
 Sex-by-Diet Glycine, serine and threonine metabolism 4 <0.001 0.003 
      
 Sex-by-Strain-by-Diet Purine metabolism 7 <0.001 0.002 
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The relationships between tissue metabolites and systems level energy balance 
traits were assessed by constructing a correlation-based network. The network consists 
of metabolites (21, 19 and 13 from liver, adipose and muscle, respectively) that were 
significantly correlated with at least one energy balance trait and with one or more 
metabolites in any of the three tissues (Fig. 6.6, Appendix F). Adiposity was correlated 
with all 53 metabolites identified. A-ketoglutarate was positively correlated with adiposity 
in adipose (r=0.34,p<0.001) and muscle tissue (r=0.27). Conversely, α-ketoglutarate 
was negatively correlated with weight (r=-0.29,p<0.001) in adipose tissue indicating that 
increased body weight due to increased muscle mass may influence a-ketoglutarate 
levels. Pantothenate, in adipose, a precursor for CoA biosynthesis, was also negatively 
correlated with adiposity (r=-0.40,p<0.001). Furthermore, pantothenate was negatively 
correlated with metabolites identified and muscle and liver, but positively correlated with 
metabolites identified in adipose tissue with the exception of cysteine. Pantothenate 
converts to coenzyme A via an enzymatic reaction requiring cysteine, which may 
explain the inverse relationship. Quinolinate, a potential marker of obesity, was 
positively correlated with adiposity (r=-.35,p<0.001) in liver tissue and negatively 
correlated with adiposity in adipose tissue (r=-.33,p<0.001), suggesting a complex 
relationship between adiposity and tissue type. 
 
6.5 Discussion 
 Genetics and diet play a major role in health; however, the fundamental 
relationship between genetics, dietary intake, and metabolism at the tissue level remain 
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poorly understood. We used an untargeted metabolomics approach to investigate the 
effects of diet, genetics, and sex on tissue metabolomes, and to relate metabolites to 
body composition and energy expenditure.  Experimental diets were designed to model 
eating patterns (American, Japanese, Mediterranean, and ketogenic) that are known to 
affect various aspects of metabolic health in humans. Diet composition varied widely in 
terms of the sources of ingredients, relative contribution of animal- and plant-based 
ingredients, and macronutrient and micronutrient composition. Furthermore, differences 
in genetic background could result in various predispositions to metabolic disease. The 
combination of diet, genetics, and sex produced a stratified response on the tissue 
metabolome. This allowed us to query the extent to which tissue metabolomes were 
influenced by diet, genetics, sex, and their various interactions, and to characterize their 
relative impact on liver, adipose, and skeletal muscle. Our model, which included 40 
unique combinations of diet, genetics, and sex, also enable us to use correlation to 
relate metabolites to body composition and energy expenditure. 
 Although sex-by-strain-by-diet exerted effects on weight and energy expenditure 
phenotypes, a considerable proportion of metabolites were influenced by strain alone. 
Surprisingly, skeletal muscle was most sensitive to strain (n=40); however, strain 
exerted effects on adipose (n=34) and liver (n=19) tissue, independent of all other 
treatments or combinations.  
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Figure 6.5: Correlations between metabolites and system phenotypes.  Pearson correlation was 
used to associate metabolites in adipose (A), muscle (B), and liver (C) with weight, adiposity, and 
metabolic phenotypes. Significant correlations (FDR < 0.05) are represented by an asterisk (*). For 
metabolites that were significantly correlated for adiposity and/or heat output, partial correlation 
was used to determine if the relationship between metabolite and trait was due to spurious 
correlation with body weight. Correlations that remained significant are indicated by a bold 
asterisk (*). 
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Figure 6.6: Cross-tissue metabolite and phenotype network.  Pearson correlation was used to 
associate metabolites within and across each tissue with weight, adiposity, and metabolic 
phenotypes. Only significant correlations (FDR < 0.05) are shown. To assess relationships within 
and across tissues and phenotypes, metabolites are clustered by their respective tissue or 
phenotype. The size of each node represents the number of edges connected to the node. A red 
line represents positively correlated metabolites, while a blue line represents negatively 
correlated metabolites.  
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Metabolites affected by strain and diet, in muscle, were involved in several 
aspects of amino acid metabolism (aminoacyl-tRNA biosynthesis, arginine and proline 
metabolism, glutamine and glutamate metabolism, alanine, aspartate, and glutamate 
metabolism). Strain altered 15 of the 20 amino acids while diet altered 11 in muscle. 
The percentage of protein in each diet varied considerably (~13-19%), which may be 
attributable to amino acid differences seen across diets. Additionally, variations in 
carbohydrate and fat levels may also contribute to diet-associated differences in amino 
acid profiles. Genetic effects on amino acid metabolism have been linked to metabolic 
diseases, such as type 2 diabetes. Additionally, GWAS studies have attributed genetic 
variants to BCAA levels. Specifically PPM1K, which activates the branched-chain alpha-
ketoacid complex via mitochondrial phosphatase and serves as the rate limiting to 
BCAA catabolism was positively associated with BCAA levels [210]. Although we 
cannot comment specifically about PPM1K in our study since we did not perform 
genetic sequencing this relationship warrants further investigation. Furthermore, insulin 
resistance in humans has been attributable to alterations in BCAA levels in muscle, as 
well as TCA cycle intermediates [211]. Methylmalonyl CoA mutase may play a role in 
BCAA availability for use in the TCA cycle and is linked to altered lipid metabolism in 
muscle. Methylmalonyl CoA is converted to succinyl CoA via this enzyme, which then 
enters the TCA cycle. FVB/NJ mice showed 434 SNP variations compared to the other 
strains, using the mouse phenome database, for methylmalonyl-CoA mutase. 
Homozygous mutations in this gene can cause increased levels of methylmalonic acid 
in plasma potentially resulting in methylmalonic aciduria, a severe metabolic disease 
[211]. While we did not measure metabolites in plasma we did find significantly 
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increased levels methylmalonic acid between strains for muscle. Whether or not tissue 
levels of methylmalonic acid play a role in metabolic dysfunction cannot be determined 
in the current study. Further studies are needed to determine the role of methylmalonic 
acid on disease. Additionally, amino acid metabolism was also affected by sex and 
strain in adipose, sex in muscle, and strain, diet, and sex-by-diet in liver tissue.  
 In contrast to strain, few metabolites responded to sex-by-strain-by-diet 
interaction. Despite this, sex-by-strain-by-diet interaction influenced purine metabolism 
in liver. Purine metabolism includes the synthesis and breakdown of purine nucleotides, 
which are building blocks of nucleic acids and cofactors that are required for energy 
metabolism. While these functions are fundamentally important for all cells, recent 
studies have associated alterations in this pathway with gene mutations and metabolic 
disease. Gout is a disease characterized by a build up of uric acid in the blood. Genome 
wide association studies have related genetic variants in GLUT9, URAT1, and ABCG2 
to prevention or progression of gout [212]. Assessing the role of GLUT9 in males and 
females from Sardinia and Chianti, Tuscany revealed that SNP rs6855911 had the 
strongest association with uric acid levels, lowering uric acid levels in individuals from 
both cohorts with this allele [213]. Furthermore, gender contributed to differences in uric 
acid levels. Women with this allele had even lower levels of uric acid than men [213]. 
Although this study did not investigate the role of dietary components on metabolism it 
has been well established that diet contributes purine metabolite levels [214-216]. Diets 
containing animal products contributed to higher purine levels compared to other diets 
[216]. Furthermore, men have a higher risk of developing gout due to higher blood 
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levels of uric acid compared to women [216]. Seven metabolites in our study were 
mapped onto purine metabolism; however, uric acid levels were not significantly altered.  
Tryptophan is an essential amino acid important for protein synthesis and the 
biosynthesis of serotonin and melatonin, two metabolites that aid in the regulation of 
mood and sleep [217]. Furthermore, tryptophan can be broken down into kynurenine, 
kynurenic acid, and quinolinate. The obesogenic state in humans has been associated 
with these three metabolites [218]. Our data identified tryptophan, kynurenine, kynurenic 
acid, and quinolinate in liver tissue displaying differences due to diet. Furthermore, 
associations with phenotypic markers of metabolism showed a positive correlation 
between quinolinate and adiposity, independent of body weight for both adipose and 
liver tissue. In contrast, kynurenine and kynurenic acid were not significantly correlated 
with any phenotype. Correlation network analysis also revealed a positive associate 
between quinolinate, in liver, and a negative correlation, in adipose tissue, with 
adiposity. Although this dual relationship with adiposity cannot be completely explained 
previous studies have associated quinolinate levels in the liver with toxicity [219]. 
Additionally, quinolinate is the precursor to NAD+ formation [220]. NAD+ is necessary 
for the TCA cycle to function, however, both the TCA cycle and NAD+ levels have been 
shown to decrease as adiposity increases [221], so the inverse relationship between 
quinolinate and adiposity in adipose tissue cannot be explained by increased NAD+ 
levels. Furthermore, our data showed no correlation between NAD+ and quinolinate for 
the correlation network analysis or between quinolinate and NAD+ in adipose tissue. It 
is possible that quinolinate was converted to nicotinamide, the intermediary metabolite 
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between quinolinate and NAD+; however, we did not measure this metabolite in our 
system. Measuring this metabolite may provide critical information regarding this 
relationship. Additionally, quinolinate phosphoribosyltransferase (QPRT) is necessary 
for the conversion of quinolinate to NAD+. Previous studies have shown a negative 
relationship between QPRT expression and markers of diabetes [218]. It is possible that 
QPRT expression was altered in our study; however, gene expression was not 
measured. Further investigation into the relationship between adiposity, quinolinate, and 
QPRT are warranted to further define this relationship. In addition to diet, quinolinate 
was significant for strain in all three tissues. All four strains differentially respond to diet-
induced obesity. Diet-induced obesity resistant A/J mice are had the lowest levels of 
quinolinate. 
Several limitations of our study should be emphasized.  In particular, the diets 
were designed to reflect common patterns of global consumption in humans. 
Accordingly, the range of variation in diet composition prevents us from associating 
specific dietary factors with metabolite patterns. We have also measured metabolites in 
a steady state, at a single time point. Effects of diet, genetics, or sex on metabolite 
turnover therefore go undetected in our study. Furthermore, the extraction method we 
used targets polar metabolites at the expense of lipids, which are also likely subject to 
extensive sex, genetic, and diet regulation. Finally, due to the specificity of the 
extraction method and the limited number of metabolites that can be identified using our 
in-house database, it is difficult to ascertain whether pathways significantly altered are 
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affected by sex, strain, diet, or their interactions or because a metabolite is more easily 
identified to due inherent biases in the experimental procedure. 
 
6.6 Conclusion 
 We profiled three tissues (adipose, muscle, and liver), which play a major role in 
energy metabolism to determine the effects of genetics, diet, and sex on the tissue 
metabolome. The stratified results showed many tissue specific effects, however, amino 
acids metabolism was universally affected. Although this study comprehensively profiles 
the interactions between genetic, sex, and diet, serum metabolites were not measured. 
Profiling serum metabolites may provide insight into the global metabolic profile. 
Nonetheless, this study has shown several metabolites that could be investigated to 
determine their role in metabolism and disease. 
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CHAPTER SEVEN  
CONCLUSION 
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Mass spectrometry based metabolomics is in its infancy but is quickly becoming 
a powerful tool to elucidate the metabolic effects of small perturbations in a system. 
Many studies have shown that this method is able identify potential biomarkers of 
disease. This dissertation had three aims: 1.) characterize the relative effects of 
genetics, sex, diet, and their interactions on tissue metabolomes, 2.) identify tissue-level 
metabolic effects of diets that are commonly recommended for health, and 3.) link tissue 
metabolite profiles to systems phenotypes relevant to metabolic syndrome. To 
accomplish these aims adipose, skeletal muscle, and liver tissue were collected from 
males and females of four strains of mice (A/J, C57BL/6J, FVB/NJ, and NOD/ShiLtJ) 
fed one of five diets (Japanese, ketogenic, Mediterranean, American, and standard 
chow). The tissues were chosen due to their known role in energy metabolism, while the 
diets were chosen for their known roles in health. The strains of mice were chosen for 
their genetic diversity. The first aim allowed us to identify metabolites sensitive to 
differences in the system due to discrepancies in diet, sex, or genetic background. This 
allowed us to query the extent to which diet, in the presence or absence of genetic or 
sex differences, influenced the tissue metabolome. The second aim allowed us to map 
altered metabolites onto KEGG pathways to query the biological role on individual 
metabolites and their role in metabolic pathways, which may influence health status. 
The third aim allowed us find associations between phenotypic metabolic data and 
altered metabolites in the body, which provides insight into the mechanism through 
which metabolites influence physiological responses. 
 In all three studies we examined each tissue metabolome across genetic, sex 
and/or diet effects. In addition to metabolome measurements we were provided 
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measurements pertaining to body weight, adiposity, RER, VO2, heat output, and activity 
levels. In the first study, we examined each tissue metabolome in C57BL/6J males and 
females fed all five diets for 7 months. In the second study, we examined each tissue 
metabolome in males and females for all four strains of mice fed a standard chow diet 
for 7 months. In the third study, we examined each tissue metabolome in males and 
females for all four strains of mice fed all five diets for 7 months.  
 Metabolism is fundamental to life and plays a critical role in the health and the 
well being of cells, tissues, and overall biological systems. Fluctuations in metabolism 
can have profound physiological impacts contributing to metabolic diseases. Moreover, 
metabolism is often sensitive to environmental stimuli, such as diet and lifestyle [112, 
222-225] while also being sensitive to genetic differences and gender [177, 210, 226, 
227]. Genetic mutations, immunological responses, and protein conformation changes 
have been much of the focus over the last 50 years when assessing disease and 
potential treatments, however, alterations in the metabolome have gained increasing 
attention in recent years. Furthermore, the ability to integrate of genomics, 
transcriptomics, proteomics, and metabolomics, provides a means with which to 
develop a comprehensive understanding of how the body may change at the cellular, 
tissue, and systems-level to promote a disease state. While the genetic information can 
provide information regarding an individual’s potential for developing a disease, the 
metabolome can provide information with respect to the beginning stages of a disease. 
Aminoadipic acid, for example, has been linked to the development of type 2 diabetes 
with higher levels circulating in the blood up to 12 years prior to the disease state [122]. 
Additionally, while this dissertation has shown tissue specific effects on the 
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metabolome, which should be taken into consideration, serum and urine metabolomes 
can be non-invasively profiled making them an ideal candidate for long-term 
surveillance for disease risk. Most metabolomics studies currently aim to identify 
metabolic differences between the diseased and non-diseased state, however, few 
have aimed to identify baseline differences between, diet, genetic, or sex differences. 
The work presented in this dissertation contributes to the later body of work. A disease 
state is difficult to interpret without understanding the “normal” state, therefore a basic 
understanding of how diet influences the metabolome under normal physiological 
conditions can aid in the understanding of which diet may improve symptoms and which 
may exacerbate symptoms. Furthermore, the environment can influence genetic 
predisposition to certain diseases. Understanding how basic genetic differences 
translate to the metabolome can provide a basic understanding of how the metabolome 
is influenced due to inherent genetic differences. Finally, many studies that have studied 
the disease state have primarily investigated these effects in men. Recently, an influx of 
studies have included women, unsurprisingly discovering that while women develop the 
same diseases as men their symptoms, treatments, and outcomes can be vastly 
different. While much of this has been attributed to sex hormones, investigating how the 
metabolome differs between genders is critical to identifying inherent differences. It may 
be discovered that a metabolite biomarker may be appropriate for one gender but not 
the other. Our research has demonstrated that specific metabolites differentiate by sex, 
while others are perturb through differences in diet (presented in chapter 3). 
Furthermore, there is a subset of metabolites that are influenced by the interaction 
between diet and gender. When we considered genetic background we demonstrated 
  144 
that genetic background was far more influential to alterations in the metabolome than 
either gender or the interaction between gender and genetics underscoring the 
importance of genetics on metabolism (presented in chapter 4). Finally, when we 
considered the influence of diet, genetics, and sex simultaneously we demonstrated that 
genetics had the largest impact across all potential combinations with gender playing a 
secondary role, however, sex-by-strain-by diet interaction influenced a subset of 
metabolites (presented in chapter 5). It is important to note that metabolites had a 
stratified response across all factors and their interactions emphasizing the complex 
relationship between diet, genetics, and sex. It must also be pointed out, however, that 
diet had the least impact on the metabolome; however, differences in diet still impacted 
the metabolome in combination with gender and genetic background. 
Metabolomics has become a powerful tool to investigate systems-level 
alterations that are the result of many biochemical reactions. While metabolomics is still 
in its infancy technological improvements have allowed for significant advancements in 
recent years. However, metabolomics studies still remain expensive ant time 
consuming. Furthermore, no one extraction method can extract all the metabolites 
present in a system requiring multiple extraction methods and a large quantity of sample 
to obtain comprehensive cover. Additionally, there are thousands of metabolites that 
have yet to be identified creating a large gap in knowledge regarding the biological role 
these metabolites have in the body. Accordingly, unknown metabolites also present a 
challenge because they can only be identified by their mass-to-charge ratio making it 
difficult to separate whole metabolites from fragments. Finally, since metabolomics is a 
young field, repositories and databases are still being formed to aid in the identification 
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and functional analysis of metabolites. The lack of databases and repositories has 
made it difficult to share raw spectral data and made it necessary for researchers to 
build their own internal databases and has made it nearly impossible to identify 
unknown analytes. 
 Metabolomics has flourished since the development of liquid chromatography, 
allowing for the identification of larger molecules. As the field continues to mature 
researchers will be able to investigate more complex biological questions. This 
dissertation shows the capacity with which metabolomics has to address complex 
relationships in a biological system. Diet has long been a complex topic to investigate 
due to the complex nature of diet composition and the many confounding variable, such 
as diet and sex, as well as potential lifestyle components. This dissertation has 
contributed to understanding the complex relationship between diet, genetics, and sex 
and their influence on the tissue metabolome. This has highlighted the potential of 
metabolomics to dissect nuanced differences among the interactions. As metabolomic 
analyses continue to increased in popularity, our understanding of the metabolome's 
contribution to disease and will continue to deepen. 
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Table A.1: Significant ANOVA p-values (FDR < 0.05) for Adipose, Muscle, and Liver Tissue in 
C57BL/6J Mice 
  Sex (i/m)q Diet (i/m)q Sex-by-Diet (i/m)q 
Liver 1-Methyl-Histidine 0.0001 0.0021 0.1715 0.0291 0.0807 0.0166 
 1-Methyladenosine 0.0962 0.0179 0.0011 0.0064 0.7719 0.0454 
 2-dehydro-D-gluconate 0.0001 0.0021 0.0006 0.0055 0.0651 0.0148 
 3-hydroxybutyryl-CoA 0.0118 0.0080 0.0031 0.0086 0.0867 0.0172 
 3-S-methylthiopropionate 0.0054 0.0059 0.0081 0.0114 0.1148 0.0195 
 4-Pyridoxic acid 0.1508 0.0215 0.0049 0.0099 0.0008 0.0018 
 6-phospho-D-gluconate 0.0000 0.0012 0.0000 0.0001 0.0705 0.0154 
 Acetyl-CoA 0.0048 0.0056 0.0063 0.0107 0.2313 0.0264 
 Acetyllysine 0.0000 0.0007 0.6248 0.0441 0.0652 0.0149 
 Adenosine 0.1108 0.0189 0.0019 0.0076 0.0007 0.0017 
 ADP-D-glucose 0.0056 0.0060 0.2238 0.0317 0.2064 0.0252 
 Allantoate 0.0000 0.0002 0.0283 0.0165 0.0751 0.0160 
 Aminoadipic acid 0.0000 0.0011 0.0007 0.0057 0.0735 0.0157 
 AMP 0.9185 0.0479 0.0014 0.0069 0.0038 0.0039 
 Asparagine 0.0103 0.0077 0.0084 0.0116 0.0006 0.0016 
 Betaine 0.6662 0.0413 0.0002 0.0042 0.0000 0.0004 
 Carnitine 0.5131 0.0365 0.8455 0.0480 0.0034 0.0037 
 Citrulline 0.0062 0.0061 0.0042 0.0094 0.0034 0.0037 
 Coenzyme A 0.0047 0.0056 0.0207 0.0151 0.1875 0.0241 
 Creatine 0.5157 0.0367 0.0020 0.0078 0.0048 0.0043 
 Cyclic-AMP 0.0006 0.0030 0.0710 0.0221 0.1013 0.0184 
 Deoxyinosine 0.2198 0.0254 0.0047 0.0097 0.0003 0.0011 
 Deoxyribose-phosphate 0.0000 0.0014 0.0010 0.0062 0.2634 0.0280 
 Deoxyuridine 0.5261 0.0370 0.0001 0.0034 0.0001 0.0009 
 Dephospho-CoA 0.9076 0.0477 0.0000 0.0031 0.0097 0.0059 
 dGMP 0.9185 0.0479 0.0014 0.0069 0.0038 0.0039 
 Dihydroxy-acetone-phosphate 0.0002 0.0024 0.7020 0.0455 0.0043 0.0042 
 FAD 0.0005 0.0029 0.0279 0.0164 0.5207 0.0389 
 Fructose-1/6-bisphosphate 0.0004 0.0028 0.1198 0.0259 0.2956 0.0294 
 Fumarate 0.2785 0.0280 0.0001 0.0033 0.1204 0.0198 
 Glucarate 0.0083 0.0069 0.0018 0.0076 0.0362 0.0110 
 Gluconate 0.0000 0.0006 0.0013 0.0068 0.0013 0.0023 
 Glucose-1/6-phosphate 0.5329 0.0372 0.0000 0.0023 0.0079 0.0054 
 
  163 
Table A continued 
  Sex (i/m)q Diet (i/m)q Sex-by-Diet (i/m)q 
 Glutamate 0.6724 0.0415 0.0000 0.0030 0.0156 0.0073 
 Glutamine 0.0000 0.0013 0.0003 0.0048 0.0185 0.0079 
 Glutathione 0.5254 0.0369 0.4719 0.0403 0.0006 0.0017 
 Glyceraldehdye-3-phosphate 0.0002 0.0024 0.7020 0.0455 0.0043 0.0042 
 Glycerol-3-phosphate 0.2279 0.0258 0.0009 0.0060 0.0077 0.0053 
 GMP 0.7821 0.0442 0.0004 0.0050 0.6924 0.0434 
 Guanine 0.0055 0.0059 0.9039 0.0488 0.0540 0.0134 
 Histidine 0.0451 0.0132 0.0015 0.0071 0.8798 0.0478 
 Homocysteic acid 0.0021 0.0044 0.0000 0.0022 0.1993 0.0247 
 Homoserine 0.0001 0.0020 0.5854 0.0431 0.0079 0.0054 
 Hydroxyisocaproic acid 0.0001 0.0019 0.0872 0.0236 0.0784 0.0163 
 Hydroxyproline 0.1762 0.0231 0.0000 0.0021 0.0886 0.0174 
 Hypoxanthine 0.7102 0.0422 0.0000 0.0023 0.0003 0.0012 
 IMP 0.0043 0.0055 0.7088 0.0456 0.0007 0.0018 
 Inosine 0.0404 0.0124 0.0591 0.0209 0.0003 0.0012 
 Leucine/isoleucine 0.0733 0.0160 0.0158 0.0140 0.0002 0.0010 
 Lysine 0.1135 0.0191 0.0007 0.0057 0.0019 0.0028 
 Methionine 0.0053 0.0059 0.0000 0.0015 0.0169 0.0076 
 N-acetyl-glutamine 0.0000 0.0007 0.0015 0.0071 0.0465 0.0125 
 N-Acetyl-L-alanine 0.0000 0.0010 0.0604 0.0210 0.0128 0.0067 
 N-acetyl-L-ornithine 0.3087 0.0291 0.0034 0.0089 0.7569 0.0451 
 NADH 0.0005 0.0029 0.0083 0.0116 0.4639 0.0368 
 Octulose 8/1P 0.6719 0.0414 0.0000 0.0004 0.0722 0.0155 
 Ornithine 0.2097 0.0249 0.0638 0.0213 0.0015 0.0025 
 Pantothenate 0.0511 0.0138 0.0232 0.0156 0.0026 0.0032 
 Proline 0.0078 0.0067 0.0036 0.0090 0.0024 0.0031 
 Riboflavin 0.0000 0.0017 0.0769 0.0227 0.0068 0.0050 
 Ribose-phosphate 0.0001 0.0021 0.2206 0.0316 0.0102 0.0061 
 Sedoheptulose bisphosphate 0.0010 0.0035 0.0637 0.0213 0.0633 0.0145 
 Sedoheptulose-1/7-phosphate 0.1508 0.0215 0.0000 0.0015 0.0199 0.0082 
 Serine 0.0077 0.0067 0.0000 0.0019 0.0008 0.0019 
 Taurine 0.1122 0.0190 0.0450 0.0191 0.0024 0.0031 
 Taurodeoxycholic acid 0.0017 0.0041 0.0422 0.0187 0.0006 0.0016 
 Threonine 0.0001 0.0020 0.5854 0.0431 0.0079 0.0054 
 Tryptophan 0.0758 0.0162 0.0024 0.0080 0.0670 0.0150 
 UDP-D-glucuronate 0.1355 0.0206 0.0051 0.0101 0.0703 0.0154 
 Uracil 0.0029 0.0049 0.0056 0.0104 0.3383 0.0316 
 Uridine 0.0000 0.0005 0.1519 0.0279 0.0165 0.0075 
 Valine 0.6864 0.0417 0.0002 0.0041 0.0000 0.0004 
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Table A continued 
  Sex (i/m)q Diet (i/m)q Sex-by-Diet (i/m)q 
 Xanthine 0.8622 0.0466 0.0034 0.0089 0.0000 0.0006 
 Xanthosine 0.1669 0.0225 0.0014 0.0070 0.0001 0.0007 
 Xanthurenic acid 0.0230 0.0101 0.0122 0.0130 0.1089 0.0190 
        
Muscle Acetyllysine 0.0028 0.0032 0.0005 0.0009 0.5030 0.0315 
 Aminoadipic acid 0.0000 0.0012 0.0000 0.0004 0.0349 0.0048 
 Deoxyribose-phosphate 0.0008 0.0022 0.0450 0.0072 0.3385 0.0242 
 Deoxyuridine 0.0002 0.0017 0.3868 0.0285 0.0028 0.0007 
 Erythrose-4-phosphate 0.0005 0.0020 0.0006 0.0010 0.0079 0.0016 
 Glucose-1/6-phosphate 0.0007 0.0021 0.0066 0.0026 0.0310 0.0045 
 Histidine 0.6679 0.0383 0.0008 0.0011 0.0009 0.0003 
 Homocysteic acid 0.0058 0.0038 0.0000 0.0002 0.0009 0.0003 
 Homoserine 0.6309 0.0369 0.0000 0.0004 0.0139 0.0025 
 Hydroxyphenylacetic acid 0.0011 0.0024 0.5603 0.0359 0.1858 0.0157 
 Hydroxyproline 0.0059 0.0038 0.0000 0.0000 0.0003 0.0001 
 Kynurenine 0.0004 0.0018 0.6971 0.0411 0.8638 0.0457 
 Methionine 0.0026 0.0031 0.0084 0.0029 0.2760 0.0210 
 N-acetyl-glutamine 0.0002 0.0016 0.9717 0.0493 0.0400 0.0053 
 N-Acetyl-L-alanine 0.0029 0.0032 0.7999 0.0443 0.3076 0.0227 
 Orotate 0.0000 0.0009 0.9987 0.0500 0.0750 0.0082 
 Pantothenate 0.0000 0.0003 0.0116 0.0032 0.0969 0.0099 
 Proline 0.5518 0.0338 0.0013 0.0014 0.0993 0.0101 
 Threonine 0.5957 0.0356 0.0000 0.0004 0.0126 0.0023 
 Tryptophan 0.0007 0.0021 0.0006 0.0010 0.0091 0.0018 
 Valine 0.6530 0.0377 0.0006 0.0010 0.0482 0.0060 
        
Adipose 1-Methyladenosine 0.0008 0.0010 0.2280 0.0226 0.0649 0.0063 
 a-ketoglutarate 0.0196 0.0035 0.0007 0.0009 0.5926 0.0336 
 Adenosine 0.0001 0.0006 0.0244 0.0061 0.1696 0.0127 
 Citrulline 0.0008 0.0010 0.0958 0.0134 0.1980 0.0142 
 Glucosamine-1/6-phosphate 0.2739 0.0197 0.0008 0.0010 0.0001 0.0001 
 Glutamine 0.8048 0.0424 0.002 0.0017 0.0000 0.0000 
 Guanosine 0.0001 0.0005 0.0819 0.0121 0.1541 0.0119 
 Hydroxyproline 0.8013 0.0422 0.0000 0.0001 0.3356 0.0219 
 Inosine 0.0007 0.0010 0.1627 0.0183 0.8314 0.0438 
 N-acetyl-glutamate 0.0000 0.0004 0.0150 0.0046 0.1040 0.0088 
 Pantothenate 0.0000 0.0001 0.1033 0.0140 0.5085 0.0300 
 Proline 0.0053 0.0018 0.0011 0.0011 0.0000 0.0001 
 S-adenosyl-L-homoCysteine 0.0000 0.0002 0.0798 0.0118 0.3760 0.0239 
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All known metabolites considered significant in the ANOVA were identified in liver, 
skeletal muscle, and adipose tissue. Bold values indicate that the metabolite is 
statistically significant. Bold metabolites are not tissue specific. Bold and italicized 
metabolites are shared between all three tissues. Benjamini-Hochberg procedure was 
performed to determine significance.  
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Table B.2: Number of Edges for Each Node in Correlation Network Analysis in C57BL/6J Mice 
Metabolite Tissue Total 
Degree 
(+/-) 
Degree 
(Adipose) 
(+/-) 
Degree 
(Muscle) 
(+/-) 
Degree 
(Liver) 
(+/-) 
Degree 
(Phenotype) 
(+/-) 
α-ketoglutarate Adipose 6 (2/4) 1 (0/1) 0 3 (0/3) 2 (2/0) 
Adenosine Adipose 6 (3/3) 0 1 (0/1) 4 (3/1) 1 (0/1) 
ADP Adipose 3 (2/1) 1 (1/0) 0 1 (1/0) 1 (0/1) 
IMP Adipose 3 (3/0) 1 (1/0) 0 1 (1/0) 1 (1/0) 
Myo-inositol Adipose 3 (2/1) 1 (1/0) 0 2 (1/1) 0 
N-acetyl-glutamate Adipose 9 (5/4) 4 (3/1) 1 (1/0) 2 (1/1) 2 (0/2) 
Pantothenate Adipose 14 (9/5) 2 (2/0) 2 (1/1) 8 (5/3) 2 (1/1) 
S-adenosyl-L-homoCysteine Adipose 6 (5/1) 1 (1/0) 1 (1/0) 2 (1/1) 2 (2/0) 
3-S-methylthiopropionate Liver 5 (1/4) 0 0 4 (1/3) 1 (0/1) 
6-phospho-D-gluconate Liver 9 (7/2) 0 0 8 (6/2) 1 (1/0) 
Acetyllysine Liver 6 (5/1) 1 (1/0) 1 (1/0) 3 (2/1) 1 (1/0) 
Adenosine Liver 4 (2/2) 0 0 2 (1/1) 2 (1/1) 
ADP-D-glucose Liver 12 (10/2) 0 0 10 (9/1) 2 (1/1) 
Allantoate Liver 11 (8/3) 3 (2/1) 1 (1/0) 6 (4/2) 1 (1/0) 
Aminoadipic acid Liver 13 (9/4) 2 (2/0) 1 (1/0) 8 (5/3) 2 (1/1) 
AMP Liver 4 (3/1) 0 0 3 (3/0) 1 (0/1) 
ATP Liver 11 (9/2) 0 0 10 (7/2) 1 (1/0) 
Butyryl-CoA Liver 11 (8/3) 2 (2/0) 1 (1/0) 7 (4/3) 1 (1/0) 
CDP Liver 7 (7/0) 0 0 6 (6/0) 1 (1/0) 
Citrulline Liver 5 (2/3) 1 (0/1) 0 2 (1/1) 2 (1/1) 
Creatine Liver 3 (3/0) 0 0 2 (2/0) 1 (1/0) 
Cytidine Liver 5 (2/3) 2 (1/1) 0 2 (1/1) 1 (0/1) 
Deoxyuridine Liver 5 (2/3) 1 (0/1) 0 2 (2/0) 2 (0/2) 
Dephospho-CoA Liver 6 (3/3) 0 1 (0/1) 4 (3/1) 1 (0/1) 
dGMP Liver 4 (3/1) 0 0 3 (3/0) 1 (0/1) 
FAD Liver 13 (10/3) 0 0 12 (9/3) 1 (1/0) 
Fructose-1,6-bisphosphate Liver 11 (9/2) 0 0 10 (8/2) 1 (1/0) 
GDP Liver 10 (10/0) 0 1 (1/0) 8 (8/0) 1 (1/0) 
Glucarate Liver 2 (1/1) 0 1 (0/1) 0 1 (1/0) 
Gluconate Liver 8 (4/4) 1 (1/0) 1 (0/1) 5 (3/2) 1 (0/1) 
Glutamine Liver 12 (6/6) 1 (1/0) 0 10 (5/5) 1 (0/1) 
GMP Liver 5 (4/1) 0 0 4 (4/0) 1 (0/1) 
Guanosine Liver 6 (5/1) 0 0 4 (3/1) 2 (2/0) 
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Table B continued 
Metabolite Tissue Total 
Degree 
(+/-) 
Degree 
(Adipose) 
(+/-) 
Degree 
(Muscle) 
(+/-) 
Degree 
(Liver) 
(+/-) 
Degree 
(Phenotype) 
(+/-) 
Hydroxyisocaproic acid Liver 3 (2/1) 0 0 2 (2/0) 1 (0/1) 
IMP Liver 3 (3/0) 0 0 2 (2/0) 1 (1/0) 
Inosine Liver 8 (8/0) 0 0 7 (7/0) 1 (1/0) 
Methionine Liver 11 (3/8) 1 (0/1) 2 (0/2) 7 (3/4) 1 (0/1) 
N-acetyl-glutamine Liver 13 (5/8) 4 (1/3) 1 (0/1) 7 (4/3) 1 (0/1) 
N-Acetyl-L-alanine Liver 13 (10/3) 1 (0/1) 2 (1/1) 8 (8/0) 2 (1/1) 
NADH Liver 8 (7/1) 1 (1/0) 0 6 (5/1) 1 (1/0) 
Octulose 8/1P Liver 4 (2/2) 1 (1/0) 0 2 (0/2) 1 (1/0) 
Riboflavin Liver 9 (9/0) 0 0 8 (8/0) 1 (1/0) 
Ribose-phosphate Liver 6 (6/0) 0 0 5 (5/0) 1 (1/0) 
Sedoheptulose bisphosphate Liver 10 (9/1) 0 0 9 (8/1) 1 (1/0) 
Taurine Liver 3 (3/0) 0 0 2 (2/0) 1 (1/0) 
UDP-N-acetyl-glucosamine Liver 9 (9/0) 0 0 8 (8/0) 1 (1/0) 
Uridine Liver 10 (5/5) 1 (0/1) 1 (1/0) 7 (4/3) 1 (0/1) 
Arginine Muscle 5 (3/2) 0 2 (2/0) 2 (0/2) 1 (1/0) 
Histidine Muscle 3 (3/0) 0 2 (2/0) 0 1 (1/0) 
Lysine Muscle 5 (2/3) 0 2 (2/0) 2 (0/2) 1 (0/1) 
Orotate Muscle 4 (2/2) 1 (0/1) 0 2 (2/0) 1 (0/1) 
Pantothenate Muscle 12 (8/4) 4 (3/1) 0 7 (4/3) 1 (1/0) 
Activity Phenotype 7 (6/1) 0 0 7 (6/1) 0 
Adiposity Phenotype 15 (9/6) 2 (1/1) 1 (0/1) 11 (7/4) 1 (1/0) 
Heat Output Phenotype 19 (10/9) 3 (2/1) 2 (1/1) 13 (7/6) 1 (0/1) 
RER Phenotype 12 (6/6) 1 (1/0) 2 (2/0) 9 (3/6) 0 
Weight Phenotype 11 (5/6) 4 (1/3) 0 5 (3/2) 2 (1/1) 
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APPENDIX C 
Table C.3: Significant ANOVA p-values (FDR < 0.05) for Adipose, Muscle, and Liver Tissue in Mice 
Fed a Standard Chow Diet 
 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Sex-by-
Strain 
(i/m)q 
Liver 1-Methyladenosine 0.3736 0.0292 0.0143 0.0265 0.2465 0.0262 
 2-dehydro-D-gluconate 0.7035 0.0408 0.0000 0.0050 0.0001 0.0008 
 2-Hydroxy-2-methylbutanedioic acid 0.0044 0.0049 0.0001 0.0076 0.1543 0.0209 
 2-Isopropylmalic acid 0.1751 0.0204 0.0008 0.0141 0.0861 0.0157 
 3-hydroxybutyryl-CoA 0.0089 0.0063 0.0007 0.0135 0.7803 0.0447 
 3-methylphenylacetic acid 0.0033 0.0045 0.4894 0.0467 0.3394 0.0305 
 3-phosphoglycerate 0.5168 0.0345 0.0000 0.0053 0.7237 0.0434 
 3-S-methylthiopropionate 0.2107 0.0223 0.0298 0.0305 0.2288 0.0252 
 4-Pyridoxic acid 0.0377 0.0108 0.0002 0.0096 0.0235 0.0089 
 6-phospho-D-gluconate 0.0739 0.0140 0.0000 0.0020 0.0030 0.0038 
 Acetyl-CoA 0.0000 0.0002 0.0000 0.0070 0.0094 0.0060 
 Acetyllysine 0.0019 0.0038 0.4096 0.0456 0.5880 0.0397 
 Aconitate 0.2581 0.0243 0.0264 0.0299 0.4087 0.0330 
 Adenine 0.8649 0.0459 0.0225 0.0290 0.2669 0.0272 
 Adenosine 0.0219 0.0089 0.0000 0.0072 0.0554 0.0131 
 Adenosine 5-phosphosulfate 0.3379 0.0279 0.0142 0.0264 0.9104 0.0479 
 ADP 0.0002 0.0018 0.0000 0.0037 0.0064 0.0052 
 ADP-D-glucose 0.0098 0.0066 0.0000 0.0042 0.0235 0.0089 
 Alanine 0.1970 0.0215 0.0003 0.0111 0.1201 0.0186 
 Allantoate 0.0001 0.0016 0.0516 0.0337 0.0042 0.0044 
 Allantoin 0.3929 0.0298 0.0007 0.0136 0.2942 0.0286 
 Aminoadipic acid 0.0010 0.0030 0.0004 0.0116 0.8011 0.0453 
 Aminoimidazole carboxamide 
ribonucleotide 
0.8912 0.0467 0.0057 0.0220 0.0334 0.0104 
 AMP 0.9086 0.0472 0.0000 0.0005 0.0387 0.0110 
 Aspartate 0.0267 0.0094 0.0001 0.0084 0.0803 0.0153 
 ATP 0.0017 0.0037 0.0002 0.0099 0.1085 0.0175 
 Atrolactic acid 0.0004 0.0023 0.0026 0.0186 0.4953 0.0364 
 Betaine 0.0005 0.0024 0.0008 0.0141 0.1546 0.0210 
 CDP 0.0196 0.0085 0.0004 0.0116 0.0032 0.0040 
 CDP-ethanolamine 0.5596 0.0361 0.0001 0.0091 0.0009 0.0024 
 Citrate 0.6513 0.0392 0.0085 0.0240 0.2581 0.0268 
 Citrate/isocitrate 0.6513 0.0393 0.0085 0.0240 0.2581 0.0268 
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Table C continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Sex-by-
Strain 
(i/m)q 
 Citrulline 0.0284 0.0097 0.0809 0.0363 0.0042 0.0044 
 CMP 0.1913 0.0211 0.0000 0.0015 0.4067 0.0330 
 Coenzyme A 0.1205 0.0174 0.0018 0.0171 0.1290 0.0191 
 Creatine 0.3737 0.0292 0.0000 0.0073 0.8408 0.0463 
 Cyclic-AMP 0.0374 0.0108 0.0000 0.0006 0.0390 0.0111 
 Cystathionine 0.1029 0.0162 0.0002 0.0096 0.3140 0.0294 
 dCMP 0.0385 0.0109 0.0020 0.0175 0.2021 0.0238 
 Deoxyinosine 0.0003 0.0021 0.0006 0.0131 0.0426 0.0115 
 Deoxyribose-phosphate 0.0036 0.0046 0.0000 0.0026 0.0159 0.0075 
 Deoxyuridine 0.3580 0.0286 0.0000 0.0013 0.0132 0.0069 
 Dephospho-CoA 0.9282 0.0479 0.0167 0.0273 0.7065 0.0429 
 dGMP 0.9086 0.0472 0.0000 0.0005 0.0387 0.0111 
 dTMP 0.9898 0.0496 0.0001 0.0075 0.7052 0.0428 
 FAD 0.0001 0.0016 0.0000 0.0002 0.0004 0.0016 
 FMN 0.0002 0.0017 0.0000 0.0023 0.3379 0.0304 
 Fructose-1,6-bisphosphate 0.3541 0.0284 0.0000 0.0018 0.0000 0.0007 
 Fumarate 0.2344 0.0233 0.0036 0.0200 0.8579 0.0467 
 GDP 0.0017 0.0037 0.0099 0.0247 0.0175 0.0079 
 Glucarate 0.0225 0.0090 0.0083 0.0238 0.0193 0.0082 
 Gluconate 0.0363 0.0107 0.0000 0.0004 0.0695 0.0144 
 Glucosamine-1/6-phosphate 0.6601 0.0395 0.0005 0.0124 0.3160 0.0295 
 Glucose-1/6-phosphate 0.5012 0.0340 0.0000 0.0036 0.9431 0.0487 
 Glutamate 0.0681 0.0136 0.0000 0.0053 0.0024 0.0035 
 Glutamine 0.0003 0.0022 0.1385 0.0394 0.0349 0.0106 
 Glutathione 0.6965 0.0407 0.0000 0.0068 0.0053 0.0050 
 Glutathione disulfide 0.8430 0.0453 0.0009 0.0146 0.0580 0.0134 
 Glycerate 0.1059 0.0164 0.0079 0.0236 0.7164 0.0432 
 Glycerol-3-phosphate 0.0070 0.0058 0.0030 0.0192 0.0290 0.0098 
 GMP 0.2765 0.0251 0.0001 0.0082 0.2461 0.0261 
 GTP 0.0203 0.0086 0.0010 0.0148 0.1005 0.0169 
 Guanosine 0.0029 0.0043 0.0010 0.0149 0.0152 0.0074 
 Homocysteic acid 0.8481 0.0454 0.0049 0.0212 0.0002 0.0012 
 Hypoxanthine 0.0607 0.0129 0.0017 0.0168 0.1584 0.0212 
 IMP 0.4582 0.0324 0.0002 0.0094 0.0477 0.0121 
 Indole 0.0939 0.0156 0.0283 0.0303 0.1126 0.0179 
 Inosine 0.0000 0.0010 0.0007 0.0138 0.1031 0.0171 
 Isocitrate 0.6513 0.0393 0.0085 0.0240 0.2581 0.0268 
 Kynurenine 0.1595 0.0195 0.0206 0.0284 0.1971 0.0236 
 Lysine 0.0548 0.0124 0.0021 0.0176 0.1371 0.0197 
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Table C continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Sex-by-
Strain 
(i/m)q 
 Malate 0.6725 0.0400 0.0000 0.0052 0.1698 0.0219 
 Methionine 0.2327 0.0232 0.0000 0.0050 0.2343 0.0255 
 N-acetyl-glucosamine-1/6-phosphate 0.2406 0.0236 0.0013 0.0157 0.1749 0.0223 
 N-acetyl-glutamine 0.0000 0.0000 0.0000 0.0014 0.0419 0.0115 
 N-Acetyl-L-alanine 0.1237 0.0176 0.0001 0.0080 0.0334 0.0105 
 N-carbamoyl-L-aspartate 0.3423 0.0280 0.0001 0.0094 0.0943 0.0164 
 NAD+ 0.0012 0.0032 0.0034 0.0198 0.0667 0.0141 
 NADH 0.0003 0.0021 0.0000 0.0025 0.0000 0.0005 
 NADP+ 0.0291 0.0098 0.0000 0.0020 0.1978 0.0236 
 NADPH 0.0002 0.0017 0.0037 0.0200 0.0979 0.0166 
 Octulose 8/1P 0.0025 0.0041 0.0000 0.0055 0.0106 0.0064 
 Orotate 0.5941 0.0372 0.0105 0.0249 0.0049 0.0048 
 Pantothenate 0.0000 0.0012 0.0070 0.0229 0.0030 0.0038 
 Phenylalanine 0.6681 0.0398 0.0048 0.0211 0.1199 0.0185 
 Phenyllactic acid 0.0004 0.0022 0.0026 0.0186 0.4953 0.0364 
 Pipecolic acid 0.0750 0.0141 0.0001 0.0082 0.1335 0.0194 
 Propionyl-CoA 0.5425 0.0355 0.0000 0.0064 0.0411 0.0114 
 Riboflavin 0.0003 0.0021 0.0017 0.0169 0.3796 0.0319 
 Ribose-phosphate 0.0009 0.0029 0.0024 0.0182 0.1765 0.0224 
 S-adenosyl-L-homoCysteine 0.0000 0.0010 0.0003 0.0115 0.1292 0.0192 
 Sarcosine 0.2018 0.0217 0.0002 0.0096 0.1304 0.0193 
 Sedoheptulose bisphosphate 0.0010 0.0030 0.1659 0.0405 0.0005 0.0017 
 Sedoheptulose-1/7-phosphate 0.5927 0.0371 0.0003 0.0114 0.1719 0.0220 
 Shikimate 0.7653 0.0427 0.0000 0.0015 0.0004 0.0016 
 Succinate 0.0611 0.0129 0.0118 0.0256 0.7422 0.0437 
 Thymidine 0.0867 0.0150 0.0001 0.0085 0.1432 0.0201 
 Tyrosine 0.6965 0.0407 0.0009 0.0144 0.3278 0.0300 
 UDP 0.0310 0.0100 0.0005 0.0127 0.0144 0.0072 
 UDP-D-glucose 0.2803 0.0252 0.0000 0.0002 0.0031 0.0039 
 UDP-D-glucuronate 0.0096 0.0066 0.0014 0.0162 0.0997 0.0168 
 UDP-N-acetyl-glucosamine 0.5977 0.0373 0.0000 0.0009 0.0740 0.0148 
 UMP 0.0677 0.0135 0.0000 0.0026 0.1308 0.0193 
 Uracil 0.1856 0.0208 0.0016 0.0167 0.0008 0.0022 
 Uridine 0.4525 0.0322 0.0002 0.0102 0.0183 0.0081 
 UTP 0.6797 0.0402 0.0001 0.0091 0.0018 0.0031 
 Valine 0.0005 0.0024 0.0008 0.0141 0.1546 0.0210 
 Xanthine 0.0158 0.0078 0.0022 0.0179 0.1751 0.0223 
 Xanthosine 0.0032 0.0044 0.0000 0.0053 0.0656 0.0139 
 Xanthosine-5-phosphate 0.0502 0.0120 0.0001 0.0087 0.7525 0.0440 
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Table C continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Sex-by-
Strain 
(i/m)q 
 Xanthurenic acid 0.2755 0.0251 0.0030 0.0193 0.2835 0.0280 
        
Muscle 2-Hydroxy-2-methylbutanedioic acid 0.0624 0.0128 0.0000 0.0008 0.1713 0.0194 
 2-Isopropylmalic acid 0.9837 0.0494 0.0282 0.0135 0.0002 0.0011 
 3-phosphoglycerate 0.1845 0.0202 0.0004 0.0030 0.1584 0.0184 
 a-ketoglutarate 0.2860 0.0247 0.0001 0.0020 0.0078 0.0041 
 Acetyllysine 0.2039 0.0211 0.0032 0.0060 0.6132 0.0397 
 ADP 0.0237 0.0087 0.0013 0.0044 0.5862 0.0388 
 Allantoin 0.2424 0.0228 0.0030 0.0059 0.5276 0.0370 
 Aminoadipic acid 0.0035 0.0038 0.0066 0.0081 0.3078 0.0273 
 Arginine 0.0041 0.0041 0.0009 0.0038 0.0165 0.0058 
 Ascorbic acid 0.0007 0.0022 0.0049 0.0072 0.0027 0.0026 
 Asparagine 0.3617 0.0279 0.0031 0.0059 0.1990 0.0212 
 Betaine 0.0027 0.0035 0.0897 0.0216 0.3606 0.0298 
 CDP-ethanolamine 0.0013 0.0026 0.0167 0.0111 0.1918 0.0207 
 Cholic acid 0.0333 0.0101 0.0012 0.0043 0.0004 0.0013 
 Citrulline 0.0530 0.0118 0.0002 0.0025 0.0079 0.0042 
 Cytidine 0.0007 0.0022 0.0002 0.0026 0.1365 0.0170 
 Deoxyribose-phosphate 0.6841 0.0396 0.0025 0.0055 0.0511 0.0104 
 Deoxyuridine 0.9631 0.0489 0.0000 0.0000 0.0400 0.0091 
 Erythrose-4-phosphate 0.0002 0.0014 0.0000 0.0012 0.2968 0.0267 
 Fructose-1,6-bisphosphate 0.5162 0.0342 0.0009 0.0037 0.1225 0.0161 
 Glucose-1/6-phosphate 0.0008 0.0022 0.0000 0.0010 0.2604 0.0247 
 Glutamine 0.0000 0.0005 0.0392 0.0154 0.0097 0.0045 
 Glycerol-3-phosphate 0.0000 0.0006 0.0000 0.0008 0.0040 0.0030 
 Histidine 0.2052 0.0212 0.0000 0.0014 0.0399 0.0091 
 Homocysteic acid 0.0075 0.0053 0.0000 0.0002 0.1424 0.0173 
 Hydroxyphenylacetic acid 0.1237 0.0168 0.0114 0.0095 0.0004 0.0013 
 Hydroxyproline 0.0000 0.0006 0.0900 0.0216 0.0541 0.0106 
 Lysine 0.0003 0.0016 0.0009 0.0037 0.0073 0.0040 
 Methionine 0.0005 0.0019 0.0008 0.0036 0.5136 0.0365 
 Myo-inositol 0.2198 0.0219 0.0001 0.0016 0.2633 0.0249 
 N-Acetyl-L-alanine 0.0053 0.0045 0.0053 0.0074 0.1231 0.0162 
 NAD+ 0.9950 0.0499 0.0064 0.0080 0.0158 0.0057 
 Ornithine 0.7939 0.0431 0.0742 0.0199 0.0022 0.0024 
 Orotate 0.0009 0.0023 0.4797 0.0394 0.0485 0.0101 
 Pantothenate 0.0000 0.0001 0.0027 0.0057 0.1678 0.0192 
 Shikimate 0.2798 0.0245 0.0334 0.0145 0.0021 0.0024 
 Taurodeoxycholic acid 0.0035 0.0038 0.0017 0.0048 0.0026 0.0026 
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Table C continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Sex-by-
Strain 
(i/m)q 
 Thymidine 0.9708 0.0491 0.0004 0.0031 0.7468 0.0439 
 Tryptophan 0.0000 0.0004 0.0213 0.0121 0.0003 0.0012 
 Tyrosine 0.0012 0.0026 0.0079 0.0085 0.3490 0.0293 
        
Adipose 2-Hydroxy-2-methylbutanedioic acid 0.1418 0.0143 0.0006 0.0031 0.1427 0.0147 
 ADP 0.5012 0.0323 0.0005 0.0029 0.9951 0.0499 
 ADP-D-glucose 0.1443 0.0145 0.0003 0.0019 0.8726 0.0471 
 Asparagine 0.0431 0.0068 0.0015 0.0049 0.4399 0.0330 
 ATP 0.1201 0.0127 0.0037 0.0072 0.5823 0.0391 
 Citrulline 0.0012 0.0010 0.0014 0.0046 0.9339 0.0487 
 Creatine 0.6733 0.0390 0.0012 0.0045 0.1488 0.0153 
 Cysteine 0.2436 0.0203 0.0010 0.0041 0.4288 0.0325 
 Dihydroxy-acetone-phosphate 0.2887 0.0228 0.0102 0.0115 0.6172 0.0401 
 Fumarate 0.7827 0.0427 0.0067 0.0096 0.3973 0.0311 
 Gluconate 0.8164 0.0439 0.0102 0.0114 0.1695 0.0170 
 Glucosamine-1/6-phosphate 0.0131 0.0034 0.0117 0.0122 0.3021 0.0262 
 Glutamine 0.0084 0.0026 0.0037 0.0072 0.0679 0.0080 
 Glyceraldehdye-3-phosphate 0.2887 0.0228 0.0102 0.0115 0.6172 0.0401 
 Guanine 0.7760 0.0425 0.0068 0.0096 0.6298 0.0406 
 Histidine 0.8567 0.0454 0.0029 0.0065 0.2742 0.0244 
 Hypoxanthine 0.3840 0.0274 0.0001 0.0012 0.6710 0.0419 
 Inosine 0.2890 0.0228 0.0018 0.0052 0.1552 0.0157 
 Isocitrate 0.8999 0.0467 0.0032 0.0068 0.0624 0.0075 
 Methionine 0.0001 0.0005 0.0000 0.0003 0.0039 0.0012 
 Methionine sulfoxide 0.0216 0.0043 0.0031 0.0068 0.1092 0.0118 
 N-Acetyl-L-alanine 0.0838 0.0103 0.0005 0.0026 0.0708 0.0083 
 N-carbamoyl-L-aspartate 0.0957 0.0110 0.0086 0.0107 0.6035 0.0397 
 Octulose 8/1P 0.5446 0.0342 0.0057 0.0089 0.4822 0.0348 
 Orotate 0.6533 0.0383 0.0053 0.0087 0.7551 0.0443 
 Pantothenate 0.0001 0.0005 0.1836 0.0319 0.0896 0.0100 
 Pyroglutamic acid 0.1618 0.0156 0.0058 0.0090 0.0817 0.0094 
 Pyrophosphate 0.0332 0.0057 0.0054 0.0088 0.0265 0.0038 
 Quinolinate 0.4481 0.0302 0.0019 0.0055 0.0314 0.0044 
 Ribose-phosphate 0.4764 0.0313 0.0121 0.0123 0.8438 0.0464 
 S-adenosyl-L-homoCysteine 0.0000 0.0001 0.0751 0.0241 0.1993 0.0190 
 Shikimate-3-phosphate 0.0586 0.0081 0.0050 0.0084 0.5047 0.0358 
 Taurine 0.7024 0.0401 0.0022 0.0057 0.1799 0.0178 
 Taurodeoxycholic acid 0.7332 0.0412 0.0002 0.0014 0.0687 0.0081 
 Threonine 0.0006 0.0008 0.0457 0.0203 0.4334 0.0327 
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Table C continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Sex-by-
Strain 
(i/m)q 
 Thymidine 0.0876 0.0106 0.0052 0.0086 0.3717 0.0298 
 Thymine 0.7119 0.0404 0.0107 0.0117 0.0693 0.0082 
 Tyrosine 0.0021 0.0013 0.0060 0.0092 0.5122 0.0361 
 Uric acid 0.3619 0.0263 0.0111 0.0118 0.4138 0.0318 
 Valine 0.4149 0.0289 0.0000 0.0006 0.6908 0.0424 
 Xanthine 0.4980 0.0322 0.0051 0.0085 0.9289 0.0485 
 
All known metabolites considered significant in the ANOVA were identified in liver, 
skeletal muscle, and adipose tissue. Bold values indicate that the metabolite is 
statistically significant. Bold metabolites are not tissue specific. Bold and italicized 
metabolites are shared between all three tissues. Benjamini-Hochberg procedure was 
performed to determine significance.  
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APPENDIX D 
Table D.4: Number of Edges for Each Node in Correlation Network Analysis in Mice Fed a 
Standard Chow Diet 
Metabolite Tissue Total 
Degree 
(+/-) 
Degree 
(Adipose) 
(+/-) 
Degree 
(Muscle) 
(+/-) 
Degree 
(Liver) 
(+/-) 
Degree 
(Phenotype) 
(+/-) 
1-Methyl-Histidine Adipose 2 (1/1) 1 (0/1) 0 0 1 (1/0) 
2-Hydroxy-2-methylbutanedioic acid Adipose 1 (0/1) 0 0 0 1 (0/1) 
Methionine Adipose 3 (2/1) 1 (1/0) 1 (0/1) 0 1 (1/0) 
N-acetyl-glutamine Adipose 3 (1/2) 2 (1/1) 0 0 1 (0/1) 
NAD+ Adipose 4 (4/0) 3 (3/0) 0 1 1 (1/0) 
Threonine Adipose 2 (2/0) 1 (1/0) 0 0 1 (1/0) 
Uric acid Adipose 2 (2/0) 1 (1/0) 0 0 1 (1/0) 
6-phospho-D-gluconate Liver 11 (11/0) 0 2 (2/0) 8 (8/0) 1 (1/0) 
ADP Liver 13 (11/2) 0 2 (1/1) 9 (9/0) 2 (1/1) 
CDP Liver 7 (7/0) 1 (1/0) 0 5 (5/0) 1 (1/0) 
CDP-ethanolamine Liver 3 (2/1) 0 0 2 (2/0) 1 (0/1) 
CMP Liver 9 (8/1) 0 1 (0/1) 7 (7/0) 1 (1/0) 
Gluconate Liver 9 (9/0) 0 1 (1/0) 7 (7/0) 1 (1/0) 
Sedoheptulose-1/7-phosphate Liver 2 (2/0) 0 0 1 (1/0) 1 (1/0) 
FAD Liver 12 (10/2) 0 2 (1/1) 8 (8/0) 2 (1/1) 
FMN Liver 10 (8/2) 0 1 (0/1) 8 (7/1) 1 (1/0) 
GDP Liver 6 (6/0) 0 1 (1/0) 4 (4/0) 1 (1/0) 
Hydroxyisocaproic acid Liver 1 (1/0) 0 0 0 1 (1/0) 
N-acetyl-glutamine Liver 3 (2/1) 0 2 (1/1) 0 1 (1/0) 
NADH Liver 13 0 2 (2/0) 9 (9/0) 2 (1/1) 
NADP+ Liver 10 (8/2) 0 2 (1/1) 7 (7/0) 1 (0/1) 
NADPH Liver 7 (7/0) 0 1 (1/0) 5 (5/0) 1 (1/0) 
Taurodeoxycholic acid Liver 1 (1/0) 0 0 0 1 (1/0) 
UDP Liver 8 (8/0) 0 2 (2/0) 5 (5/0) 1 (1/0) 
Acetyl-CoA Liver 10 (10/0) 0 4 (4/0) 4 (4/0) 2 (2/0) 
Adenosine Liver 4 (2/2) 0 1 (1/0) 2 (1/1) 1 (0/1) 
Allantoate Liver 4 (3/1) 0 1 (0/1) 2 (2/0) 1 (1/0) 
dAMP Liver 1 (0/1) 0 0 0 1 (0/1) 
Glutathione disulfide Liver 6 0 0 6 0 
Pantothenate Liver 3 (2/1) 0 1 (0/1) 1 (1/0) 1 (1/0) 
Glycerol-3-phosphate Liver 4 (3/1) 0 1 (0/1) 2 (2/0) 1 (1/0) 
Ascorbic acid Muscle 4 (1/3) 0 0 3 (1/2) 1 (0/1) 
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Table D continued 
Metabolite Tissue Total 
Degree 
(+/-) 
Degree 
(Adipose) 
(+/-) 
Degree 
(Muscle) 
(+/-) 
Degree 
(Liver) 
(+/-) 
Degree 
(Phenotype) 
(+/-) 
CDP Muscle 1 (1/0) 0 0 0 1 (1/0) 
CDP-ethanolamine Muscle 2 (1/1) 0 1 (1/0) 0 1 (0/1) 
Gluconate Muscle 2 (1/1) 0 1 (1/0) 0 1 (0/1) 
Taurodeoxycholic acid Muscle 2 (0/2) 1 (0/1) 0 0 1 (0/1) 
Acetyl-CoA Muscle 1 (0/1) 0 0 0 1 (0/1) 
Arginine Muscle 7 (6/1) 0 4 (4/0) 2 (2/0) 1 (0/1) 
Cytidine Muscle 5 (0/5) 0 0 4 (0/4) 1 (0/1) 
Deoxyribose-phosphate Muscle 3 (3/0) 0 1 (1/0) 1 (1/0) 1 (1/0) 
Hydroxyproline Muscle 4 (2/2) 0 2 (1/1) 1 (1/0) 1 (0/1) 
Lysine Muscle 8 (7/1) 0 4 (4/0) 2 (2/0) 2 (1/1) 
Methionine Muscle 7 (7/0) 0 4 (4/0) 2 (2/0) 1 (1/0) 
Pantothenate Muscle 6 (1/5) 0 2 (1/1) 2 (0/2) 2 (0/2) 
Glycerol-3-phosphate Muscle 16 (16/0) 0 5 (5/0) 9 (9/0) 2 (2/0) 
Tryptophan Muscle 7 (6/1) 0 4 (4/0) 1 (1/0) 2 (1/1) 
RER Phenotype 3 (0/3) 0 3 (0/3) 0 0 
VO2 Phenotype 7 (4/3) 1 (0/1) 4 (2/2) 2 (2/0) 0 
Weight Phenotype 3 (1/2) 0 2 (0/2) 1 (1/0) 0 
Activity Phenotype 19 (18/1) 2 (2/0) 4 (4/0) 13 (12/1) 0 
Adiposity Phenotype 9 (7/2) 2 (1/1) 0 7 (6/1) 0 
Heat Phenotype 13 (8/5) 2 (2/0) 7 (3/4) 4 (3/1) 0 
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APPENDIX E 
Table E.5: Significant ANOVA p-values (FDR < 0.05) for Adipose, Muscle, and Liver Tissue 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-
Strain 
(i/m)q Sex-by-
Diet 
(i/m)q Strain-by-
Diet 
(i/m)q Sex-by-Strain-by-
Diet 
(i/m)q 
Adipose 1-Methyl-Histidine 0.0000 0.0049 0.0014 0.0299 0.0041 0.0128 0.0627 0.0250 0.0019 0.0034 0.3293 0.0340 0.5772 0.0424 
 1-Methyladenosine 0.2433 0.0296 0.0056 0.0335 0.1824 0.0292 0.0163 0.0177 0.3079 0.0292 0.0658 0.0179 0.9080 0.0487 
 2-dehydro-D-gluconate 0.0004 0.0068 0.0000 0.0013 0.0000 0.0017 0.0001 0.0053 0.1366 0.0200 0.0000 0.0013 0.0984 0.0215 
 2-Hydroxy-2-
methylbutanedioic acid 
0.0037 0.0100 0.0000 0.0003 0.7897 0.0458 0.0292 0.0207 0.0607 0.0137 0.0629 0.0176 0.8399 0.0477 
 2-Isopropylmalic acid 0.2764 0.0308 0.0000 0.0083 0.7094 0.0440 0.0002 0.0065 0.1719 0.0222 0.1519 0.0253 0.3395 0.0349 
 2,3-Diphosphoglyceric acid 0.1154 0.0235 0.0004 0.0276 0.9770 0.0496 0.0201 0.0187 0.7688 0.0443 0.8603 0.0485 0.0067 0.0071 
 3-hydroxybutyryl-CoA 0.0000 0.0037 0.0000 0.0187 0.0000 0.0048 0.0599 0.0247 0.1278 0.0194 0.0043 0.0065 0.5031 0.0404 
 3-phosphoglycerate 0.0559 0.0188 0.0000 0.0009 0.0000 0.0067 0.0877 0.0273 0.9886 0.0497 0.1055 0.0217 0.1134 0.0227 
 3-S-methylthiopropionate 0.2506 0.0298 0.0030 0.0319 0.0302 0.0186 0.3150 0.0381 0.8472 0.0464 0.6414 0.0442 0.0035 0.0053 
 4-aminobutyrate 0.5791 0.0399 0.0043 0.0329 0.2506 0.0319 0.0000 0.0044 0.0987 0.0171 0.2452 0.0305 0.2371 0.0306 
 4-Pyridoxic acid 0.0077 0.0117 0.0000 0.0051 0.0180 0.0167 0.0024 0.0111 0.4661 0.0354 0.0542 0.0166 0.1770 0.0272 
 6-phospho-D-gluconate 0.9790 0.0495 0.0000 0.0127 0.0080 0.0143 0.0000 0.0038 0.0066 0.0054 0.0000 0.0009 0.3010 0.0335 
 a-ketoglutarate 0.9399 0.0487 0.1187 0.0432 0.8911 0.0479 0.0000 0.0028 0.0131 0.0070 0.1668 0.0262 0.2957 0.0332 
 Acetyl-CoA 0.0000 0.0042 0.0080 0.0344 0.0010 0.0101 0.0046 0.0132 0.1633 0.0217 0.1027 0.0215 0.0184 0.0107 
 Acetyllysine 0.0000 0.0011 0.0012 0.0295 0.0048 0.0131 0.0142 0.0172 0.1849 0.0230 0.2044 0.0282 0.4267 0.0379 
 Aconitate 0.8617 0.0470 0.0001 0.0235 0.3599 0.0356 0.0446 0.0230 0.1676 0.0219 0.1349 0.0240 0.4453 0.0387 
 Adenine 0.0711 0.0202 0.0000 0.0179 0.5298 0.0403 0.9940 0.0499 0.0664 0.0143 0.2755 0.0319 0.0120 0.0090 
 Adenosine 0.0130 0.0131 0.0000 0.0195 0.0009 0.0099 0.0443 0.0229 0.1035 0.0175 0.0000 0.0007 0.0027 0.0049 
 ADP 0.0331 0.0163 0.0000 0.0065 0.1513 0.0277 0.1241 0.0301 0.1123 0.0183 0.0017 0.0045 0.0067 0.0071 
 ADP-D-glucose 0.5662 0.0396 0.0000 0.0003 0.0004 0.0091 0.0004 0.0077 0.0260 0.0095 0.3260 0.0339 0.1772 0.0272 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-
Strain 
(i/m)q Sex-by-
Diet 
(i/m)q Strain-by-
Diet 
(i/m)q Sex-by-Strain-by-
Diet 
(i/m)q 
 Alanine 0.9207 0.0483 0.0033 0.0322 0.4595 0.0385 0.1873 0.0335 0.3180 0.0297 0.9851 0.0498 0.0001 0.0017 
 Allantoate 0.0000 0.0004 0.0567 0.0407 0.0000 0.0035 0.0004 0.0078 0.0001 0.0013 0.0037 0.0061 0.0178 0.0106 
 Allantoin 0.6372 0.0417 0.0000 0.0011 0.0431 0.0201 0.0832 0.0269 0.2847 0.0282 0.1440 0.0246 0.0689 0.0187 
 Aminoadipic acid 0.0000 0.0030 0.0000 0.0009 0.0000 0.0035 0.0005 0.0082 0.1753 0.0224 0.0465 0.0157 0.0264 0.0125 
 Aminoimidazole carboxamide 
ribonucleotide 
0.0142 0.0134 0.0000 0.0064 0.0003 0.0085 0.0018 0.0105 0.1174 0.0187 0.3551 0.0351 0.1158 0.0228 
 AMP 0.0735 0.0204 0.0000 0.0004 0.0000 0.0049 0.0000 0.0039 0.4048 0.0332 0.0607 0.0174 0.1822 0.0275 
 Asparagine 0.1322 0.0247 0.0027 0.0316 0.0093 0.0148 0.1709 0.0325 0.0177 0.0080 0.0640 0.0177 0.0299 0.0132 
 Aspartate 0.0002 0.0061 0.0000 0.0048 0.0142 0.0160 0.0002 0.0065 0.6120 0.0399 0.0205 0.0112 0.3001 0.0334 
 ATP 0.0011 0.0080 0.0000 0.0151 0.4052 0.0370 0.6667 0.0456 0.1717 0.0222 0.0469 0.0157 0.0279 0.0128 
 Atrolactic acid 0.0004 0.0069 0.0000 0.0129 0.0000 0.0070 0.0714 0.0260 0.1390 0.0202 0.0012 0.0040 0.4139 0.0375 
 Betaine 0.5131 0.0382 0.0000 0.0024 0.0000 0.0021 0.5178 0.0430 0.0002 0.0017 0.2061 0.0284 0.0011 0.0035 
 Butyryl-CoA 0.0001 0.0051 0.8310 0.0495 0.0000 0.0050 0.0019 0.0107 0.0000 0.0009 0.0645 0.0178 0.3372 0.0349 
 Carnitine 0.6484 0.0420 0.0856 0.0420 0.0154 0.0163 0.0235 0.0195 0.0787 0.0154 0.6097 0.0432 0.0012 0.0036 
 CDP 0.0529 0.0185 0.0000 0.0130 0.0009 0.0099 0.1673 0.0324 0.0111 0.0066 0.0017 0.0046 0.0117 0.0089 
 CDP-ethanolamine 0.0455 0.0178 0.0000 0.0044 0.0000 0.0031 0.0007 0.0087 0.9762 0.0494 0.0911 0.0205 0.0000 0.0007 
 Cellobiose 0.3134 0.0322 0.1345 0.0436 0.0159 0.0164 0.9630 0.0496 0.6496 0.0411 0.5528 0.0419 0.0033 0.0052 
 Cholic acid 0.3126 0.0322 0.0846 0.0420 0.3382 0.0350 0.0000 0.0012 0.0006 0.0022 0.0037 0.0061 0.4155 0.0375 
 Citrate 0.1837 0.0272 0.0004 0.0275 0.6178 0.0423 0.2009 0.0341 0.0505 0.0125 0.0080 0.0080 0.5600 0.0420 
 Citrate/isocitrate 0.1837 0.0273 0.0004 0.0275 0.6178 0.0423 0.2009 0.0341 0.0505 0.0125 0.0080 0.0080 0.5600 0.0420 
 Citrulline 0.0180 0.0141 0.0004 0.0276 0.0000 0.0049 0.0002 0.0067 0.0049 0.0048 0.2557 0.0310 0.1376 0.0244 
 CMP 0.6122 0.0410 0.0000 0.0059 0.0630 0.0219 0.0560 0.0243 0.0846 0.0160 0.0302 0.0131 0.1564 0.0259 
 Coenzyme A 0.0156 0.0136 0.0000 0.0202 0.0161 0.0165 0.0683 0.0255 0.3280 0.0302 0.1970 0.0278 0.2300 0.0302 
 Creatine 0.2576 0.0302 0.0009 0.0290 0.0000 0.0069 0.1717 0.0326 0.0000 0.0011 0.0029 0.0056 0.4198 0.0377 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 Creatinine 0.2695 0.0305 0.0185 0.0369 0.6998 0.0439 0.7552 0.0470 0.5329 0.0375 0.2867 0.0323 0.0319 0.0135 
 Cyclic-AMP 0.0000 0.0030 0.0000 0.0002 0.1362 0.0269 0.0784 0.0266 0.2582 0.0271 0.1199 0.0228 0.0186 0.0108 
 Cystathionine 0.0000 0.0010 0.0000 0.0017 0.0001 0.0076 0.1691 0.0324 0.1739 0.0223 0.7153 0.0458 0.0846 0.0203 
 Cytidine 0.9220 0.0483 0.0003 0.0264 0.0001 0.0073 0.3281 0.0385 0.0474 0.0122 0.0968 0.0211 0.2085 0.0291 
 dAMP 0.0568 0.0189 0.3762 0.0472 0.0000 0.0047 0.3938 0.0401 0.0094 0.0062 0.4501 0.0386 0.3035 0.0336 
 dCMP 0.6813 0.0427 0.0000 0.0185 0.0389 0.0196 0.0900 0.0276 0.1788 0.0227 0.2338 0.0298 0.2613 0.0316 
 Deoxyinosine 0.0000 0.0022 0.0000 0.0101 0.9754 0.0496 0.0081 0.0151 0.3619 0.0314 0.0088 0.0083 0.0043 0.0059 
 Deoxyribose-phosphate 0.0000 0.0029 0.0000 0.0121 0.0083 0.0145 0.1144 0.0296 0.6289 0.0404 0.1437 0.0246 0.8076 0.0471 
 Deoxyuridine 0.7644 0.0447 0.0000 0.0001 0.0009 0.0099 0.3970 0.0402 0.1155 0.0186 0.0080 0.0080 0.0228 0.0117 
 Dephospho-CoA 0.8525 0.0468 0.0000 0.0044 0.0018 0.0111 0.7060 0.0462 0.2807 0.0281 0.2897 0.0324 0.7622 0.0464 
 dGMP 0.0735 0.0204 0.0000 0.0004 0.0000 0.0049 0.0000 0.0039 0.4048 0.0332 0.0607 0.0174 0.1822 0.0275 
 Dihydroorotate 0.0071 0.0115 0.0002 0.0261 0.8219 0.0466 0.2042 0.0342 0.2537 0.0269 0.0657 0.0179 0.5978 0.0429 
 Dihydroxy-acetone-phosphate 0.0000 0.0025 0.0000 0.0161 0.0236 0.0176 0.0089 0.0155 0.7658 0.0442 0.4219 0.0377 0.0067 0.0071 
 dTMP 0.1007 0.0225 0.0000 0.0086 0.1277 0.0264 0.4300 0.0410 0.0775 0.0154 0.4457 0.0385 0.1908 0.0280 
 dUMP 0.6505 0.0420 0.0000 0.0179 0.0000 0.0062 0.0028 0.0116 0.0077 0.0057 0.2889 0.0324 0.0397 0.0148 
 dUTP 0.3649 0.0340 0.0062 0.0338 0.3503 0.0354 0.0043 0.0130 0.7209 0.0431 0.5208 0.0410 0.0312 0.0134 
 FAD 0.0000 0.0034 0.0000 0.0014 0.0078 0.0143 0.9817 0.0498 0.5971 0.0395 0.1043 0.0216 0.0062 0.0069 
 FMN 0.0000 0.0032 0.0000 0.0023 0.7111 0.0441 0.1752 0.0328 0.2651 0.0275 0.2949 0.0326 0.1235 0.0234 
 Fructose-1,6-bisphosphate 0.0030 0.0097 0.0000 0.0050 0.1295 0.0265 0.0000 0.0047 0.4141 0.0336 0.0311 0.0132 0.0025 0.0047 
 Fumarate 0.0001 0.0051 0.0000 0.0047 0.0015 0.0108 0.0001 0.0053 0.3089 0.0293 0.0556 0.0168 0.0842 0.0202 
 GDP 0.0440 0.0176 0.0195 0.0372 0.9181 0.0485 0.6257 0.0450 0.0741 0.0150 0.0240 0.0120 0.0025 0.0047 
 Glucarate 0.0000 0.0022 0.0000 0.0198 0.0000 0.0020 0.2185 0.0348 0.0517 0.0127 0.0013 0.0042 0.5061 0.0405 
 Gluconate 0.0000 0.0035 0.0000 0.0027 0.0000 0.0042 0.0078 0.0150 0.0165 0.0078 0.0371 0.0142 0.1732 0.0269 
 Glucosamine-1/6-phosphate 0.4592 0.0366 0.0234 0.0378 0.9812 0.0497 0.3864 0.0399 0.7252 0.0432 0.3038 0.0330 0.0767 0.0195 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 Glucose-1/6-phosphate 0.0130 0.0131 0.0000 0.0230 0.0003 0.0088 0.0028 0.0115 0.1450 0.0206 0.0265 0.0125 0.0403 0.0150 
 Glutamate 0.3158 0.0323 0.0000 0.0022 0.0000 0.0024 0.0000 0.0030 0.0052 0.0049 0.0749 0.0189 0.0612 0.0178 
 Glutamine 0.0000 0.0033 0.0062 0.0337 0.0102 0.0150 0.2142 0.0347 0.0090 0.0060 0.0030 0.0056 0.0381 0.0145 
 Glutathione 0.2494 0.0297 0.0000 0.0029 0.4916 0.0392 0.0465 0.0232 0.1787 0.0226 0.4340 0.0381 0.0069 0.0072 
 Glutathione disulfide 0.3952 0.0348 0.0004 0.0274 0.1783 0.0290 0.8891 0.0488 0.3757 0.0319 0.1594 0.0257 0.0677 0.0185 
 Glyceraldehdye-3-phosphate 0.0000 0.0025 0.0000 0.0161 0.0236 0.0176 0.0089 0.0155 0.7658 0.0442 0.4219 0.0377 0.0067 0.0071 
 Glycerate 0.2982 0.0317 0.0000 0.0214 0.0352 0.0192 0.0284 0.0205 0.0402 0.0113 0.4576 0.0389 0.0308 0.0133 
 Glycerol-3-phosphate 0.0017 0.0086 0.0000 0.0164 0.0003 0.0087 0.1050 0.0288 0.0048 0.0048 0.0008 0.0034 0.0059 0.0068 
 GMP 0.0633 0.0195 0.0000 0.0008 0.0000 0.0067 0.0010 0.0093 0.9425 0.0487 0.1123 0.0223 0.6920 0.0450 
 GTP 0.0121 0.0128 0.0000 0.0091 0.0084 0.0145 0.1819 0.0332 0.0686 0.0145 0.0074 0.0078 0.0316 0.0135 
 Guanine 0.0009 0.0077 0.0000 0.0152 0.7370 0.0446 0.0086 0.0153 0.7175 0.0430 0.5445 0.0416 0.2093 0.0292 
 Guanosine 0.0156 0.0136 0.0000 0.0126 0.0542 0.0211 0.0000 0.0010 0.4558 0.0350 0.0364 0.0141 0.2387 0.0306 
 Histidine 0.1014 0.0226 0.0000 0.0183 0.0135 0.0159 0.0005 0.0082 0.2804 0.0281 0.0982 0.0212 0.0280 0.0128 
 Homocysteic acid 0.0000 0.0020 0.0000 0.0016 0.0022 0.0115 0.0016 0.0102 0.0145 0.0074 0.0075 0.0078 0.0041 0.0058 
 Homoserine 0.2124 0.0285 0.0517 0.0404 0.0083 0.0145 0.0041 0.0127 0.0002 0.0015 0.5412 0.0415 0.0007 0.0029 
 Hydroxyisocaproic acid 0.0418 0.0174 0.0024 0.0313 0.0038 0.0126 0.0001 0.0054 0.8997 0.0478 0.3197 0.0337 0.0953 0.0212 
 Hydroxyproline 0.2524 0.0299 0.3878 0.0473 0.0000 0.0010 0.1415 0.0312 0.3256 0.0301 0.0005 0.0029 0.0528 0.0169 
 Hypoxanthine 0.4370 0.0360 0.0000 0.0121 0.0005 0.0092 0.0027 0.0115 0.0206 0.0086 0.0014 0.0043 0.0168 0.0104 
 IMP 0.0321 0.0163 0.0000 0.0190 0.0065 0.0138 0.2426 0.0358 0.2016 0.0240 0.0209 0.0113 0.0670 0.0184 
 Indole 0.9572 0.0491 0.0008 0.0287 0.2731 0.0328 0.4842 0.0423 0.4810 0.0358 0.0462 0.0156 0.0806 0.0198 
 Inosine 0.0000 0.0020 0.0000 0.0086 0.0148 0.0161 0.0001 0.0062 0.4932 0.0361 0.0484 0.0159 0.0002 0.0018 
 Isocitrate 0.1837 0.0273 0.0004 0.0275 0.6178 0.0423 0.2009 0.0341 0.0505 0.0125 0.0080 0.0080 0.5600 0.0420 
 Kynurenic acid 0.1045 0.0229 0.0072 0.0341 0.0000 0.0038 0.0041 0.0128 0.1434 0.0205 0.0231 0.0118 0.6396 0.0438 
 Kynurenine 0.3775 0.0343 0.0000 0.0206 0.0028 0.0119 0.0157 0.0176 0.6743 0.0417 0.0053 0.0069 0.4986 0.0403 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-
Strain 
(i/m)q Sex-by-
Diet 
(i/m)q Strain-by-
Diet 
(i/m)q Sex-by-Strain-by-
Diet 
(i/m)q 
 L-arginino-succinate 0.0102 0.0124 0.0000 0.0119 0.0000 0.0060 0.0000 0.0011 0.1986 0.0238 0.1626 0.0259 0.2104 0.0292 
 Leucine/isoleucine 0.7346 0.0440 0.0000 0.0158 0.0011 0.0103 0.1409 0.0312 0.0297 0.0099 0.1848 0.0271 0.0000 0.0004 
 Lipoate 0.1032 0.0228 0.0065 0.0339 0.0308 0.0187 0.2490 0.0360 0.7897 0.0449 0.5105 0.0406 0.8632 0.0481 
 Lysine 0.0000 0.0039 0.0004 0.0271 0.0000 0.0066 0.3996 0.0403 0.4134 0.0335 0.0005 0.0030 0.0154 0.0101 
 Malate 0.0023 0.0092 0.0000 0.0019 0.0057 0.0135 0.1372 0.0309 0.2643 0.0274 0.0018 0.0046 0.5116 0.0407 
 Methionine 0.1683 0.0265 0.0000 0.0007 0.0000 0.0050 0.1057 0.0289 0.1452 0.0206 0.0001 0.0018 0.4681 0.0394 
 Myo-inositol 0.7449 0.0443 0.0000 0.0065 0.0000 0.0047 0.0057 0.0139 0.5057 0.0365 0.1321 0.0238 0.0764 0.0195 
 N-acetyl-glucosamine-1/6-
phosphate 
0.8722 0.0473 0.0000 0.0140 0.7675 0.0453 0.0002 0.0069 0.2602 0.0271 0.4178 0.0376 0.3569 0.0356 
 N-acetyl-glutamate 0.0178 0.0141 0.0000 0.0087 0.0002 0.0083 0.6038 0.0446 0.0045 0.0046 0.3751 0.0359 0.7214 0.0457 
 N-acetyl-glutamine 0.0000 0.0001 0.0000 0.0020 0.0000 0.0038 0.0000 0.0029 0.0530 0.0128 0.0002 0.0021 0.0126 0.0092 
 N-Acetyl-L-alanine 0.0066 0.0113 0.0000 0.0010 0.0836 0.0234 0.0000 0.0036 0.0633 0.0140 0.0695 0.0183 0.0185 0.0107 
 N-acetyl-L-ornithine 0.4949 0.0377 0.1667 0.0443 0.0000 0.0021 0.0412 0.0227 0.7817 0.0447 0.2177 0.0290 0.4354 0.0383 
 N-carbamoyl-L-aspartate 0.0000 0.0032 0.0004 0.0271 0.5260 0.0402 0.7269 0.0466 0.2267 0.0254 0.0236 0.0119 0.4638 0.0393 
 NAD+ 0.0005 0.0070 0.0000 0.0165 0.8303 0.0468 0.1113 0.0294 0.0186 0.0082 0.1112 0.0222 0.1227 0.0234 
 NADH 0.0001 0.0056 0.0000 0.0045 0.0012 0.0104 0.0008 0.0090 0.0874 0.0162 0.0035 0.0060 0.0075 0.0074 
 NADP+ 0.0159 0.0137 0.0000 0.0037 0.0375 0.0195 0.0234 0.0195 0.3396 0.0306 0.4952 0.0401 0.1758 0.0271 
 NADPH 0.0043 0.0104 0.0010 0.0294 0.0221 0.0175 0.0215 0.0190 0.6927 0.0422 0.5423 0.0416 0.0232 0.0117 
 Nicotinate 0.0272 0.0155 0.0131 0.0358 0.2339 0.0313 0.5890 0.0443 0.3560 0.0312 0.6546 0.0445 0.0818 0.0199 
 Octulose 8/1P 0.0020 0.0090 0.0075 0.0342 0.0000 0.0008 0.0381 0.0222 0.1601 0.0215 0.0730 0.0187 0.2585 0.0314 
 Ornithine 0.0067 0.0113 0.5801 0.0485 0.0131 0.0158 0.0002 0.0066 0.0275 0.0096 0.7049 0.0456 0.0213 0.0113 
 Orotate 0.9861 0.0497 0.0635 0.0411 0.7142 0.0441 0.7072 0.0463 0.0797 0.0155 0.0340 0.0137 0.0049 0.0062 
 Pantothenate 0.0000 0.0020 0.0004 0.0273 0.0211 0.0173 0.0000 0.0018 0.0022 0.0036 0.3535 0.0350 0.1215 0.0233 
 Phenylalanine 0.3649 0.0340 0.0000 0.0164 0.7544 0.0450 0.0223 0.0192 0.4711 0.0355 0.0320 0.0134 0.0303 0.0133 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 Phenyllactic acid 0.0004 0.0069 0.0000 0.0129 0.0000 0.0070 0.0714 0.0260 0.1390 0.0202 0.0012 0.0040 0.4139 0.0375 
 Phenylpyruvate 0.0210 0.0147 0.0001 0.0246 0.6360 0.0426 0.7831 0.0474 0.6779 0.0418 0.6907 0.0453 0.2464 0.0310 
 Phosphoenolpyruvate 0.8485 0.0468 0.0000 0.0112 0.0001 0.0074 0.0576 0.0244 0.0732 0.0149 0.7217 0.0459 0.0156 0.0102 
 Pipecolic acid 0.3104 0.0321 0.0000 0.0131 0.5129 0.0397 0.5350 0.0433 0.0225 0.0089 0.4605 0.0390 0.0441 0.0156 
 Proline 0.0589 0.0191 0.7651 0.0493 0.0001 0.0078 0.2964 0.0375 0.0125 0.0069 0.1588 0.0257 0.5870 0.0426 
 Propionyl-CoA 0.9113 0.0481 0.0000 0.0019 0.0712 0.0225 0.0119 0.0165 0.0026 0.0038 0.1564 0.0256 0.0011 0.0035 
 Pyroglutamic acid 0.0621 0.0194 0.0007 0.0287 0.9677 0.0494 0.0024 0.0112 0.0319 0.0102 0.6115 0.0433 0.7806 0.0467 
 Quinolinate 0.5871 0.0402 0.0000 0.0154 0.0083 0.0144 0.0741 0.0262 0.6131 0.0399 0.0021 0.0049 0.0381 0.0145 
 Riboflavin 0.0000 0.0022 0.0000 0.0054 0.6711 0.0433 0.0053 0.0137 0.0181 0.0081 0.0004 0.0028 0.0008 0.0031 
 Ribose-phosphate 0.0000 0.0024 0.0000 0.0148 0.1216 0.0260 0.9830 0.0498 0.6742 0.0417 0.0994 0.0213 0.2324 0.0304 
 S-adenosyl-L-homoCysteine 0.0000 0.0042 0.0000 0.0049 0.0003 0.0087 0.1997 0.0341 0.0038 0.0043 0.0047 0.0067 0.1892 0.0280 
 Sarcosine 0.9575 0.0491 0.0133 0.0358 0.1507 0.0277 0.2366 0.0356 0.1413 0.0203 0.9072 0.0490 0.0001 0.0016 
 Sedoheptulose bisphosphate 0.0286 0.0158 0.0000 0.0173 0.2539 0.0320 0.0014 0.0099 0.3370 0.0305 0.4439 0.0384 0.0083 0.0076 
 Sedoheptulose-1/7-phosphate 0.0025 0.0093 0.0000 0.0067 0.0000 0.0066 0.0027 0.0114 0.0565 0.0132 0.0006 0.0031 0.0685 0.0187 
 Serine 0.0889 0.0217 0.0000 0.0218 0.0000 0.0045 0.0038 0.0125 0.0007 0.0023 0.2802 0.0321 0.0905 0.0209 
 Shikimate 0.0077 0.0117 0.0000 0.0039 0.5618 0.0410 0.0000 0.0022 0.2331 0.0258 0.0001 0.0017 0.2360 0.0305 
 Succinate 0.4517 0.0364 0.0003 0.0268 0.5160 0.0398 0.1563 0.0318 0.0032 0.0040 0.1942 0.0276 0.0205 0.0112 
 Taurine 0.0560 0.0188 0.0431 0.0398 0.0000 0.0038 0.0029 0.0116 0.0504 0.0124 0.2293 0.0296 0.0037 0.0055 
 Taurodeoxycholic acid 0.0003 0.0065 0.0000 0.0038 0.0122 0.0156 0.7355 0.0467 0.0091 0.0061 0.0000 0.0011 0.0000 0.0005 
 Threonine 0.2124 0.0285 0.0517 0.0404 0.0083 0.0145 0.0041 0.0127 0.0002 0.0015 0.5412 0.0415 0.0007 0.0029 
 Thymidine 0.2656 0.0304 0.0000 0.0011 0.0315 0.0188 0.4946 0.0425 0.2291 0.0256 0.1184 0.0227 0.3366 0.0348 
 Trehalose-6-Phosphate 0.3551 0.0337 0.8403 0.0496 0.0878 0.0237 0.0046 0.0132 0.9271 0.0484 0.5500 0.0418 0.4569 0.0391 
 Trehalose/sucrose 0.3462 0.0334 0.1309 0.0435 0.0184 0.0168 0.9609 0.0496 0.6495 0.0410 0.5262 0.0412 0.0037 0.0055 
 Tryptophan 0.0008 0.0076 0.5920 0.0486 0.0004 0.0090 0.0000 0.0016 0.2766 0.0279 0.1695 0.0264 0.0136 0.0096 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-
Strain 
(i/m)q Sex-by-
Diet 
(i/m)q Strain-by-
Diet 
(i/m)q Sex-by-Strain-by-
Diet 
(i/m)q 
 Tyrosine 0.3830 0.0345 0.0004 0.0272 0.0000 0.0025 0.5846 0.0442 0.6903 0.0422 0.4933 0.0401 0.0521 0.0168 
 UDP 0.0428 0.0174 0.0001 0.0236 0.0028 0.0120 0.0180 0.0182 0.3909 0.0325 0.1094 0.0221 0.0327 0.0137 
 UDP-D-glucose 0.0239 0.0151 0.0000 0.0019 0.0026 0.0118 0.0000 0.0021 0.6455 0.0409 0.0270 0.0126 0.0001 0.0012 
 UDP-D-glucuronate 0.0013 0.0082 0.0000 0.0035 0.0019 0.0112 0.0956 0.0280 0.3813 0.0322 0.1785 0.0268 0.0019 0.0043 
 UDP-N-acetyl-glucosamine 0.9251 0.0484 0.0000 0.0060 0.0805 0.0232 0.0008 0.0089 0.4819 0.0358 0.1317 0.0237 0.0425 0.0153 
 UMP 0.8893 0.0476 0.0000 0.0010 0.8932 0.0479 0.0002 0.0064 0.5044 0.0365 0.1319 0.0237 0.6774 0.0447 
 Uracil 0.0094 0.0121 0.0000 0.0055 0.0001 0.0073 0.0001 0.0063 0.0347 0.0106 0.0823 0.0197 0.0536 0.0170 
 Uric acid 0.1273 0.0244 0.1748 0.0445 0.4596 0.0385 0.0169 0.0179 0.7108 0.0428 0.0807 0.0195 0.2923 0.0331 
 Uridine 0.0738 0.0204 0.0000 0.0023 0.0003 0.0087 0.0000 0.0008 0.1862 0.0230 0.2376 0.0300 0.0212 0.0113 
 UTP 0.0000 0.0046 0.0000 0.0087 0.0092 0.0148 0.0042 0.0129 0.4238 0.0339 0.0100 0.0086 0.0040 0.0057 
 Valine 0.5131 0.0382 0.0000 0.0025 0.0000 0.0021 0.5178 0.0430 0.0002 0.0017 0.2061 0.0284 0.0011 0.0035 
 Xanthine 0.7840 0.0451 0.0000 0.0198 0.0741 0.0227 0.0251 0.0198 0.0180 0.0081 0.0647 0.0178 0.0001 0.0012 
 Xanthosine 0.0000 0.0043 0.0000 0.0029 0.0154 0.0163 0.0137 0.0171 0.7029 0.0425 0.0014 0.0043 0.0000 0.0004 
 Xanthosine-5-phosphate 0.3373 0.0330 0.0000 0.0112 0.8075 0.0463 0.0539 0.0240 0.1144 0.0185 0.3032 0.0329 0.1579 0.0260 
 Xanthurenic acid 0.0019 0.0089 0.0004 0.0274 0.0000 0.0037 0.0187 0.0184 0.0380 0.0110 0.0016 0.0045 0.5376 0.0414 
                
Muscle 1-Methyl-Histidine 0.0000 0.0010 0.0000 0.0091 0.1049 0.0092 0.0072 0.0074 0.3358 0.0247 0.5765 0.0368 0.7318 0.0410 
 2-dehydro-D-gluconate 0.0958 0.0156 0.0004 0.0160 0.3677 0.0204 0.0140 0.0090 0.6572 0.0383 0.5187 0.0344 0.3209 0.0235 
 2-Hydroxy-2-
methylbutanedioic acid 
0.1363 0.0180 0.0000 0.0006 0.4680 0.0255 0.0219 0.0106 0.1395 0.0140 0.3105 0.0253 0.2310 0.0189 
 2-Isopropylmalic acid 0.6523 0.0384 0.0000 0.0018 0.0038 0.0031 0.0000 0.0023 0.9280 0.0475 0.0582 0.0086 0.0000 0.0004 
 2-oxo-4-methylthiobutanoate 0.0000 0.0020 0.0002 0.0141 0.6761 0.0350 0.8607 0.0464 0.5314 0.0332 0.5685 0.0365 0.6895 0.0395 
 3-methylphenylacetic acid 0.8050 0.0437 0.0002 0.0142 0.9067 0.0460 0.0662 0.0157 0.1628 0.0155 0.2122 0.0199 0.0008 0.0015 
 3-phosphoglycerate 0.8040 0.0437 0.0005 0.0164 0.9271 0.0469 0.0227 0.0108 0.7060 0.0400 0.3006 0.0247 0.0919 0.0105 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 3-S-methylthiopropionate 0.0019 0.0063 0.3632 0.0429 0.6688 0.0347 0.4249 0.0333 0.6377 0.0375 0.9120 0.0480 0.9900 0.0496 
 6-phospho-D-gluconate 0.4584 0.0316 0.0000 0.0073 0.1411 0.0109 0.0895 0.0176 0.2677 0.0213 0.0164 0.0037 0.6982 0.0398 
 a-ketoglutarate 0.7424 0.0417 0.0000 0.0010 0.3584 0.0198 0.0026 0.0056 0.4361 0.0292 0.1653 0.0168 0.0445 0.0066 
 Acetyllysine 0.0584 0.0132 0.0182 0.0273 0.0021 0.0027 0.2508 0.0264 0.2824 0.0220 0.3239 0.0260 0.4650 0.0300 
 Aconitate 0.1821 0.0202 0.0025 0.0204 0.7792 0.0400 0.3865 0.0318 0.3349 0.0247 0.8509 0.0464 0.8551 0.0451 
 Adenosine 0.1083 0.0165 0.0000 0.0111 0.5141 0.0275 0.0302 0.0119 0.5743 0.0349 0.0767 0.0100 0.2417 0.0195 
 ADP 0.0027 0.0069 0.0000 0.0105 0.4054 0.0223 0.4164 0.0330 0.8162 0.0439 0.1025 0.0121 0.2074 0.0177 
 ADP-D-glucose 0.0646 0.0137 0.0065 0.0234 0.2443 0.0152 0.0878 0.0174 0.4774 0.0309 0.1173 0.0132 0.6014 0.0360 
 Allantoate 0.1254 0.0174 0.0028 0.0207 0.1079 0.0095 0.0724 0.0161 0.0435 0.0061 0.4781 0.0328 0.0004 0.0014 
 Allantoin 0.6491 0.0383 0.0000 0.0041 0.0009 0.0024 0.0572 0.0148 0.3027 0.0232 0.2750 0.0237 0.5184 0.0324 
 Aminoadipic acid 0.0000 0.0013 0.0000 0.0046 0.0003 0.0021 0.6086 0.0390 0.7523 0.0416 0.1263 0.0141 0.0409 0.0064 
 AMP 0.0003 0.0044 0.0000 0.0111 0.3490 0.0194 0.4544 0.0343 0.2681 0.0214 0.6529 0.0396 0.2143 0.0181 
 Arginine 0.0286 0.0113 0.0001 0.0132 0.0000 0.0010 0.1300 0.0201 0.1641 0.0156 0.2201 0.0205 0.8818 0.0461 
 Ascorbic acid 0.4139 0.0298 0.0056 0.0229 0.7306 0.0377 0.0482 0.0140 0.0822 0.0095 0.0571 0.0084 0.5782 0.0350 
 Asparagine 0.0364 0.0119 0.0004 0.0155 0.4692 0.0256 0.0480 0.0139 0.0860 0.0098 0.1930 0.0188 0.5943 0.0356 
 Aspartate 0.0034 0.0073 0.0000 0.0045 0.7005 0.0361 0.0305 0.0119 0.7209 0.0405 0.0298 0.0055 0.1171 0.0123 
 ATP 0.3402 0.0269 0.0002 0.0144 0.6114 0.0320 0.0194 0.0102 0.6619 0.0385 0.4079 0.0300 0.4183 0.0281 
 Betaine 0.6897 0.0398 0.0000 0.0091 0.0000 0.0013 0.7783 0.0441 0.0349 0.0052 0.4405 0.0313 0.5025 0.0316 
 CDP-ethanolamine 0.0000 0.0026 0.0001 0.0123 0.8423 0.0429 0.0889 0.0175 0.0750 0.0089 0.5103 0.0340 0.7414 0.0414 
 Citraconic acid 0.0104 0.0091 0.0576 0.0326 0.3673 0.0204 0.0000 0.0020 0.1370 0.0138 0.0072 0.0023 0.4579 0.0297 
 Citrate 0.1830 0.0203 0.0001 0.0122 0.0317 0.0054 0.1726 0.0226 0.8251 0.0443 0.7279 0.0425 0.5124 0.0320 
 Citrate/isocitrate 0.1830 0.0203 0.0001 0.0122 0.0317 0.0054 0.1726 0.0226 0.8251 0.0443 0.7279 0.0425 0.5124 0.0321 
 Citrulline 0.0000 0.0026 0.0000 0.0046 0.0548 0.0067 0.6214 0.0394 0.7766 0.0426 0.5762 0.0368 0.3294 0.0240 
 CMP 0.0020 0.0064 0.0002 0.0145 0.7914 0.0405 0.9060 0.0474 0.4214 0.0285 0.2040 0.0195 0.4693 0.0302 
 
 
 
 
  184 
Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 Creatine 0.0183 0.0102 0.0000 0.0032 0.4930 0.0267 0.0036 0.0061 0.1330 0.0135 0.2149 0.0201 0.5382 0.0333 
 CTP 0.3956 0.0291 0.0185 0.0274 0.0670 0.0074 0.0258 0.0112 0.8240 0.0442 0.0369 0.0065 0.4616 0.0299 
 Cyclic-AMP 0.0019 0.0063 0.0000 0.0021 0.0597 0.0070 0.1891 0.0235 0.1252 0.0129 0.0087 0.0025 0.0191 0.0042 
 Cystathionine 0.6501 0.0383 0.0000 0.0052 0.6061 0.0318 0.0028 0.0058 0.7844 0.0429 0.0016 0.0010 0.0703 0.0088 
 Cysteine 0.6737 0.0391 0.0017 0.0192 0.3291 0.0186 0.1648 0.0222 0.4562 0.0301 0.1050 0.0123 0.6201 0.0366 
 Cytidine 0.0000 0.0024 0.0000 0.0091 0.0443 0.0061 0.0000 0.0006 0.7640 0.0421 0.4208 0.0305 0.0392 0.0062 
 Deoxyribose-phosphate 0.3048 0.0255 0.0000 0.0029 0.8472 0.0432 0.0001 0.0029 0.1793 0.0164 0.1327 0.0146 0.4333 0.0288 
 Deoxyuridine 0.1808 0.0201 0.0000 0.0000 0.0071 0.0037 0.0011 0.0046 0.7049 0.0399 0.1715 0.0172 0.3997 0.0274 
 dGMP 0.0003 0.0044 0.0000 0.0111 0.3490 0.0195 0.4544 0.0343 0.2681 0.0214 0.6529 0.0397 0.2143 0.0181 
 Dihydroxy-acetone-phosphate 0.1376 0.0181 0.0000 0.0120 0.0979 0.0089 0.1059 0.0186 0.0808 0.0094 0.0636 0.0090 0.0251 0.0048 
 Erythrose-4-phosphate 0.0000 0.0015 0.0000 0.0025 0.2011 0.0134 0.1512 0.0215 0.0021 0.0009 0.0001 0.0004 0.0415 0.0064 
 FAD 0.6770 0.0393 0.0001 0.0136 0.0626 0.0071 0.5587 0.0377 0.4911 0.0315 0.1791 0.0178 0.0065 0.0027 
 Fructose-1,6-bisphosphate 0.4267 0.0303 0.0000 0.0029 0.6733 0.0349 0.0012 0.0046 0.5929 0.0357 0.2987 0.0246 0.3343 0.0243 
 Fumarate 0.9473 0.0483 0.0007 0.0172 0.8793 0.0448 0.1891 0.0234 0.7636 0.0421 0.3980 0.0294 0.0710 0.0089 
 GDP 0.2692 0.0240 0.0012 0.0184 0.3293 0.0187 0.5723 0.0381 0.5431 0.0336 0.4584 0.0320 0.0805 0.0096 
 Gluconate 0.0024 0.0067 0.1874 0.0389 0.9951 0.0498 0.0110 0.0084 0.7986 0.0434 0.8783 0.0471 0.2835 0.0216 
 Glucono-lactone-6-phosphate 0.0000 0.0020 0.0000 0.0031 0.1396 0.0109 0.0200 0.0103 0.0843 0.0097 0.4512 0.0317 0.0139 0.0036 
 Glucosamine-1/6-phosphate 0.1590 0.0192 0.3067 0.0418 0.4988 0.0269 0.0032 0.0059 0.2132 0.0183 0.0221 0.0045 0.0362 0.0060 
 Glucose-1/6-phosphate 0.0000 0.0011 0.0000 0.0022 0.4646 0.0252 0.0073 0.0074 0.0370 0.0055 0.0016 0.0010 0.0056 0.0026 
 Glutamate 0.0916 0.0154 0.0024 0.0203 0.0008 0.0023 0.3884 0.0318 0.0544 0.0071 0.0059 0.0019 0.1080 0.0117 
 Glutamine 0.0003 0.0043 0.0110 0.0252 0.1537 0.0115 0.2881 0.0280 0.0732 0.0088 0.4706 0.0325 0.2292 0.0189 
 Glyceraldehdye-3-phosphate 0.1971 0.0208 0.0001 0.0126 0.2033 0.0135 0.0782 0.0167 0.0991 0.0109 0.0870 0.0108 0.0420 0.0065 
 Glycerol-3-phosphate 0.0035 0.0073 0.0000 0.0029 0.1290 0.0105 0.0076 0.0075 0.0008 0.0005 0.5612 0.0361 0.6204 0.0366 
 GMP 0.0009 0.0053 0.0000 0.0031 0.9982 0.0500 0.1827 0.0231 0.2833 0.0221 0.8429 0.0461 0.5142 0.0321 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-
Strain 
(i/m)q Sex-by-
Diet 
(i/m)q Strain-by-
Diet 
(i/m)q Sex-by-Strain-by-
Diet 
(i/m)q 
 Histidine 0.0107 0.0092 0.0000 0.0014 0.0002 0.0019 0.0021 0.0053 0.0133 0.0027 0.5881 0.0372 0.1158 0.0122 
 Homocysteic acid 0.0015 0.0060 0.0000 0.0009 0.0000 0.0008 0.1069 0.0187 0.3046 0.0233 0.0654 0.0092 0.0000 0.0008 
 Homocysteine 0.7585 0.0421 0.0004 0.0160 0.0000 0.0011 0.0116 0.0085 0.5030 0.0320 0.5682 0.0365 0.1078 0.0117 
 Homoserine 0.0032 0.0072 0.0035 0.0214 0.0000 0.0003 0.0741 0.0163 0.0320 0.0048 0.7973 0.0447 0.1586 0.0148 
 Hydroxyphenylacetic acid 0.0475 0.0127 0.0008 0.0174 0.6882 0.0356 0.0000 0.0013 0.0534 0.0070 0.5641 0.0363 0.2367 0.0192 
 Hydroxyproline 0.0062 0.0082 0.0271 0.0290 0.0000 0.0000 0.9725 0.0493 0.0727 0.0088 0.7487 0.0433 0.3149 0.0232 
 IMP 0.0700 0.0140 0.0000 0.0066 0.3673 0.0204 0.4483 0.0341 0.5552 0.0341 0.6307 0.0387 0.4130 0.0279 
 Inosine 0.0850 0.0149 0.7518 0.0480 0.7809 0.0401 0.0011 0.0046 0.5129 0.0324 0.1090 0.0125 0.0216 0.0044 
 Isocitrate 0.1830 0.0203 0.0001 0.0122 0.0317 0.0054 0.1726 0.0226 0.8251 0.0443 0.7279 0.0425 0.5124 0.0321 
 Lactate 0.0607 0.0134 0.0244 0.0285 0.3127 0.0180 0.0033 0.0060 0.7768 0.0426 0.2374 0.0215 0.5041 0.0317 
 Leucine/isoleucine 0.1111 0.0167 0.0015 0.0190 0.0008 0.0023 0.3168 0.0291 0.1403 0.0141 0.1475 0.0155 0.7102 0.0402 
 Lysine 0.0002 0.0041 0.0000 0.0106 0.0000 0.0004 0.0164 0.0096 0.2050 0.0180 0.1185 0.0134 0.1364 0.0133 
 Malate 0.6042 0.0367 0.0002 0.0143 0.8104 0.0416 0.0771 0.0165 0.6215 0.0369 0.2009 0.0192 0.0174 0.0040 
 Methionine 0.0001 0.0034 0.0000 0.0083 0.0000 0.0007 0.1730 0.0226 0.0081 0.0018 0.1177 0.0133 0.2855 0.0218 
 Methylcysteine 0.7080 0.0405 0.0003 0.0154 0.0000 0.0011 0.0102 0.0083 0.4992 0.0318 0.6178 0.0383 0.1196 0.0124 
 Methylmalonic acid 0.1990 0.0210 0.0049 0.0224 0.7269 0.0375 0.0482 0.0140 0.1769 0.0163 0.2044 0.0195 0.4817 0.0307 
 Myo-inositol 0.5719 0.0356 0.0000 0.0112 0.2383 0.0148 0.5843 0.0385 0.3961 0.0273 0.5158 0.0343 0.6665 0.0385 
 N-acetyl-glucosamine-1/6-
phosphate 
0.0025 0.0068 0.0000 0.0050 0.3744 0.0207 0.8535 0.0462 0.0772 0.0091 0.0055 0.0019 0.0871 0.0101 
 N-acetyl-glutamate 0.0541 0.0130 0.0000 0.0089 0.9853 0.0494 0.2622 0.0268 0.7660 0.0422 0.3365 0.0266 0.7386 0.0413 
 N-acetyl-glutamine 0.0000 0.0014 0.0165 0.0268 0.2282 0.0143 0.0007 0.0042 0.1448 0.0144 0.9535 0.0490 0.1669 0.0153 
 N-Acetyl-L-alanine 0.0000 0.0029 0.0107 0.0251 0.8385 0.0427 0.0740 0.0163 0.5533 0.0340 0.3309 0.0263 0.7092 0.0402 
 NAD+ 0.1876 0.0205 0.0000 0.0041 0.3424 0.0191 0.0089 0.0079 0.5314 0.0332 0.3226 0.0259 0.1065 0.0116 
 NADH 0.4313 0.0305 0.0179 0.0272 0.4605 0.0251 0.3687 0.0311 0.9352 0.0478 0.3559 0.0275 0.3734 0.0263 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 NADP+ 0.1318 0.0178 0.0000 0.0115 0.8232 0.0421 0.2351 0.0257 0.4457 0.0296 0.7960 0.0446 0.0198 0.0043 
 NADPH 0.1244 0.0174 0.0000 0.0106 0.4071 0.0224 0.0123 0.0087 0.7213 0.0405 0.0480 0.0075 0.5164 0.0323 
 Nicotinamide ribotide 0.3778 0.0284 0.2638 0.0409 0.5009 0.0270 0.1904 0.0235 0.0073 0.0017 0.0069 0.0022 0.0011 0.0017 
 Ornithine 0.0147 0.0098 0.0000 0.0063 0.0043 0.0032 0.0989 0.0182 0.2048 0.0180 0.6521 0.0396 0.7173 0.0404 
 Orotate 0.0000 0.0009 0.0693 0.0335 0.0912 0.0086 0.0879 0.0174 0.7447 0.0414 0.3943 0.0292 0.1754 0.0157 
 Pantothenate 0.0000 0.0001 0.0000 0.0034 0.1562 0.0116 0.0998 0.0183 0.0067 0.0016 0.2403 0.0217 0.2550 0.0203 
 Phosphoenolpyruvate 0.9511 0.0485 0.0017 0.0193 0.9133 0.0463 0.0067 0.0072 0.9315 0.0477 0.3292 0.0262 0.1161 0.0122 
 Proline 0.0996 0.0158 0.0000 0.0059 0.0000 0.0009 0.0622 0.0153 0.4494 0.0298 0.2988 0.0246 0.0988 0.0110 
 Pyrophosphate 0.2282 0.0224 0.0404 0.0309 0.8888 0.0451 0.0000 0.0022 0.2598 0.0208 0.0132 0.0032 0.4125 0.0279 
 Quinolinate 0.0429 0.0123 0.0051 0.0226 0.3700 0.0205 0.0002 0.0032 0.0013 0.0007 0.2783 0.0238 0.0262 0.0049 
 Ribose-phosphate 0.0118 0.0093 0.0000 0.0046 0.2968 0.0174 0.1480 0.0214 0.3928 0.0272 0.8201 0.0456 0.0451 0.0067 
 Serine 0.0207 0.0105 0.0025 0.0204 0.0007 0.0023 0.6352 0.0399 0.3510 0.0255 0.4327 0.0310 0.4561 0.0296 
 Shikimate 0.6408 0.0380 0.0000 0.0102 0.0065 0.0036 0.0000 0.0011 0.9771 0.0493 0.2193 0.0204 0.3566 0.0254 
 Succinate 0.1990 0.0210 0.0049 0.0224 0.7269 0.0375 0.0482 0.0140 0.1769 0.0163 0.2044 0.0195 0.4817 0.0307 
 Taurine 0.1149 0.0168 0.0118 0.0255 0.5497 0.0292 0.0324 0.0121 0.0004 0.0003 0.2048 0.0195 0.2178 0.0183 
 Taurodeoxycholic acid 0.5504 0.0348 0.0000 0.0080 0.2672 0.0161 0.0007 0.0042 0.1161 0.0122 0.0000 0.0004 0.3763 0.0265 
 Threonine 0.0032 0.0072 0.0035 0.0214 0.0000 0.0003 0.0741 0.0163 0.0320 0.0048 0.7973 0.0447 0.1586 0.0148 
 Thymidine 0.0709 0.0141 0.0000 0.0016 0.2775 0.0164 0.0566 0.0147 0.2483 0.0200 0.4443 0.0314 0.9148 0.0471 
 Tryptophan 0.0000 0.0023 0.1440 0.0374 0.0000 0.0015 0.0052 0.0068 0.0002 0.0002 0.0435 0.0071 0.5789 0.0350 
 Tyrosine 0.0364 0.0119 0.0000 0.0114 0.0000 0.0006 0.0097 0.0081 0.0027 0.0010 0.1487 0.0156 0.4456 0.0293 
 UDP 0.0000 0.0024 0.0001 0.0126 0.3289 0.0186 0.2700 0.0272 0.6575 0.0383 0.0683 0.0093 0.0683 0.0086 
 UDP-D-glucose 0.8775 0.0460 0.0000 0.0023 0.5912 0.0311 0.9917 0.0498 0.1057 0.0115 0.1151 0.0131 0.0002 0.0012 
 UDP-D-glucuronate 0.2100 0.0215 0.0000 0.0039 0.3328 0.0188 0.1449 0.0211 0.1699 0.0159 0.1238 0.0138 0.0021 0.0020 
 UDP-N-acetyl-glucosamine 0.0009 0.0053 0.0000 0.0027 0.8148 0.0417 0.1872 0.0233 0.2415 0.0197 0.0690 0.0094 0.0001 0.0008 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-
Strain 
(i/m)q Sex-by-
Diet 
(i/m)q Strain-by-
Diet 
(i/m)q Sex-by-Strain-by-
Diet 
(i/m)q 
 UMP 0.0014 0.0059 0.0000 0.0062 0.6930 0.0358 0.4694 0.0347 0.2138 0.0184 0.8966 0.0475 0.5068 0.0318 
 Uracil 0.2372 0.0227 0.0008 0.0174 0.1842 0.0127 0.2904 0.0281 0.3817 0.0267 0.2698 0.0234 0.1845 0.0162 
 Uric acid 0.0154 0.0099 0.0002 0.0140 0.4695 0.0256 0.7785 0.0441 0.4164 0.0282 0.2189 0.0204 0.0029 0.0022 
 Uridine 0.3418 0.0270 0.0000 0.0034 0.0024 0.0028 0.0000 0.0005 0.0393 0.0057 0.0437 0.0071 0.2388 0.0193 
 UTP 0.1888 0.0206 0.0004 0.0157 0.5637 0.0299 0.0882 0.0175 0.4895 0.0314 0.2541 0.0225 0.7713 0.0423 
 Valine 0.6897 0.0398 0.0000 0.0092 0.0000 0.0013 0.7783 0.0441 0.0349 0.0052 0.4405 0.0313 0.5025 0.0316 
 Xanthine 0.1720 0.0197 0.0102 0.0249 0.2479 0.0153 0.0246 0.0110 0.7752 0.0425 0.7331 0.0427 0.1210 0.0124 
 Xanthosine 0.2670 0.0238 0.0070 0.0236 0.3806 0.0211 0.0107 0.0083 0.3209 0.0240 0.1314 0.0146 0.9667 0.0487 
                
Liver 2-Hydroxy-2-
methylbutanedioic acid 
0.3591 0.0348 0.0000 0.0099 0.1217 0.0145 0.3291 0.0366 0.3661 0.0224 0.4126 0.0382 0.0966 0.0103 
 2-Isopropylmalic acid 0.0008 0.0054 0.0000 0.0031 0.4955 0.0349 0.0059 0.0111 0.6728 0.0371 0.0258 0.0114 0.0311 0.0048 
 3-methylphenylacetic acid 0.0020 0.0066 0.0008 0.0190 0.0000 0.0001 0.0079 0.0123 0.0844 0.0070 0.0017 0.0023 0.0165 0.0033 
 3-phospho-serine 0.4091 0.0366 0.0190 0.0285 0.7751 0.0442 0.1156 0.0270 0.3121 0.0193 0.1298 0.0241 0.8198 0.0450 
 3-phosphoglycerate 0.0897 0.0211 0.0000 0.0085 0.8867 0.0471 0.0026 0.0086 0.3556 0.0218 0.9809 0.0497 0.2907 0.0223 
 6-phospho-D-gluconate 0.9959 0.0499 0.0032 0.0225 0.2809 0.0249 0.0674 0.0233 0.0859 0.0071 0.1413 0.0252 0.2221 0.0182 
 a-ketoglutarate 0.6638 0.0429 0.0000 0.0070 0.2158 0.0210 0.0001 0.0027 0.0279 0.0028 0.0080 0.0058 0.0028 0.0013 
 Acetyllysine 0.0028 0.0071 0.0016 0.0209 0.2101 0.0208 0.5183 0.0412 0.3074 0.0190 0.0708 0.0185 0.5246 0.0341 
 Adenosine 0.0010 0.0057 0.0000 0.0077 0.0282 0.0052 0.1796 0.0308 0.2317 0.0151 0.0091 0.0063 0.0003 0.0006 
 ADP 0.6995 0.0437 0.0056 0.0241 0.1167 0.0140 0.4641 0.0402 0.5657 0.0319 0.0181 0.0095 0.0028 0.0013 
 ADP-D-glucose 0.1450 0.0254 0.0002 0.0159 0.0439 0.0070 0.4617 0.0402 0.2425 0.0156 0.3631 0.0365 0.4644 0.0315 
 Allantoin 0.3076 0.0329 0.0000 0.0056 0.0578 0.0083 0.0087 0.0127 0.0143 0.0016 0.3419 0.0357 0.1513 0.0141 
 Aminoadipic acid 0.0042 0.0079 0.0000 0.0025 0.3708 0.0295 0.5421 0.0418 0.2721 0.0170 0.2925 0.0338 0.9317 0.0482 
 AMP 0.5093 0.0392 0.4817 0.0461 0.7868 0.0446 0.0001 0.0030 0.0613 0.0052 0.1157 0.0229 0.1117 0.0115 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 Arginine 0.0455 0.0160 0.0096 0.0260 0.1004 0.0126 0.5090 0.0410 0.3477 0.0213 0.1708 0.0272 0.0939 0.0101 
 Ascorbic acid 0.7015 0.0437 0.0002 0.0156 0.2869 0.0253 0.6770 0.0445 0.8770 0.0458 0.5495 0.0420 0.0821 0.0094 
 Asparagine 0.0002 0.0043 0.0051 0.0237 0.8771 0.0468 0.0277 0.0179 0.4290 0.0257 0.3392 0.0357 0.0361 0.0055 
 Aspartate 0.0002 0.0041 0.0018 0.0212 0.6974 0.0419 0.0004 0.0048 0.0600 0.0051 0.0706 0.0184 0.0008 0.0008 
 ATP 0.3083 0.0329 0.0014 0.0204 0.0083 0.0030 0.0043 0.0103 0.2961 0.0184 0.0945 0.0209 0.0649 0.0081 
 CDP-ethanolamine 0.0000 0.0012 0.3567 0.0444 0.0264 0.0050 0.0003 0.0045 0.8530 0.0448 0.0508 0.0159 0.3961 0.0277 
 Cellobiose 0.3255 0.0336 0.0014 0.0205 0.5036 0.0352 0.2615 0.0343 0.1263 0.0095 0.0176 0.0094 0.1025 0.0108 
 Citrate 0.2100 0.0288 0.0001 0.0129 0.9097 0.0477 0.6394 0.0437 0.6814 0.0375 0.2521 0.0320 0.4895 0.0326 
 Citrate/isocitrate 0.2100 0.0288 0.0001 0.0129 0.9097 0.0477 0.6394 0.0437 0.6814 0.0375 0.2521 0.0320 0.4895 0.0326 
 Citrulline 0.0000 0.0005 0.0000 0.0111 0.0001 0.0008 0.0560 0.0221 0.0979 0.0079 0.4249 0.0386 0.0407 0.0059 
 CMP 0.0260 0.0132 0.0001 0.0132 0.8155 0.0452 0.2727 0.0347 0.5221 0.0300 0.6501 0.0442 0.2638 0.0207 
 Creatine 0.0036 0.0076 0.0000 0.0072 0.0643 0.0090 0.1939 0.0316 0.1919 0.0131 0.1291 0.0240 0.1968 0.0167 
 Creatinine 0.0002 0.0040 0.0790 0.0355 0.0041 0.0022 0.0956 0.0256 0.3227 0.0199 0.2703 0.0328 0.0825 0.0095 
 Cysteine 0.1367 0.0249 0.0000 0.0119 0.6311 0.0396 0.0047 0.0105 0.0088 0.0010 0.0874 0.0202 0.4040 0.0281 
 Cytidine 0.8365 0.0468 0.0005 0.0177 0.2141 0.0210 0.0011 0.0065 0.7204 0.0394 0.0069 0.0053 0.2997 0.0227 
 Deoxyuridine 0.0415 0.0155 0.0008 0.0190 0.1249 0.0149 0.1496 0.0294 0.6008 0.0336 0.1677 0.0270 0.1211 0.0121 
 dGMP 0.5093 0.0392 0.4817 0.0462 0.7868 0.0446 0.0001 0.0031 0.0613 0.0053 0.1157 0.0229 0.1117 0.0115 
 Dihydroorotate 0.0007 0.0052 0.1802 0.0401 0.0893 0.0116 0.3803 0.0380 0.1285 0.0097 0.1051 0.0218 0.2312 0.0187 
 Dihydroxy-acetone-phosphate 0.8518 0.0471 0.0000 0.0054 0.1744 0.0182 0.0064 0.0114 0.0074 0.0008 0.3033 0.0343 0.1937 0.0166 
 dUMP 0.0137 0.0110 0.0021 0.0215 0.2003 0.0201 0.0373 0.0197 0.3893 0.0235 0.1069 0.0220 0.6019 0.0372 
 FAD 0.3383 0.0341 0.0079 0.0253 0.6128 0.0391 0.3780 0.0380 0.6759 0.0372 0.0220 0.0106 0.2740 0.0213 
 Fructose-1,6-bisphosphate 0.1885 0.0278 0.0001 0.0150 0.6551 0.0405 0.0020 0.0080 0.0168 0.0018 0.9126 0.0486 0.6821 0.0405 
 Fumarate 0.0596 0.0177 0.0000 0.0044 0.7627 0.0438 0.0277 0.0179 0.4617 0.0273 0.0177 0.0094 0.7425 0.0425 
 Glucarate 0.0994 0.0219 0.0076 0.0251 0.4996 0.0350 0.1150 0.0270 0.4859 0.0285 0.3637 0.0365 0.4262 0.0292 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 Gluconate 0.0567 0.0174 0.0270 0.0300 0.4462 0.0330 0.0971 0.0257 0.7679 0.0414 0.2675 0.0327 0.3989 0.0278 
 Glucosamine-1/6-phosphate 0.0017 0.0063 0.0776 0.0354 0.1192 0.0143 0.0243 0.0171 0.3067 0.0190 0.0353 0.0134 0.0340 0.0052 
 Glucose-1/6-phosphate 0.0009 0.0055 0.3695 0.0447 0.1709 0.0180 0.1226 0.0276 0.8050 0.0430 0.0818 0.0197 0.0984 0.0105 
 Glutamine 0.0026 0.0070 0.0000 0.0024 0.3708 0.0295 0.1311 0.0282 0.2747 0.0172 0.1280 0.0239 0.0106 0.0026 
 Glyceraldehdye-3-phosphate 0.8518 0.0471 0.0000 0.0054 0.1744 0.0182 0.0064 0.0114 0.0074 0.0008 0.3033 0.0343 0.1937 0.0165 
 Glycerate 0.2129 0.0289 0.0027 0.0220 0.1744 0.0182 0.6039 0.0431 0.3480 0.0214 0.0859 0.0201 0.0980 0.0105 
 Glycerol-3-phosphate 0.1424 0.0252 0.0006 0.0182 0.1862 0.0190 0.0129 0.0141 0.0057 0.0007 0.1882 0.0284 0.0706 0.0085 
 GMP 0.2375 0.0300 0.3990 0.0451 0.7902 0.0447 0.0000 0.0014 0.0479 0.0042 0.2583 0.0322 0.0761 0.0089 
 Guanidoacetic acid 0.1300 0.0243 0.0000 0.0097 0.0029 0.0020 0.1765 0.0307 0.9387 0.0479 0.2534 0.0321 0.8941 0.0472 
 Guanine 0.0743 0.0196 0.0000 0.0095 0.5686 0.0375 0.0050 0.0106 0.0611 0.0052 0.0393 0.0141 0.2483 0.0198 
 Guanosine 0.0018 0.0064 0.0000 0.0096 0.1760 0.0183 0.0036 0.0098 0.3098 0.0192 0.0751 0.0189 0.1187 0.0119 
 Histidine 0.2594 0.0310 0.0003 0.0164 0.0344 0.0059 0.9710 0.0496 0.8927 0.0463 0.4148 0.0383 0.0275 0.0045 
 Homocysteic acid 0.0356 0.0146 0.0051 0.0238 0.7000 0.0419 0.0366 0.0196 0.4872 0.0285 0.3268 0.0353 0.4485 0.0306 
 Homocysteine 0.8352 0.0467 0.0000 0.0085 0.2918 0.0256 0.0006 0.0055 0.8867 0.0461 0.0159 0.0089 0.0384 0.0056 
 Homoserine 0.0001 0.0038 0.0355 0.0312 0.0606 0.0086 0.0979 0.0258 0.1036 0.0082 0.0973 0.0211 0.0021 0.0011 
 Hydroxyisocaproic acid 0.0024 0.0068 0.0000 0.0015 0.0714 0.0098 0.8148 0.0472 0.5287 0.0303 0.0067 0.0052 0.3967 0.0277 
 Hydroxyphenylacetic acid 0.5740 0.0409 0.3127 0.0436 0.7670 0.0440 0.0053 0.0108 0.8383 0.0443 0.3317 0.0354 0.3669 0.0263 
 Hydroxyphenylpyruvate 0.3703 0.0352 0.0920 0.0364 0.0222 0.0047 0.0004 0.0048 0.0372 0.0036 0.0537 0.0163 0.1650 0.0150 
 Hydroxyproline 0.0037 0.0076 0.0196 0.0287 0.0000 0.0000 0.2407 0.0336 0.0013 0.0002 0.0037 0.0036 0.3762 0.0267 
 Hypoxanthine 0.8138 0.0461 0.0028 0.0221 0.2980 0.0259 0.0937 0.0254 0.9118 0.0469 0.0261 0.0114 0.0630 0.0080 
 IMP 0.2155 0.0291 0.0001 0.0137 0.0062 0.0026 0.1961 0.0318 0.0632 0.0054 0.1536 0.0261 0.0309 0.0048 
 Isocitrate 0.2100 0.0288 0.0001 0.0130 0.9097 0.0477 0.6394 0.0437 0.6814 0.0375 0.2521 0.0320 0.4895 0.0326 
 Lysine 0.0072 0.0091 0.0111 0.0267 0.3281 0.0274 0.0473 0.0212 0.6954 0.0382 0.1763 0.0275 0.1571 0.0144 
 Malate 0.0029 0.0072 0.0483 0.0327 0.5864 0.0382 0.1010 0.0261 0.1454 0.0106 0.1144 0.0228 0.1039 0.0110 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-
Strain 
(i/m)q Sex-by-
Diet 
(i/m)q Strain-by-
Diet 
(i/m)q Sex-by-Strain-by-
Diet 
(i/m)q 
 Methionine 0.0000 0.0019 0.0024 0.0217 0.4843 0.0345 0.0049 0.0105 0.3216 0.0198 0.1236 0.0235 0.0106 0.0026 
 Methionine sulfoxide 0.0000 0.0015 0.0000 0.0070 0.0302 0.0055 0.0612 0.0227 0.5116 0.0296 0.1168 0.0230 0.0090 0.0024 
 Methylcysteine 0.9653 0.0494 0.0000 0.0108 0.2295 0.0219 0.0018 0.0078 0.8053 0.0430 0.0383 0.0138 0.1131 0.0115 
 Myo-inositol 0.0012 0.0059 0.0001 0.0141 0.0163 0.0041 0.0093 0.0129 0.5403 0.0308 0.0011 0.0018 0.5926 0.0369 
 N-acetyl-glucosamine-1/6-
phosphate 
0.0393 0.0152 0.0000 0.0066 0.4362 0.0325 0.0318 0.0187 0.2356 0.0153 0.9045 0.0485 0.2177 0.0179 
 N-acetyl-glutamate 0.0000 0.0008 0.1612 0.0394 0.0020 0.0018 0.0002 0.0042 0.2158 0.0144 0.0258 0.0114 0.4491 0.0306 
 N-Acetyl-L-alanine 0.7315 0.0444 0.0007 0.0188 0.5160 0.0356 0.2915 0.0354 0.3389 0.0208 0.0699 0.0183 0.4504 0.0307 
 N-acetyl-L-ornithine 0.0062 0.0088 0.0300 0.0304 0.0157 0.0040 0.6739 0.0445 0.0348 0.0034 0.0091 0.0063 0.0134 0.0029 
 NAD+ 0.0015 0.0061 0.0238 0.0294 0.0007 0.0013 0.0311 0.0185 0.5742 0.0323 0.0002 0.0007 0.9326 0.0482 
 NADH 0.0007 0.0052 0.0264 0.0299 0.9249 0.0481 0.9120 0.0487 0.8172 0.0435 0.1247 0.0236 0.8984 0.0473 
 NADP+ 0.0347 0.0144 0.3693 0.0446 0.1921 0.0195 0.0016 0.0075 0.2297 0.0150 0.2037 0.0295 0.6443 0.0390 
 NADPH 0.0024 0.0069 0.0074 0.0250 0.9815 0.0496 0.8686 0.0481 0.9283 0.0475 0.2488 0.0318 0.8663 0.0462 
 Octulose 8/1P 0.0096 0.0098 0.9317 0.0496 0.0411 0.0067 0.0955 0.0256 0.0286 0.0029 0.0130 0.0078 0.0674 0.0082 
 Ornithine 0.0000 0.0023 0.4251 0.0454 0.0875 0.0114 0.1179 0.0272 0.3136 0.0194 0.4429 0.0391 0.0033 0.0014 
 Orotate 0.0637 0.0183 0.0055 0.0240 0.9405 0.0485 0.9810 0.0497 0.4629 0.0274 0.1058 0.0219 0.6614 0.0396 
 Pantothenate 0.0000 0.0002 0.0000 0.0055 0.0084 0.0030 0.0000 0.0004 0.0235 0.0024 0.0002 0.0007 0.0516 0.0069 
 Proline 0.0001 0.0031 0.0023 0.0217 0.0434 0.0069 0.0216 0.0167 0.5678 0.0321 0.0531 0.0162 0.0125 0.0029 
 Pyrophosphate 0.4032 0.0364 0.0231 0.0293 0.0278 0.0052 0.7105 0.0453 0.8977 0.0464 0.4674 0.0398 0.1186 0.0119 
 Quinolinate 0.1750 0.0271 0.0000 0.0042 0.0249 0.0049 0.1320 0.0282 0.8226 0.0437 0.0114 0.0073 0.1389 0.0133 
 Ribose-phosphate 0.0318 0.0141 0.0000 0.0048 0.2692 0.0243 0.0008 0.0060 0.9509 0.0483 0.6383 0.0439 0.9442 0.0486 
 S-adenosyl-L-homoCysteine 0.0000 0.0003 0.0000 0.0044 0.2848 0.0251 0.0001 0.0033 0.4586 0.0271 0.0288 0.0120 0.0766 0.0089 
 Sedoheptulose-1/7-phosphate 0.1324 0.0246 0.0000 0.0061 0.5624 0.0372 0.3638 0.0376 0.0130 0.0014 0.2936 0.0339 0.2532 0.0201 
 Serine 0.0006 0.0050 0.0153 0.0277 0.1951 0.0198 0.0212 0.0166 0.2766 0.0173 0.0272 0.0118 0.0048 0.0017 
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Table E continued 
Tissue Metabolite Sex (i/m)q Strain (i/m)q Diet (i/m)q Sex-by-Strain (i/m)q Sex-by-Diet (i/m)q Strain-by-Diet (i/m)q Sex-by-Strain-by-Diet (i/m)q 
 Shikimate 0.2509 0.0306 0.0013 0.0203 0.9423 0.0486 0.0021 0.0081 0.0372 0.0036 0.1042 0.0218 0.1387 0.0132 
 Shikimate-3-phosphate 0.7714 0.0452 0.0003 0.0167 0.5578 0.0370 0.8653 0.0480 0.2207 0.0146 0.2984 0.0341 0.3113 0.0235 
 Taurine 0.0957 0.0217 0.0000 0.0033 0.0194 0.0044 0.1541 0.0298 0.5894 0.0331 0.1035 0.0217 0.0428 0.0062 
 Taurodeoxycholic acid 0.0410 0.0154 0.0010 0.0195 0.0343 0.0059 0.0665 0.0232 0.4358 0.0260 0.0013 0.0019 0.0192 0.0036 
 Threonine 0.0001 0.0038 0.0355 0.0312 0.0606 0.0086 0.0979 0.0258 0.1036 0.0083 0.0973 0.0211 0.0021 0.0011 
 Thymidine 0.0333 0.0143 0.0017 0.0210 0.2038 0.0203 0.0755 0.0239 0.2522 0.0160 0.3049 0.0344 0.1822 0.0158 
 Thymine 0.0045 0.0081 0.1007 0.0368 0.7023 0.0420 0.1651 0.0302 0.2758 0.0172 0.3011 0.0343 0.4404 0.0301 
 Trehalose/sucrose 0.4650 0.0380 0.0000 0.0101 0.2901 0.0255 0.2803 0.0350 0.3366 0.0207 0.0302 0.0125 0.0580 0.0075 
 Tryptophan 0.0004 0.0046 0.3154 0.0437 0.5306 0.0361 0.0270 0.0177 0.6649 0.0367 0.1508 0.0259 0.1654 0.0150 
 Tyrosine 0.0001 0.0033 0.0038 0.0230 0.2289 0.0218 0.0206 0.0165 0.5620 0.0318 0.2551 0.0321 0.0117 0.0028 
 UDP 0.1094 0.0227 0.2388 0.0419 0.9686 0.0493 0.0066 0.0117 0.7293 0.0398 0.1261 0.0238 0.3177 0.0238 
 UDP-D-glucuronate 0.4915 0.0388 0.4478 0.0457 0.6484 0.0403 0.0031 0.0092 0.9333 0.0477 0.2235 0.0306 0.0826 0.0095 
 UMP 0.4726 0.0382 0.4387 0.0455 0.5778 0.0379 0.0002 0.0040 0.1982 0.0134 0.1140 0.0228 0.0796 0.0092 
 Uracil 0.0053 0.0085 0.6503 0.0478 0.5844 0.0382 0.0002 0.0040 0.6371 0.0354 0.0340 0.0132 0.1709 0.0154 
 Uric acid 0.0070 0.0091 0.6690 0.0480 0.5637 0.0373 0.0005 0.0052 0.1857 0.0128 0.3580 0.0363 0.3276 0.0243 
 Uridine 0.0035 0.0076 0.0592 0.0339 0.2255 0.0217 0.0025 0.0085 0.1593 0.0116 0.0625 0.0175 0.1262 0.0124 
 Valine 0.0010 0.0056 0.0000 0.0086 0.2494 0.0231 0.0327 0.0188 0.7115 0.0390 0.0316 0.0127 0.0039 0.0015 
 Xanthine 0.0360 0.0147 0.6862 0.0481 0.4075 0.0313 0.0026 0.0087 0.3041 0.0188 0.0570 0.0167 0.1272 0.0124 
 
All known metabolites considered significant in the ANOVA were identified in liver, skeletal muscle, and adipose tissue. 
Bold values indicate that the metabolite is statistically significant. Bold metabolites are not tissue specific. Bold and 
italicized metabolites are shared between all three tissues. Benjamini-Hochberg procedure was performed to determine 
significance. 
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Table F.6: Number of Edges for Each Node in Correlation Network Analysis Across Strains and 
Diets 
Metabolite Tissue Total 
Degree 
(+/-) 
Degree 
(Adipose) 
(+/-) 
Degree 
(Muscle) 
(+/-) 
Degree 
(Liver) 
(+/-) 
Degree 
(Phenotype) 
(+/-) 
3-methylphenylacetic acid Adipose 13 (9/4) 6 (6/0) 2 (0/2) 1 (1/0) 4 (2/2) 
4-aminobutyrate Adipose 5 (3/2) 2 (2/0) 0 1 (0/1) 2 (1/1) 
AMP Adipose 15 (12/3) 12 (10/2) 0 1 (1/0) 2 (1/1) 
CDP-ethanolamine Adipose 18 (15/3) 13 (12/1) 1 (1/0) 1 (0/1) 3 (2/1) 
GMP Adipose 15 (12/3) 12 (10/2) 0 0 3 (2/1) 
IMP Adipose 14 (10/4) 12 (10/2) 0 0 2 (0/2) 
N-acetyl-glutamate Adipose 21 (15/6) 12 (11/1) 2 (1/1) 2 (0/2) 5 (3/2) 
NAD+ Adipose 13 (12/1) 12 (11/1) 0 0 1 (0/1) 
S-adenosyl-L-homoCysteine Adipose 18 (9/9) 6 (6/0) 4 (0/4) 4 (1/3) 4 (2/2) 
UMP Adipose 13 (10/3) 12 (10/2) 0 0 1 (0/1) 
a-ketoglutarate Adipose 9 (7/2) 2 (2/0) 3 (2/1) 2 (2/0) 2 (1/1) 
Cysteine Adipose 16 (13/3) 10 (9/1) 3 (2/1) 2 (1/1) 1 (1/0) 
dGMP Adipose 15 (12/3) 12 (10/2) 0 1 (1/0) 2 (1/1) 
Inosine Adipose 6 (3/3) 4 (3/1) 1 (0/1) 0 1 (0/1) 
Pantothenate Adipose 28 
(13/15) 
12 (11/1) 6 (0/6) 6 (0/6) 4 (2/2) 
Quinolinate Adipose 13 (3/10) 0 5 (1/4) 7 (2/5) 1 (0/1) 
Glycerol-3-phosphate Adipose 11 (10/1) 8 (8/0) 1 (1/0) 1 (1/0) 1 (0/1) 
Trehalose/sucrose Adipose 12 (5/7) 7 (1/6) 1 (1/0) 3 (2/1) 1 (1/0) 
Uracil Adipose 11 (7/4) 6 (6/0) 1 (0/1) 2 (0/2) 2 (1/1) 
2-Hydroxy-2-methylbutanedioic acid Liver 20 (19/1) 1 (1/0) 6 (5/1) 11 (11/0) 2 (2/0) 
4-Pyridoxic acid Liver 9 (5/4) 2 (2/0) 4 (1/3) 2 (2/0) 1 (0/1) 
Cellobiose Liver 12 (11/1) 0 0 10 (10/0) 2 (1/1) 
Glucarate Liver 15 (6/9) 5 (0/5) 1 (0/1) 5 (4/1) 4 (2/2) 
FMN Liver 24 (9/15) 5 (3/2) 7 (1/6) 8 (2/6) 4 (3/1) 
IMP Liver 19 (14/5) 3 (0/3) 1 (0/1) 13 (13/0) 2 (1/1) 
N-Acetyl-L-alanine Liver 22 (19/3) 3 (2/1) 4 (4/0) 13 (12/1) 2 (1/1) 
N-acetyl-glutamine Liver 23 (16/7) 3 (0/3) 5 (5/0) 12 (10/2) 3 (1/2) 
Adenine Liver 10 (8/2) 0 0 7 (7/0) 3 (1/2) 
Adenosine Liver 11 (7/4) 2 (1/1) 2 (1/1) 5 (4/1) 2 (1/1) 
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Table F continued 
Metabolite Tissue Total 
Degree 
(+/-) 
Degree 
(Adipose) 
(+/-) 
Degree 
(Muscle) 
(+/-) 
Degree 
(Liver) 
(+/-) 
Degree 
(Phenotype) 
(+/-) 
Citrulline Liver 5 (2/3) 1 (0/1) 0 1 (1/0) 3 (1/2) 
Cystathionine Liver 12 (7/5) 1 (1/0) 2 (1/1) 7 (4/3) 2 (1/1) 
dAMP Liver 4 (2/2) 0 0 1 (0/1) 3 (2/1) 
Deoxyinosine Liver 21 (17/4) 2 (0/2) 4 (4/0) 12 (12/0) 3 (1/2) 
Deoxyuridine Liver 22 (19/3) 2 (1/1) 6 (5/1) 13 (12/1) 1 (1/0) 
Guanosine Liver 16 (15/1) 0 2 (2/0) 12 (12/0) 2 (1/1) 
Homocysteic acid Liver 10 (9/1) 1 (1/0) 4 (3/1) 4 (4/0) 1 (1/0) 
Inosine Liver 19 (14/5) 1 (0/1) 2 (2/0) 13 (11/2) 3 (1/2) 
Quinolinate Liver 4 (3/1) 0 0 3 (2/1) 1 (1/0) 
Ribose-phosphate Liver 22 (16/6) 2 (0/2) 3 (2/1) 14 (13/1) 3 (1/2) 
Trehalose/sucrose Liver 12 (11/1) 0 0 10 (10/0) 2 (1/1) 
1-Methyl-Histidine Muscle 18 (13/5) 2 (0/2) 4 (4/0) 9 (8/1) 3 (1/2) 
2-Hydroxy-2-methylbutanedioic acid Muscle 20 (17/3) 2 (2/0) 6 (5/1) 11 (9/2) 1 (1/0) 
2-Isopropylmalic acid Muscle 14 (2/12) 2 (0/2) 6 (0/6) 5 (2/3) 1 (0/1) 
2-dehydro-D-gluconate Muscle 13 (9/4)) 3 (1/2) 8 (6/2) 1 (1/0) 1 (1/0) 
6-phospho-D-gluconate Muscle 12 2 (0/2) 5 (4/1) 4 (3/1) 1 (1/0) 
N-Acetyl-L-alanine Muscle 11 (7/4) 3 (0/3) 5 (5/0) 1 (1/0) 2 (1/1) 
N-acetyl-glutamine Muscle 15 (8/7) 3 (0/3) 6 (5/1) 3 (2/1) 3 (1/2) 
NADPH Muscle 6 (4/2) 1 (0/1) 3 (3/0) 1 (0/1) 1 (1/0) 
a-ketoglutarate Muscle 18 (13/5) 2 (1/1) 8 (6/2) 7 (5/2) 1 (1/0) 
Asparagine Muscle 14 (11/3) 2 (1/1) 8 (7/1) 3 (2/1) 1 (1/0) 
Lysine Muscle 10 (5/5) 3 (3/0) 0 5 (1/4) 2 (1/1) 
Orotate Muscle 15 (8/7) 4 (0/4) 5 (5/0) 3 (2/1) 3 (1/2) 
Xanthosine Muscle 3 (1/2) 1 (0/1) 1 (0/1) 0 1 (1/0) 
RER Phenotype 4 (2/2) 2 (1/1) 0 2 (1/1) 0 
VO2 Phenotype 7 (1/6) 5 (0/5) 0 2 (1/1) 0 
Weight Phenotype 28 
(11/17) 
10 (9/1) 4 (0/4) 14 (2/12) 0 
Activity Phenotype 6 (6/0) 3 (3/0) 1 (1/0) 2 (2/0) 0 
Adiposity Phenotype 53 
(30/23) 
19 (4/15) 13 (10/3) 21 (16/5) 0 
Heat Output Phenotype 14 (6/8) 3 (3/0) 3 (0/3) 8 (3/5) 0 
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D12052701 - 06
OpenStandard Diet with tBHQ and Same With Modifications
Product # D12052701 D12052702 D12052703 D12052704 D12052705 D12052706
OpenStandard Diet Mediterranean Diet Japanese Hunter-Gatherer Western Ketogenic
(Modified)
Ingredient gm gm gm gm gm gm
Casein 200 44 0 0 38.5 160
Soy Protein Isolate, Supro 661 0 0 16 0 0 0
Fish Protein Isolate 0 27 27 152 8.5 0
Egg White 0 9 6 48 55 0
Beef, Cooked 0 61.9 7 126.5 76.9 0
L-Cystine 3 3 3 3 3 3
Corn Starch 641 0 0 0 30 0
Wheat Starch 0 365 0 0 195 0
Rice Starch 0 0 763.5 0 0 0
Potato Starch 0 0 0 333 30 0
Sucrose 0 61 70 60 205 0
Fructose 0 19 6 29 22 0
Cellulose, BW200 75 40.7 10 75 18.2 37.5
Inulin 25 13.5 38 25 6 12.5
Soybean Oil 70 0 10.5 0 0 0
Corn Oil 0 0 0 0 34.4 8
Menhaden Oil (200 ppm tBHQ) 0 13.2 5 24.6 1 8
Trisun Sunflower Oil 0 0 0 0 0 0
Palm Kernal Oil 0 9.9 0 14.7 0 0
Butter, Anhydrous 0 7.4 4.2 0 54.1 161
Lard 0 0 0 0 0 161
Safflower Oil 0 0 0 11.8 0 0
Flaxseed Oil 0 6.1 0 34.4 1 0
Olive Oil 0 117.7 11 0 27.5 0
t-BHQ 0.0049 0.0023 0.0039 0 0.0047 0.0033
Mineral Mix S10026 10 10 10 10 10 10
Dicalcium Phosphate 13 13 13 13 13 13
Calcium Carbonate 5.5 5.5 5.5 5.5 5.5 5.5
Potassium Citrate, 1 H2O 16.5 16.5 16.5 16.5 16.5 16.5
Vitamin Mix V10001 10 10 10 10 10 10
Biotin (1%) 0 0.014 0.014 0.1 0.1 0
Choline Bitartrate 2 2 2 2 2 2
Cholesterol 0 0 0.19 0.27 1.5 1.5
Red Wine Extract 0 0.045 0 0 0 0
Green Tea Extract 0 0 0.215 0 0 0
FD&C Red Dye #5 0 0.05 0 0.025 0 0.025
FD&C Yellow Dye #40 0.05 0 0.025 0.025 0 0
FD&C Blue Dye #1 0 0 0.025 0 0.05 0.025
Total 1071.0549 855.5113 1034.6729 994.42 864.7547 609.5533
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D12052701 - 06
OpenStandard Diet with tBHQ and Same With Modifications
D12052701 D12052702 D12052703 D12052704 D12052705 D12052706
g OpenStandard Diet Mediterranean Diet Japanese Hunter-Gatherer Western Ketogenic
Protein 177.0 115.7 120.8 271.1 140.7 142.2
Carbohydrate 570.3 406.7 689.1 362.1 455.3 3.1
Fat 72.4 172.3 44.6 123.2 139.7 339.9
Cholesterol 0.0 0.21 0.23 0.62 1.81 2.09
Fiber 93.8 50.8 50.0 93.8 22.7 46.9
g%
Protein 16.5 13.5 11.7 27.3 16.3 23.3
Carbohydrate 53.2 47.5 66.6 36.4 52.6 0.5
Fat 6.8 20.1 4.3 12.4 16.2 55.8
Cholesterol 0.0 0.024 0.023 0.063 0.210 0.342
Fiber 8.8 5.9 4.8 9.4 2.6 7.7
kcal
Protein 708 463 483 1084 563 569
Carbohydrate 2281 1627 2757 1448 1821 13
Fat 652 1551 401 1109 1257 3059
Total 3641 3641 3641 3641 3641 3641
kcal%
Protein 19 12.71 13 30 15 16
Carbohydrate 63 44.69 76 40 50 0
Fat 18 42.60 11 30 35 84
g% Contribution to Protein sources
Casein 98.3 33.1 0.0 0.0 23.8 97.9
Soy Protein Isolate, Supro 661 0.0 0.0 11.5 0.0 0.0 0.0
Fish Protein Isolate 0.0 22.2 21.2 53.3 5.7 0.0
Egg White 0.0 6.3 4.0 14.4 31.7 0.0
Beef, Cooked 0.0 35.8 3.9 31.3 36.6 0.0
Rice Starch 0.0 0.0 56.9 0.0 0.0 0.0
L-Cystine 1.7 2.6 2.5 1.1 2.1 2.1
g% Contribution to Carb sources
Corn Starch 100.0 0.0 0.0 0.0 5.9 0.0
Wheat Starch 0.0 80.1 0.0 0.0 38.4 0.0
Rice Starch 0.0 0.0 88.8 0.0 0.0 0.0
Potato Starch 0.0 0.0 0.0 74.7 5.3 0.0
Sucrose 0.0 15.1 10.3 17.0 45.6 0.0
Fructose 0.0 4.7 0.9 8.2 4.9 0.0
Cellulose, BW200 (Insoluble) (g/kg) 70.0 47.6 9.7 75.4 21.0 61.5
Inulin (Soluble) (g/kg) 23.3 15.8 36.7 25.1 6.9 20.5
Total Fiber (g/kg) (includes starch source) 87.5 59.4 48.3 94.3 26.3 76.9
Cholesterol (mg/kg) 37.3 239.8 225.3 627.8 2096.2 3422.9
Red Wine Extract (mg/kg) 0 52.6 0 0 0 0
Green Tea Extract (mg/kg) 0 0 207.8 0 0 0
tBHQ (mg/3641 kcals) 4.9 4.9 4.9 4.9 4.9 4.9
Biotin (mg/3641 kcals) 0.20 0.34 0.34 1.20 1.20 0.20
  196 
APPENDIX H 
  197 
Typical Fatty Acid Profiles of D12052701 - 06 Based on
Data from the Manufacturers of the Fats Listed
D12052701 D12052702 D12052703 D12052704 D12052705 D12052706
OSD Mediterranean Japanese Hunter-Gatherer Western Ketogenic
Ingredient (g) gm gm gm gm gm
Corn Oil 34.4 8
Menhaden Oil, ARBP-F 13.2 5 24.6 1 8
Beef, Cooked 61.9 7 126.5 76.9
Butter, Anhydrous 7.4 4.2 54.1 161
Lard 161
Palm Kernal Oil 9.9 14.7
Olive Oil 117.7 11 27.5
Safflower Oil, USP 11.8
Flaxseed Oil 6.1 34.4 1
Soybean Oil, USP 70 10.5
Total 70 216.2 37.7 212 194.9 338
C2, Acetic 0.0 0.0 0.0 0.0 0.0 0.0
C4, Butyric 0.0 0.2 0.1 0.0 1.7 5.2
C6, Caproic 0.0 0.1 0.1 0.0 1.0 3.1
C8, Caprylic 0.0 0.6 0.0 0.8 0.6 1.8
C10, Capric 0.0 0.6 0.1 0.6 1.4 4.1
C12, Lauric 0.0 4.7 0.1 6.7 1.5 4.7
C14, Myristic 0.0 3.6 0.8 4.9 6.1 18.5
C14:1, Myristoleic 0.0 0.3 0.1 0.3 1.0 2.4
C15:0 0.0 0.1 0.0 0.3 0.1 0.2
C16, Palmitic 7.3 22.1 4.6 14.5 25.9 75.3
C16:1, Palmitoleic 0.0 3.5 0.8 3.6 2.4 6.7
C16:2 0.0 0.2 0.1 0.4 0.0 0.1
C16:3 0.0 0.2 0.1 0.4 0.0 0.1
C16:4 0.0 0.2 0.1 0.4 0.0 0.1
C17:0 0.0 0.2 0.0 0.5 0.2 0.6
C17:1, n-9 0.0 0.2 0.0 0.3 0.2 0.0
C18, Stearic 2.7 6.2 1.5 6.2 10.2 36.9
C18:1, Oleic, n-9 17.0 95.5 12.6 26.2 50.5 96.1
C18:1, Vaccenic, n-7 0.0 0.7 0.1 1.5 0.9 0.0
C18:2, Linoleic, n-6 37.5 17.6 7.3 16.9 26.5 47.9
C18:3, gamma-Linolenic, n- 0.0 0.0 0.0 0.0 0.0 0.0
C18:3, alpha-Linolenic, n-3 5.5 4.4 1.0 19.4 2.0 4.6
C18:4, Stearidonic, n-3 0.0 0.4 0.2 0.8 0.0 0.2
C20, Arachidic 0.0 0.6 0.1 0.1 0.7 1.8
C20:1, n-9 0.0 0.5 0.1 0.5 0.2 1.1
C20:2, Eicosadienoic, n-6 0.0 0.0 0.0 0.1 0.0 1.3
C20:3, n-6 0.0 0.1 0.0 0.2 0.0 0.2
C20:3, n-3 0.0 0.0 0.0 0.0 0.0 0.0
C20:4, Arachidonic, n-6 0.0 0.4 0.1 0.7 0.1 0.6
C20:4, n-3 0.0 0.0 0.0 0.0 0.0 0.0
C20:5, Eicosapentaenoic, n 0.0 1.9 0.7 3.5 0.1 1.1
C21:0 0.0 0.0 0.0 0.0 0.0 0.0
C21:5, n-3 0.0 0.1 0.0 0.2 0.0 0.1
C22, Behenic 0.0 0.0 0.0 0.0 0.0 0.0
C22:1, Erucic 0.0 0.0 0.0 0.1 0.0 0.0
C22:4, Clupanodonic, n-6 0.0 0.0 0.0 0.1 0.0 0.0
C22:5, n-3 0.0 0.4 0.1 0.7 0.0 0.4
C22:5, n-6 0.0 0.0 0.0 0.0 0.0 0.0
C22:6, Docosahexaenoic, n 0.0 1.4 0.5 2.5 0.1 0.8
C24, Lignoceric 0.0 0.1 0.0 0.2 0.0 0.0
C24:1 0.0 0.0 0.0 0.1 0.0 0.0
Total 69.9 167.4 31.7 113.5 133.7 316.3
Research Diets, Inc.
7/18/12
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Typical Fatty Acid Profiles of D12052701 - 06 Based on
Data from the Manufacturers of the Fats Listed
OSD Mediterranean Japanese Hunter-Gatherer Western Ketogenic
Saturated (g) 9.9 39.0 7.6 33.9 49.1 151.3
Monounsaturated (g) 17.0 100.6 13.6 31.9 54.1 106.4
Polyunsaturated (g) 42.9 26.5 10.0 44.8 29.0 57.3
Saturated (%) 14.2 23.3 23.9 29.9 36.7 47.9
Monounsaturated (%) 24.3 60.1 43.0 28.2 40.5 33.6
Polyunsaturated (%) 61.4 15.9 31.6 39.5 21.7 18.1
Total Omega-6 (g) 37.5 18.1 7.5 17.9 26.7 50.1
Total Omega-6 (%) 53.6 10.8 23.6 15.8 20.0 15.9
Total Omega-3 (g) 5.5 8.5 2.6 27.1 2.4 7.2
Total Omega-3 (%) 7.8 5.1 8.1 23.9 1.8 2.3
n6 : n3 Ratio 6.9 2.1 2.9 0.66 11.3 6.9
Research Diets, Inc.
7/18/12
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Uncertainty Analysis Addendum For Chapter 5 
kNN Imputation 
 Values may be missing from a dataset because they are not measured in a 
sample or because they are below the limit of detection.  Imputation methods may be 
used to replace missing values. Missing values in metabolomics data are often replaced 
with some value since it is often accepted that a metabolite may be missing because it 
is below the detection limit of the mass spectrometer. Furthermore, missing values in 
metabolomics data are not well tolerated when performing multivariate analyses, such 
as PLSDA and PCA. The data analyzed in this dissertation used the kNN imputation 
method. 
The original kNN imputation was performed using data that was missing 70% or 
less of metabolite values across samples and averaged 10 neighbors (see chapter 5 for 
results). This follow-up analysis has reduced the number of missing values to 10% or 
less and reduced the number of neighbors from 10 to 4. This resulted in a reduction of 
initial metabolites in the dataset by 33.1%, 26%, and 35.1% for adipose, skeletal 
muscle, and liver tissue with 13.7%, 14%, and 14% of the metabolites for each tissue is 
attributable to knowns (Table I.1). 
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Table I.7: Number of Metabolites Present in Each Raw File Before Imputation 
??????? ?????? ??????????? ??????? ????????? ??????
???????? ???? ?????????????? ???? ????? ?????
? ???? ?????????????? ???? ????? ?????
? ??????????????????? ?????? ?????? ??????
? ? ? ? ?
??????? ???? ?????????????? ???? ????? ?????
? ???? ?????????????? ???? ????? ?????
? ??????????????????? ?????? ?????? ??????
? ? ? ? ?
?????? ???? ?????????????? ???? ????? ?????
? ???? ?????????????? ???? ????? ?????
? ??????????????????? ?????? ?????? ??????
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Comparison of ANOVA Analyses 
 ANOVA was used to assess the significance of each metabolite for sex, strain, 
and strain-by-sex interaction. The previous analysis determined that there were 85, 10, 
and 2 significant metabolites for strain, sex, and sex-by-strain interaction (Fig. 5.2), 
while the new analysis found 66, four, and one significant metabolites for each factor 
(Fig. I.1). Several metabolites were specific to one analysis for each factor (Fig. I.2). 
Since there were fewer metabolites in the second analysis due to the more stringent 
requirements, some of the metabolites in the first analysis are specific because they are 
no longer present in the second analysis (Table I.2). In adipose tissue six metabolites 
that were significant for strain were removed from the second analysis and in liver tissue 
11 metabolites were removed from the second analysis for strain. 
Comparison of Pathway Analyses 
 Functional pathway analysis was performed to map significant metabolites onto 
KEGG pathways. Several pathways were found in both analyses; however, some 
pathways were unique to each analysis (Table I.3, and Table 5.2). In the first analysis 
there were no significantly altered pathways for sex-by-strain interaction; however, in 
the second analysis sex-by-strain interaction altered pyrimidine metabolism in liver 
tissue. In addition, the number of hits for each pathway that were found in both analyses 
was altered. Purine metabolism, in liver, which was altered by strain, had 20 metabolites 
mapped onto this pathway but in the new analysis 17 metabolites mapped onto this 
pathway.
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Figure I.1: Shared and unique effects of strain on tissue metabolomes. The sets of metabolites 
that differed significantly, based on ANOVA (FDR < 0.05) by strain across tissues, (A), and by sex, 
strain, and sex-by-strain interaction in liver (B), adipose (C), and muscle (D) were visualized for 
shared and factor-specific effects using Venn diagrams. Metabolites that differed significantly for 
strain in adipose (E), muscle (F), and liver (G) were assessed for pairwise comparisons using 
Tukey’s HSD and visualized for shared and specific effects using Venn diagrams.  
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Figure I.2: Venn diagrams depicting overlap of significant metabolites from ANOVA that began 
with up to 70% of the values missing from each metabolite and ANOVA that began with up to 10% 
of the values missing from each metabolite. Comparison of each data analysis was performed for 
sex (A), strain (B), and sex-by-strain (C) for all tissues combined; sex (D), strain (E), and sex-by-
strain (F) for adipose tissue; sex (G), strain (H), sex-by-strain (I) for muscle; and sex (J), strain (K), 
and sex-by-strain (L) for liver tissue. 
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Table I.8: Comparison of Significant Metabolites from ANOVA 
??????? ???????????? ??????????? ???? ??????? ??????????????
???????? ??????????????????????????????? ?? ??????? ??
? ????? ?? ??? ??
? ????????????????????????????????????????????? ?????? ?????? ??????
? ? ? ? ?
??????? ??????????????????????????????? ?????? ?????? ??????
? ????? ??? ??? ??
? ????????????????????????????????????????????? ?????? ?????? ??????
? ? ? ? ?
?????? ??????????????????????????????? ?????? ???????? ??????
? ????? ??? ??? ???
? ????????????????????????????????????????????? ?????? ?????? ??????
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Table I.9: KEGG Pathway Enrichment of Metabolites Affected by Sex, Strain, and Sex-by-Strain 
??????? ??????? ???????? ????? ???????? ???????
???????????? ???? ??????? ?????????? ?? ??????? ??????
? ? ? ? ? ?
? ??????? ??????? ?????????? ??? ??????? ??????
? ? ???? ?????? ?????????? ??? ??????? ??????
? ? ????????????????????????????????? ?????????? ?? ??????? ??????
? ? ??????????????????????? ?????????? ?? ??????? ??????
? ? ?????????????????????????? ?? ?????? ??????
? ? ?????????????????????????????????? ?? ?????? ??????
? ? ???????????????????????????? ??? ?????? ??????
? ? ???????????????????????????? ?????????? ?? ?????? ??????
? ? ? ? ? ?
???????? ???? ????????????? ?????????? ?????????? ?? ?????? ??????
? ? ? ? ? ?
? ??????? ??????? ?????????? ?? ??????? ??????
? ? ???? ?????? ?????????? ?? ?????? ??????
? ? ????????????????????? ?????????? ?? ?????? ??????
? ? ???????????????????????????? ?? ?????? ??????
? ? ? ? ? ?
??????? ???? ???????????????????????????? ?? ?????? ??????
? ? ? ? ? ?
? ??????? ???????????????????????????? ?? ?????? ??????
? ? ???????????????????? ?? ?????? ??????
? ? ? ? ? ?
?????? ???? ??????? ?????????? ?? ??????? ??????
? ? ??????????? ?????????? ?? ?????? ??????
? ? ? ? ? ?
? ??????? ??????? ?????????? ??? ??????? ??????
? ? ???? ?????? ?????????? ??? ??????? ??????
? ? ?????????????????????????????????? ?? ?????? ??????
? ? ? ? ? ?
? ?????????????? ???? ?????? ?????????? ?? ?????? ??????
Pathways in bold represent pathways also found in chapter 5. 
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Comparison of Correlation Analyses 
 Assessing correlations between metabolite profiles in each tissue and systems 
level energy balance traits revealed that 32, 11, and 51 metabolites were associated 
with one or more phenotypes for adipose, muscle, and liver tissue in the previous 
analysis (Fig. 5.5). There were 24, 11, and 55 metabolites in adipose, muscle, and liver 
tissue associated with one or more phenotypes in the new analysis (Fig. I.3). Many of 
the metabolites that were associated with one or more phenotypes were in both 
analyses; however there were a few metabolites that were specific to each analysis. In 
adipose tissue, nine metabolites were specific to the previous analysis, while one 
metabolite was specific to the new analysis. In muscle, two metabolites were specific to 
the previous analysis and two were specific to the new analysis. In liver, two metabolites 
were specific to the previous analysis and three metabolites were specific to the new 
analysis.  
When comparing correlations that were assessed between and across tissues 
the new analysis had a greater number of metabolites correlated with phenotypes and 
one or more tissues. The previous analysis showed that eight, 15, and 24 metabolites 
were associated with one or more traits and one or more metabolites within or across 
tissues in adipose muscle, and liver tissue. The new analysis showed that 11, 19, and 
30 metabolites were now significantly correlated for adipose, muscle, and liver tissue 
(Fig. I.4). 
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Figure I.3: Correlations between metabolites and system phenotypes.  Pearson correlation was 
used to associate metabolites in adipose (A), muscle (B), and liver (C) with weight, adiposity, and 
metabolic phenotypes. Significant correlations (FDR < 0.05) are represented by an asterisk (*).  
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Figure I.4: Cross-tissue metabolite and phenotype network.  Pearson correlation was used to 
associate metabolites within and across each tissue with weight, adiposity, and metabolic 
phenotypes. Only significant correlations (FDR < 0.05) are shown. To assess relationships within 
and across tissues and phenotypes, metabolites are clustered by their respective tissue or 
phenotype. The size of each node represents the number of edges connected to the node. A red 
line represents positively correlated metabolites, while a blue line represents negatively 
correlated metabolites.  
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Summary 
 Comparing the results from two analyses showed that the level of stringency 
applied to the KNN imputation might result in alteration of the results. The first analysis 
used 10 nearest neighbors and allowed for up to 70% of the samples to be missing from 
each metabolite. The second analysis used 4 nearest neighbors and allowed for up to 
10% of the samples to be missing from each metabolite. Reducing the number of 
neighbors increased the local effects and reduced the chance of averaging values 
across treatments. This may have produced values that were more specific to the 
treatment and less general to the entire population. Caution should be taken when 
determining the number of missing values and the number of neighbors to perform KNN 
imputation as it can impact the results of the data. 
 
  211 
VITA 
 Ann E. Wells was born in Melrose, MA. She received her Bachelor’s degree of 
Science in Microbiology at the University of Tennessee-Knoxville. She began her Ph.D. 
at the University of Tennessee-Knoxville in the UT-ORNL Graduate School of Genome 
Science and Technology in August 2012. She expected to receive her Ph.D. in 
December 2017. 
 
 
